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Abstract 
Transcription, the first step of gene expression, is accomplished in all domain of life by 
the multisubunit RNA polymerase (RNAP). Accordingly, the RNAP is an ancient enzyme 
that is highly conserved in all cellular organisms. However, in-depth bioinformatics has 
led to the identification of proteins distantly related to the multisubunit RNAP, such as 
YonO and ORF6 RNAP. Whilst being putative single subunit RNAPs, YonO and ORF6 
RNAP are completely unrelated to T7 RNAP. YonO, encoded by the Bacillus subtilis SPβ 
prophage, has incredibly little similarity to RNAP. Conversely, ORF6 RNAP belonging to 
the Kluyveromyces lactis killer system contains half of the conserved RNAP active 
centre. YonO and ORF6 RNAP are potentially novel RNAPs and their characterisation 
will give new insights into mechanisms of transcription as well as the biology of the 
organisms which they belong to.      
Despite lacking most of the conserved RNAP active centre, we have shown YonO is a 
very efficient DNA dependant RNAP. Striking, unlike all of its multisubunit relatives, 
YonO is able to initiate transcription on double stranded DNA without accessory 
factors (such as σ factors in bacteria). Furthermore, our work suggests YonO is 
expressed during induction of SPβ and functions to transcribe the SPβ late genes. This 
potentially makes YonO the first bacteriophage single subunit RNAP that resembles the 
multisubunit RNAP. On the other hand, ORF6 RNAP was very poor at polymerisation, 
with or without its putative accessory subunit. This suggests additional, currently 
unknown proteins are required for RNAP activity and potentially a new molecular 
mechanism of RNA polymerisation.  
YonO homologues exist in a wide range of bacteria including fermicutes and 
cyanobacteria. YonO represents a new class of RNAP and our discoveries potentially 
open up a new area of research as well as being potentially useful for biotechnology 
and synthetic biology. In contrast, transcription by ORF6 RNAP is more complex than 
previously thought, with alternative lines of investigation required to identify 
additional factors that contribute to ORF6 RNAP activity.    
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Chapter 1: Transcription and the Multisubunit RNA Polymerase 
 
The first step of gene expression is the converting of the genetic information encoded 
in a DNA template into RNA. This template dependant synthesis of RNA is referred to 
as transcription. In all cellular organisms, the multisubunit DNA dependant RNA 
polymerase (RNAP) accomplishes transcription. RNAP synthesises RNA according to 
the sequence of template DNA using ribonucleoside triphosphates (NTPs) as 
substrates. The structure of RNAP and its mechanism of catalysis are highly conserved 
across all three domains of life. Such conservation implies an ancient, singular origin 
for this crucial enzyme.  
With the advancement of genome sequencing and bioinformatics, hypothetical 
proteins with distant and unusual homology to RNAP have been identified. 
Interestingly, these proteins appear to be related to multisubunit RNAPs, despite being 
single polypeptide chains. No homology with known single subunit RNAPs has been 
detected. These hypothetical proteins may be representatives of a novel class of RNAP 
with previously undescribed structures and mechanisms of catalysis.  
This introduction aims to briefly describe the structure of multisubunit RNAP, the 
stages of transcription and the mechanism of catalysis. Subsequently, YonO and ORF6 
RNAP, two examples of single proteins distantly related to RNAP, will be introduced 
and discussed.    
1.1: Structure of RNAP 
Bacteria utilise a single RNAP comprised of 4 subunits: β’, β, α2 and ω (Figure 1-2a). 
This is in contrast to eukaryotes in which three RNAPs (RNAP I, RNAP II and RNAP III) 
accomplish transcription. Eukaryotic RNAPs are comprised of an increased number of 
subunits. RNAP I, II and III are formed by 14, 12 and 17 subunits, respectively. Over the 
past decade, it has become apparent that plants utilise two additional RNAP: RNAP VI 
and V (Reviewed in Haag and Pikaard (2011)). Both of these RNAP, whilst residing in 
the nucleus, do not function in canonical gene expression. Rather, they function in 
DNA methylation and gene silencing (Haag et al., 2012). Mass spectroscopy showed 
that whilst they are distinct enzymes, RNAP VI and V are clearly evolved from RNAP II 
(Ream et al., 2009). Like bacteria, archaea utilise a single RNAP. However this RNAP is 
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comprised of 12 subunits, resembling RNAP II. Despite such differences, a high degree 
of conservation exists in RNAP across all domains of life. The bacterial RNAP represents 
a minimal set of subunits that is conserved in eukaryotic and archaeal RNAPs (Figure 1-
1). Eukaryotic and archaeal homologues for each of the five bacterial subunits have 
been identified. In addition to structural conservation, all RNAPs synthesise RNA by the 
same mechanism of catalysis. Therefore, the bacterial RNAP can be exploited as a 
model for the investigation into the key principles and processes of transcription. 
Unless stated, the remainder of this introduction will describe bacterial RNAP.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1: Conservation of the multisubunit RNAP. Taken from Werner (2008). The 
crystal structures of bacterial, archaeal and eukaryotic RNAP (RNAP II, S. cerevisiae) are 
shown to demonstrate conservation of the structure and core subunits. The bacterial 
RNAP represents a minimal set of subunits which is conserved in all domains of life, 
despite increased subunits in the archaeal and eukaryotic RNAPs. The legend shows 
the colouring scheme of the subunits.    
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1.1.1: Bacterial RNAP 
Bacterial RNAP has a molecular weight of approximately 400 KDa (Zhang et al., 1999). 
The two largest subunits, β’ (170 KDa) and β (124 KDa) form the bulk of the core 
enzyme. β’ and β subunits form a crab claw structure, with each subunit representing a 
pincer of the claw. Between the two subunits is the main channel in which 
downstream duplex DNA enters the enzyme (Figure 1-2b). On the back wall of the 
main channel, towards the centre of the enzyme resides the active centre which is 
formed by amino acid residues of both β’ and β subunits. The active centre is where 
catalysis occurs and is discussed in section 1.1.4.  
The two α subunits (35 KDa) interact by their N-terminal domains to form a 
homodimer (α2) that is found towards the rear of the enzyme, behind the β’ and β crab 
claw. The function of the α2 dimer is to act as a platform for the assembly of β’ and β 
(Zhang et al., 1999). The ω subunit also functions in the assembly of RNAP by bringing 
together the C-terminal tail and N-terminal domain of β’. This has been suggested to 
increase the stability of the β’ subunit and encourage its assembly into RNAP 
(Minakhin et al., 2001).  
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Figure 1-2: Structure and layout of bacterial RNA polymerase. a) Subunit composition of bacterial RNAP. Thermus thermophilus core RNAP 
structure (PDB accession number 2PPB. Modelled with pymol). The catalytic Mg2+ ions are coloured magenta. Structural Zn2+ ions are coloured 
yellow. Individual subunits are labelled and coloured. Image on the left is the profile view of RNAP and is rotated by 90⁰ to give the front view. b) 
Entry of DNA into RNAP. Colouring and structure is as before. RNA, Template and non-template DNA strands are coloured red, blue and green, 
respectively. RNAP is transparent to emphasise the path of DNA. Image on the left is a top down view to reveal 90⁰ kink in template DNA. c), d) and 
e) are 
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modified from Burukhov and Nudler, 2008. c) Structure of Thermus aquaticus core 
RNAP, taken from Zhang et a., 1999. Front view of core RNAP. Coloured based on 
functional motifs described in the text and shown in Figure 1d. d) Schematic 
representation of the Thermus aquaticus core RNAP structure. Schematic based on 
the structure presented in Figure 1c. The channels and functional motifs contacting 
nucleic acid chains, as discussed in the text, are indicated. The coloured motifs match 
those of Figure 1c. e) The organisation of nucleic acid chains within RNAP. Using the 
same schematic as Figure 1-2d, the pathway of DNA and RNA through the main 
channel and RNA exit channel is shown, along with approximations of nucleic acid 
lengths (bp – basepairs, nt – nucleotides).   
 
1.1.2: Nucleic acids within RNAP 
Double stranded DNA enters RNAP through the main channel, which accommodates 
12 base pairs (bp) of the downstream DNA (Figure 1-2b). As the downstream duplex 
DNA enters RNAP, it is unwound into the template and non-template strands 
immediately before the active centre (Gnatt et al., 2001, Vassylyev et al., 2007a). The 
template DNA strand passes through the active centre, where it directs the synthesis 
of complementary RNA (Figure 1-2b) (Gnatt et al., 2001). The two DNA strands reform 
a duplex 11 nucleotides upstream from the active centre. The region of melted DNA is 
referred to as the transcription bubble. A transcription bubble of 13 nucleotides is 
maintained throughout transcription (Figure 1e). During transcription, RNAP can 
accommodate a 8-9 bp RNA:DNA hybrid (Bochkareva et al., 2012, Sidorenkov et al., 
1998, Vassylyev et al., 2007a, Nudler et al., 1997). Upon reaching a length greater than 
9 nucleotides, the 5’ nascent RNA is threaded through the RNA exit channel (Figure 
1.2e).  
In addition to the main channel and the RNA exit channel, a third channel exists in 
RNAP. The secondary channel is a 12 Å wide channel which runs from the surface of 
the enzyme to the active centre (Gnatt et al., 2001). The opening of the funnel in the 
active centre is referred to as the pore. It is thought that NTPs diffuse through the 
secondary channel to reach the active centre where cognate NTPs are selected for and 
incorporated into the 3’ end of elongating RNA (Batada et al., 2004, Westover et al., 
2004). However, contradictory data exists which suggests substrate NTPs arrive into 
the active centre through the main channel (Gong et al., 2005).   
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Many contacts are made between RNAP and the nucleic acids running through it 
(Figure 1-2d). Referring back to the crab claw analogy, the majority of the β’ ‘pincer’ 
forms the clamp domain (Cramer et al., 2001). The clamp is a large mobile domain that 
swings on a hinge (called the switch region) during transcription initiation to narrow 
the width of the main channel by 8 Å, thereby increasing RNAPs hold on downstream 
DNA (Chakraborty et al., 2012). The clamp’s grip on the downstream DNA accounts for 
the high stability and processivity of RNAP during elongation. Within the clamp, 
smaller functional motifs are present. The rudder increases the stability of the 
elongating RNAP whilst the lid and zipper are loops which function in maintenance of 
hybrid length and RNA displacement from the template DNA (Gnatt et al., 2001, 
Kuznedelov et al., 2002, Vassylyev et al., 2007a, Zenkin et al., 2006a). Furthermore, the 
zipper may also interact with upstream DNA (Yuzenkova et al., 2011) .  
In addition to β’, the β subunit also makes contacts with nucleic acid chains. 
Approximately half of the RNA exit channel wall is formed by the β flap domain, with 
the β’ zipper, lid and Zn2+ finger also contributing to the formation of the RNA exit 
channel. The β lobe domains are responsible for contacts with the non-template 
strand DNA (Korzheva et al., 2000). Typically, upstream non-template DNA is not 
included in nucleic acid scaffolds used for the crystallisation of RNAP. However, even 
when present, it is not visible in electron density suggesting a flexible, mobile 
conformation (Andrecka et al., 2009, Kettenberger et al., 2004). Cross linking and 
single molecule studies revealed that the non-template DNA passes through the 
polymerase and makes contact with β lobes 1 and 2 on the roof of the main channel 
(Korzheva et al., 2000, Andrecka et al., 2009). 
1.1.3: Organisation of the Active centre 
At the heart of the RNAP active centre are two Mg2+ ions that are essential for catalysis 
(Sosunov et al., 2003). The first Mg2+ ion, Mg I, is permanently bound in the active 
centre. (Sosunov et al., 2003, Sosunov et al., 2005, Zaychikov et al., 1996). The 
aspartate triad motif, NADFDGD, is responsible for the strong chelation of Mg I. The 
aspartate triad motif is absolutely conserved in all RNAP and substitution of the 
aspartate residues results in abolishment of catalytic activity (Sosunov et al., 2005, 
Zaychikov et al., 1996). The second Mg2+ ion, Mg II is brought to the active centre 
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bound to each incoming substrate during elongation and is thus weakly bound in the 
active centre (Sosunov et al., 2003).    
Two mobile domains contribute to the formation of the active centre (Figure 1-3). 
Spanning across the active centre, from the β’ subunit to β, is the β’ bridge helix (Zhang 
et al., 1999). In close proximity to the bridge helix is the β’ trigger loop. Both the 
trigger loop and the bridge helix play key roles during catalysis by RNAP (Bar-Nahum et 
al., 2005, Wang et al., 2006, Yuzenkova et al., 2010, Zhang et al., 2010).  
 
  
Figure 1-3: The active centre of RNAP. Made using the crystal structure of Thermus 
thermophilus RNAP elongation complex (PDB accession code: 2O5J. From Vassylyev et 
al., 2007). a) Organisation of catalytic motifs of the active centre. The prominent 
domains that function during catalysis are shown. The mobile domains, trigger loop 
(blue) and bridge helix (orange) are formed by residues of the β’ domain. The trigger 
loop exists in two states, unfolded and folded. Here, the trigger loop is captured in a 
folded state as it interacts with the phosphate moieties of the incoming NTP (grey). 
Mg2+ II (purple) is chelated by the NTP whereas the permanent Mg2+ I is bound by the 
aspartate triad (green). The NTP is base paired with the template DNA (blue) and 
positioned next to the 3’ NTP of the growing RNA chain (red). b) Localisation of the 
active centre within RNAP. The location of the bridge helix, trigger loop and aspartate 
triad in the RNAP structure is shown. The bridge helix spans across the active centre 
from the β’ subunit (transparent yellow) to β (transparent pink). The aspartate triad is 
present at the centre of the enzyme, in close proximity to the catalytic residues of the 
trigger loop.  
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1.1.4: Mechanism of Catalysis 
The primary function of RNAP is to synthesise RNA in a template dependant manner. It 
does so through catalysing phosphodiester bond formation between the 3’ OH of the 
growing RNA and the α phosphate of the substrate NTP. A pyrophosphate molecule is 
released as a byproduct of phosphodiester bond formation. RNAP accomplishes this 
reaction using Mg2+ ions in a general two ion mechanism utilised by all nucleic acid 
polymerases (Sosunov et al., 2003, Steitz, 1998).  
In the general two ion mechanism, Mg I and II orient the NTP substrate to the optimal 
position to trigger a nucleophilic attack on the α phosphate of the substrate NTP by the 
3’ OH of the RNA. Specifically, Mg I activates the 3’ OH group of RNA whilst 
coordinating the substrate NTP α phosphate. Mg II orients all three NTP substrate 
phosphates into the optimal spatial position for the nucleophilic attack. The catalytic 
mechanism and amino acid residues involved are shown in Figure 1-4a. Together, Mg I 
and II stabilise the pentacovalent transition state, thus contributing to the catalysis of 
phosphodiester bond formation (Sosunov et al., 2003, Steitz, 1998, Steitz and Steitz, 
1993). 
The trigger loop plays a crucial role in catalysis. Its deletion or impediment drastically 
diminishes any catalytic activity of RNAP (Temiakov et al., 2005, Yuzenkova et al., 
2010) Structural studies show the trigger loop existing in an open and closed 
conformation (Figure 1-4b) (Vassylyev et al., 2007b, Wang et al., 2006). During 
catalysis, the trigger loop adopts a folded conformation upon binding of the correct 
NTP substrate. This is stabilised by interactions between the trigger loop M1238 
residue and the base of the incoming NTP (Yuzenkova et al., 2010). Due to incorrect 
hydrogen bonding with the i+1 template base, non-cognate substrates are not 
correctly positioned within the active centre. It has been proposed this prevents full 
folding of the trigger loop due to a steric clash between the M1238 of the trigger loop 
and the base of the non-cognate substrate. Since a closed off active centre is required 
for efficient catalysis, the trigger loop contributes to the fidelity of transcription via an 
induced fit mechanism (Yuzenkova and Zenkin, 2010).  
Folding of the trigger loop positions its catalytic residues into the active centre, 
bringing them in close proximity with the Mg I, Mg II and the substrate NTP. The H1242 
and R1239 residues (T. aquaticus numbering) are central to the trigger loops 
14 
  
participation in catalysis. H1242 and R1239 contribute to catalysis by coordinating the 
triphosphate moieties of the substrate NTP to a position optimal for transition state 
stabilisation (Yuzenkova et al., 2010).  
In addition to phosphodiester bond formation, RNAP is able to catalyse 
pyrophosphorolysis and phosphodiester bond hydrolysis through a general metal ion 
mechanism. Pyrophosphorolysis is the direct reverse reaction of phosphodiester bond 
formation and results in the removal of the 3’ NMP of the RNA chain. In this reaction, 
Mg II is bound by the pyrophosphate, which carries out the nucleophilic attack on the 
phosphodiester bond between the final and penultimate NMP of the RNA chain. The 
role of Mg II is reversed for pyrophosphorolysis and hydrolysis, as this ion rather than 
Mg I activates the attacking nucleophile (Sosunov et al., 2003).  
As with phosphodiester bond synthesis, the trigger loop also plays a crucial role in 
phosphodiester bond hydrolysis. During RNAP hydrolysis, the 3’ NMP of the RNA chain 
contributes to catalysing the hydrolysis of the penultimate phosphodiester bond by 
reorienting in the active centre to chelate Mg II (discussed further in section 1.4.3) 
(Zenkin et al., 2006b). The trigger loop functions in hydrolysis by positioning the 3’ 
NMP into the active centre. As with polymerisation, H1242 of the trigger loop is central 
to hydrolysis, with the residue being responsible for the repositioning of the 3’ NMP 
(Yuzenkova and Zenkin, 2010).      
 
Figure 1-4: Mechanism of RNAP catalysis. a) Catalysis of phosphodiester bond 
formation. Adapted from Nudler, 2009. The active centre is shown in schematic 
representation. T. thermophilus residue numbering is used, with β’ subunit residues in 
blue and β in orange. The aspartate triad residues (highlighted by a red box) 
permanently bind Mg2+I (shown as Mg2+ A in the Figure) in the active centre. Mg2+ II 
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(Shown as Mg2+ B) is delivered to the active centre by substrate NTP (red). Mg2+ ions 
and the trigger loop (residues in blue boxes) coordinate the phosphates of the NTP. 
Mg2+ I activation of 3’ OH group on the RNA coupled to optimal orientation of the NTP 
catalyses a nucleophilic attack (curved arrows), resulting in the synthesis of a 
phosphodiester bond and release of PPi. b) Folding of the trigger loop to contact NTP 
substrate Taken from Yuzenkova et al., 2010. Shown is the active centre of Thermus 
thermophilus elongation complex (PDB 2PPB and 2O5J). When the correct NTP is 
present, the trigger loop undergoes conformation change, from an unfolded (purple) 
to folded (green) state. In doing so, residues such as R1239 and H1242 contact the 
phosphates of the NTP (orange) to contribute to the substrate orientation.  
1.1.5: Double ψ β Barrel Domains   
Analysis of the structure of the β’ subunit revealed the aspartate triad is present on a 
double Ψ β barrel fold (DPBB). The fold is characterised by the topology of the β 
sheets, which involves 6 β sheets and resembles two inverted Ψ symbols. A schematic 
of this fold is shown in Figure 1-5a (Castillo et al., 1999). Each DPBB has two additional 
variable regions situated between strands 2 and 3 and strands 5 and 6. Two psi-loops 
exist in the fold, between β strands 1 and 2 and strand 5 and 4. In the β’ subunit DPBB, 
the catalytic aspartate triad is present on the second variable region which protrudes 
into the active centre.  
A second DPBB motif was identified in the β subunit of RNAP. There is no sequence 
conservation between the β’ and β DPBB folds, with the β DPBB only being identified 
through visual inspection of structure (Iyer et al., 2003). The β’ and β DPBB folds are 
directly adjacent to each other, with a cleft running between the two folds. The 
aspartate triad is projected into this cleft (Figure 1-5b).  Just as β’ DPBB provides 
functional residues, so does the β DPBB. Two lysine residues protrude into the cleft 
and make contacts with the incoming NTP substrate (Iyer et al., 2003). The aspartate 
triad and the Mg2+ ion it chelates are regarded as the active centre, thus the two DPBB 
folds contribute to the formation of RNAP active centre.  
Along with the aspartate triad, two DPBB folds are conserved across all multisubunit 
RNAPs. This conservation highlights the substantial role the two folds play in the 
structural formation of the active centre. The presence of an aspartate triad and two 
DPBB folds can serve as a hallmark of RNA polymerase activity, aiding in the 
identification of distantly related RNAPs.  
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Figure 1-5: The two double Ψ β barrel (DPBB) folds of RNAP. a) Topology of a DPBB 
fold. Modified from Castillo et al., 1999. The topology of a standard DPBB fold is 
shown. The amino acid chain and β sheets are green, whilst the Ψ loops are labelled 
and coloured red. The β sheets are numbered according to the order in the amino acid 
chain. The Mg2+ I chelating aspartate triad is shown in red above the variable loop 2, 
where it occurs in the β’ DPBB. b) Structure of the β’ and β DPBB folds. β’ DPBB 
(green) and β DPBB (yellow) are shown, with the essential aspartate triad residues and 
conserved lysines in pink and blue, respectively. In the structure, the triad is chelating 
Mg2+ I, represented by a pink sphere. The active centre is present in the cleft running 
between the two DPBB folds. The Figure was made using the crystal structure of 
Thermus thermophilus RNAP elongation complex (PDB accession code: 2PPB. From 
Vassylyev et al., 2007). c) and d) β’ and β DPBB folds in the context of the RNAP. DPBB 
folds are in ribbon representation and coloured as before. The DPBB are present at the 
back wall of the main channel formed by β’ and β subunits. In d) the placement of the 
aspartate triad, shown chelating Mg2+ I, into the active centre by the protusion of β’ 
variable loop 2 can be seen.         
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1.2: Single subunit RNA polymerases 
Despite multisubunit RNAP accomplishing canonical transcription in all cellular 
organisms, single subunit DNA dependant RNA polymerases have been identified. The 
most studied example is T7 RNAP of the T7 coliphage. T7 RNAP specifically transcribes 
T7 genes during the late phase of E. coli infection. Comparisons of T7 RNAP with 
multisubunit RNAPs have revealed the two classes of enzymes are extremely unalike, 
with no sequence and structural similarities. The structure and amino acid alignments 
of T7 RNAP and other related single subunit RNAPs show they resemble Pol I class DNA 
polymerases and HIV reverse transcriptase (Sousa et al., 1993). Thus single subunit 
RNAPs are members of a discrete clade of related nucleic acid polymerases distinct to 
the multisubunit RNAP (Delarue et al., 1990, Sousa et al., 1993, Salgado et al., 2006).  
The structure of T7 RNAP and related protein resembles a right hand, a striking 
contrast to the  crab claw like structure of the multisubunit RNAP (Sousa et al., 1993). 
The comparison to a right hand extends to the nomenclature of the T7 RNAP domains, 
which include the finger, palm and thumb domains. Like multisubunit RNAPs, right 
handed RNAPs perform catalysis using a general two ion mechanism (Steitz, 1998, 
Steitz and Steitz, 1993). However, the mechanics and structural domains participating 
in catalysis are very different to multisubunit RNAPs. No aspartate triad is present in T7 
RNAP. Instead, two aspartates (D537 and D812), 250 amino acid sequences apart on 
the polypeptide chain, are responsible for chelating Mg2+ ions. The presence of the 
aspartate triad motif is therefore solely characteristic of multisubunit RNAP and 
further highlights the differences between the two classes of RNAP.  
1.3: The Stages of Transcription 
Each round of transcription can be divided into three discrete phases: initiation, 
elongation and termination. Below, each phase will briefly be discussed.  
1.4: Initiation of Transcription    
For transcription to begin, RNAP is required to find and bind specific promoter double 
stranded DNA sequences. Alone, RNAP cannot accomplish this task. All RNAPs require 
additional proteins, transcription factors, for recruitment to specific promoters and 
melting of the duplex DNA.  
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In bacteria, a σ factor binds the core RNAP to form the holoenzyme. The σ factors 
function as transcription factors by recruiting RNAP to promoters through recognising 
specific DNA sequences. Once RNAP is bound to double stranded DNA, σ factors are 
then responsible for the melting of the DNA duplex. Multiple σ factors exist in most 
bacterial species, with each σ factor recruiting RNAP to a different class of genes. In E. 
coli, σ70 is required to initiate transcription of housekeeping genes. Homologues of σ70 
carry out the same function across other species of bacteria. In the Bacillus and 
Thermus genera, the housekeeping σ factor is σA. The details of σ70 aided transcription 
initiation are described below and shown in figure 1-6.  
 
Figure 1-6: Bacterial transcription initiation facilitated by σ70. Adapted from Nudler 
and Borukhov, 2008. The domains of RNAP are coloured as in figure 1-2, whilst σ70 is 
shown in pink. At the beginning of the transcription cycle, core RNAP binds to σ70 to 
become the holoenzyme. As shown, the domains of σ70 thread through the active 
centre of RNAP, with σ2 and σ4 domains being on the surface of the holoenzyme. This 
allows the σ2 and σ4 domains to contact the -35 and -10 elements (encircled in red), 
respectively. The holoenzyme bound to the double stranded DNA is referred to as the 
closed promoter complex. However, upon σ2 facilitating the melting of duplex DNA 
downstream of the -10 element, the complex becomes known as an open promoter 
complex. At this stage, RNAP undergoes abortive initiation. This is a cyclic process 
where short transcripts are synthesised and released, until eventually a nascent 
transcript enters the RNA exit channel. As σ70 occupies the RNA exit channel, this 
extension of RNA results in the eventual release of σ70 which allows RNAP to pass 
through promoter clearance and enter productive elongation.       
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σ70 is composed of 4 conserved domains: σ1, σ2, σ3 and σ4, with each domain being 
connected by flexible linkers (Campbell et al., 2002). Upon binding to RNAP, σ domains 
2 and 4 are solvent exposed, allowing them to recognise and bind their cognate 
promoter DNA sequences (Murakami et al., 2002b). σ70 promoters are centred around 
two DNA sequences, the -35 element and -10 element. The -35 element is 35 bp 
upstream from the transcription start site (+1) and has a consensus sequence of 
TTGACA that interacts with the σ4 domain. The -10 element is 10 bp upstream of the 
start site and has a consensus sequence of TATAAT that is bound by the σ2 domain 
(Murakami et al., 2002a). The holoenzyme bound to double stranded DNA is referred 
to as the closed complex.  Subsequent to closed complex formation, the σ2 domain 
triggers the melting of the DNA duplex 11 basepairs (-11 site) upstream from the 
transcription start site (+1 site) (Murakami et al., 2002a, Juang and Helmann, 1994, 
Panaghie et al., 2000).  This DNA melting extends downstream and results in the 
placement of the +1 transcription start site on the template strand into the active 
centre, ready for RNAP to begin transcription. A second outcome of DNA melting is the 
formation of the transcription bubble which stretches from the -11 position to +2. 
Holoenzyme complexed with melted DNA is referred to as the open complex due to 
the open conformation of the DNA strands. Most open complexes are very stable and 
are capable of withstanding high ionic strength.   
RNAP is not able to enter the processive elongation phase immediately after open 
complex formation. With σ70 still bound, RNAP undergoes a cycle of synthesising and 
releasing small RNA chains 2 - 8 nt in length, a process referred to as abortive 
initiation. In addition to binding and melting promoter DNA, σ70 functions during 
abortive initiation. σ3 and σ4 domains are linked by the flexible σ3.2 domain which 
features a loop that protrudes towards the active centre (Murakami et al., 2002b, 
Vassylyev et al., 2002). Correlating with its insertion into the active centre, σ3.2 has 
been shown to be required for binding the first nucleotides and the formation of the 
phosphodiester bond between them (Kulbachinskiy and Mustaev, 2006, Pupov et al., 
2014).   
Domain σ3.2 also facilitates promoter clearance, the event in which RNAP breaks 
contact with the promoter element to enter processive elongation. After numerous 
cycles of abortive initiation, RNAP eventually synthesises RNA which extends into the 
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RNA exit channel. The σ3.2 domain is partially blocking the RNA exit channel and so 
competes with the growing RNA chain (Murakami et al., 2002b). It is thought that upon 
clashing with the RNA chain, the removal of σ3.2 from the RNA exit channel triggers a 
series of steps which ultimately results in the breaking of contacts between σ70 and the 
-35 element, allowing RNAP to transcribe away from the promoter (promoter 
clearance) (Kulbachinskiy and Mustaev, 2006, Pupov et al., 2014). During promoter 
clearance, σ70 is displaced from RNAP. However, experimental evidence has revealed 
the expulsion of σ70 is not obligatory for RNAP to convert into a processive elongation 
complex (Bar-Nahum and Nudler, 2001). Rather, the conserved domains of RNAP, 
including β’ clamp, contribute to processivity by tightening interactions on the nucleic 
acid upon transitioning into the elongation phase (Vassylyev et al., 2007a).    
Eukaryotic transcription initiation is a complex processes, involving a multitude of 
transcription factors (Reviewed in Vannini and Cramer, 2012). Initiation of RNAP II 
transcription requires the assembly of the pre-initiation complex (PIC). Briefly, the PIC 
is a complex formed by numerous transcription factors: TBP, TFIIA, TFIIB, TFIID, TFIIE, 
TFIIF and TFIIH. The PIC functions in recruitment of RNAP to promoter DNA, DNA 
unwinding, open complex stabilisation, transcription start site selection, and 
stimulation of early polymerisation. RNAP I and III require fewer external proteins for 
initiation; the additional core subunits of RNAP I and RNAP III have homology to the 
transcription factors utilised by RNAP II. Archaeal transcription is reminiscent of 
eukaryotic RNAP II transcription. However, the PIC is reduced to three transcription 
factors: TBP, TFB (TFIIB homologue) and TFE (TFIIE homologue) (Werner and Weinzierl, 
2005). TBP recognises the TATA box promoter element whilst RNAP is recruited to TBP 
and promoter DNA by TFB. TFE stimulates the formation of the open promoter 
complex. TFB resembles σ70 in that it has a B finger domain which protrudes into the 
active centre of the RNAP and stimulates the initial catalytic activity of RNAP (Werner 
and Weinzierl, 2005).   
Broadly speaking, the principles of transcription initiation are shared across all three 
domains of life despite increased complexity in eukaryotic organisms. All multisubunit 
RNAPs are dependent on transcription factors for recognition and binding of promoter 
DNA, followed by melting of the DNA to form the open complex. This is demonstrated 
by the resemblance shared between the σ3.2 of bacterial σ70 and the B finger of TFIIB 
21 
  
and TFB in eukaryotes and archaea, respectively. All three proteins feature a domain 
which protrudes towards the active centre and stimulates the initial catalytic activity of 
RNAP. Furthermore, all three domains are displaced from the RNA exit channel by the 
growing RNA chain which leads to processive transcription (Kulbachinskiy and 
Mustaev, 2006, Sainsbury et al., 2013, Werner and Weinzierl, 2005).  
The disparity between RNAP and single subunit RNAPs continues to transcription 
initiation. T7 RNAP is able to initiate transcription independent of additional factors. 
The 300 amino acid N Terminal domain (promoter binding domain) and specificity loop 
of T7 RNAP are able to recognise the 17 base pair promoter sequence. Transcription 
initiation by T7 RNAP is accompanied by gross conformational rearrangements 
(Durniak et al., 2008, Yin and Steitz, 2002). During progression to elongation, the N 
terminal domain contacting the promoter DNA undergoes a large structural change to 
break DNA contacts, allowing promoter clearance. The conformational change results 
in the opening of the enzyme to accommodate an 8bp RNA:DNA hybrid (Yin and Steitz, 
2002). Prior to this structural rearrangement, T7 RNAP can only accommodate a hybrid 
of 3 bp. This reflects the scale of the change in conformation. An additional outcome of 
the rearrangement is the formation of the RNA exit channel. Together, the increased 
hybrid length and RNA exit channel allow for an increase in the processivity of the 
enzyme.  
1.5: Transcription Elongation 
Unlike transcription initiation, the elongation phase of transcription is conserved 
across all multisubunit RNAPs. Below, bacterial elongation will be discussed.  
1.5.1: Nucleotide addition cycle  
During the elongation phase of transcription, RNAP catalyses the rapid and processive 
incorporation of substrate NMPs into the growing 3’ end of RNA. The process of NMP 
incorporation is repeated for each position along the template DNA. This process is 
referred to as the nucleotide addition cycle (NAC). The steps of the NAC are shown in 
Figure 1-7.   
The RNAP active centre has two binding sites, i and i+1 (insertion site), which the 3’ 
end of RNA and the incoming substrate NTP can occupy. At the beginning of the NAC, 
elongation complexes are in a post-translocated state. In this state the 3’ end of RNA 
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occupies the i site and i+1 is vacant. The incoming NTP arrives to the active centre and 
is positioned into the i+1 site where it forms hydrogen bonds with the complementary 
template base, ready for catalysis. Crystal structures, supported by biochemistry, have 
revealed additional nucleotide binding sites within the active centre, notably the pre-
insertion site (Kettenberger et al., 2004, Vassylyev et al., 2007b). The pre-insertion site 
is thought to serve as an initial binding site for substrate NTPs. If the correct NTP is 
bound, the NTP repositions into the i+1 site. This is coupled to the folding of the trigger 
loop which closes off the active centre to bring about catalysis.  
The result of catalysis is the incorporation of substrate NMP present in the i+1 site into 
the 3’ end of the transcript. Therefore, after catalysis the new 3’ end of RNA occupies 
the i+1 site, leaving the complexes in a pre-translocated state. Translocation is the 
lateral movement of the RNAP by one position on the template DNA strand. To carry 
on elongation, RNAP translocates to position the new 3’ RNA end into the i site 
thereby freeing the i+1 site for the next NTP and returning the complexes to a post-
translocated state. At any position on the DNA template, RNAP is able to oscillate from 
a pre-translocated to post-translocated state due to thermal motion. In the presence 
of NTPS, forward translocation and stabilisation of the post-translocated state is 
thought to occur by a Brownian ratchet mechanism as the binding of the next NTP in 
the now empty i+1 site favours the forward position of RNAP (Bar-Nahum et al., 2005).  
1.5.2: Pausing and Backtracking 
Despite primarily moving in a forward direction, occasionally RNAP can pause on the 
DNA. The pausing of RNAP on the DNA is considered to control the overall speed of 
elongation and so pausing features in various regulatory mechanisms including 
transcription termination and attenuation (reviewed in Landick, 2006). The pause itself 
is induced by the DNA sequence, which can be recognised by RNAP (Bochkareva et al., 
2012, Kireeva and Kashlev, 2009). One outcome of transcribing a pause sequence is 
reverse movement of the RNAP along the RNA:DNA hybrid. This reverse movement is 
backtracking (bottom of Figure 1-7). For backtracking to occur, the 3’ end of RNA 
disengages from the active centre and is fed into the secondary channel as RNAP slides 
backwards along the hybrid. In addition to pause sequences, the incorporation of the 
wrong nucleotide (misincorporation) can trigger backtracking. As the 3’ end of RNA is 
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no longer within the active centre, backtracking events need to be resolved before the 
resumption of transcription.  
Given the importance of transcription, auxiliary factors exist to modulate the rate of 
elongation. Two examples of elongation factors are NusA and NusG, which control 
elongation speeds by promoting and suppressing RNAP pauses, respectively 
(Artsimovitch and Landick, 2000, Herbert et al., 2010). Backtracking events are 
resolved through the removal of the 3’ nascent RNA. RNAP has an intrinsic RNA 
hydrolysis activity which can accomplish the removal of nascent RNA (Orlova et al., 
1995). However, in vivo, Gre proteins in bacteria and TFIIS for RNAP II exist to cleave 
the RNA and rescue backtracked RNAP (Borukhov and Nudler, 2008, Cipres-Palacin and 
Kane, 1994).  
 
Figure 1-7: The Nucleotide addition cycle. At the beginning of the cycle, the RNAP is in 
a post-translocated state. The 3’ RNA (red) occupies the i site. The incoming substrate 
NTP,chelating Mg2+ II, binds to the preinsertion site. The trigger loop (purple) folds, 
positioning the NTP in the i+1 site. The folded trigger loop and Mg2+ ions catalyse the 
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formation of a phosphodiester bond. The reaction results in the release of a 
pyrophosphate (PPi). After catalysis the RNAP is in a pre-translocated state. RNAP 
translocates to vacate the i+1 site, ready for another round of nucleotide addition. 
RNAP can oscillate between the pre and post-translocated states, as shown by the 
double headed arrow. RNAP is able to backtrack on the RNA:DNA hybrid. Backtracked 
RNAP cannot continue RNA synthesis. Through its own hydrolytic activity, or a cleavage 
factor, the nascent 3’ RNA is removed to return the RNAP to a post-translocated state.   
1.5.3: Hydrolysis and proof reading 
Misincorporation, incorporation of the wrong nucleotide, leads to the production of 
inaccurate transcripts that can have a potentially drastic effect on gene expression. 
Therefore maintaining high fidelity is an important aspect of transcription. In vitro 
studies have helped to delineate the determinants of transcription fidelity. The 
prevention of misincorporation occurs in a multistep process during the binding of the 
substrate (Yuzenkova et al., 2010). The major selection step occurs upon the binding of 
the substrate and the folding of the trigger loop. Key residues of the trigger loop, 
including the catalytic R1239 and H1242 residues, are able to discriminate against 
incorrect NTPs such as non-complementary or 2’deoxyNTPs (dNTPs) that have wrongly 
been positioned in the i+1 site. In the instance of an incorrect NTP in i+1, steric clashes 
with the folding trigger loop cause catalysis to occur very slowly which favours the 
expulsion of the NTP from the active centre (Yuzenkova et al., 2010).     
In addition to substrate discrimination, RNAP contributes to fidelity by removing 
misincorporated NTPs through catalysing hydrolysis. In the event of misincorporation, 
RNAP backtracks by one position, placing the penultimate NMP of the RNA into the i+1 
site. Upon backtracking, the 3’ misincorporated NMP is flexible as it is not base paired 
with the template DNA. The E site is an additional nucleotide binding site in the active 
centre in which the incoming NTP substrate is thought to bind first. The flexibility of 
the 3’ misincorporated NMP allows it to bind in the E site and provide chemical groups 
which function in the catalysis of hydrolysis, including the stabilisation of Mg II (Zenkin 
et al., 2006b). The trigger loop, in particular the H1242 residue is thought to facilitate 
the positioning of the 3’ NMP into the E site (Yuzenkova and Zenkin, 2010). The result 
of hydrolysis is the release of a dinucleotide and a return to the post-translocated 
state. This process is referred to as transcript assisted hydrolysis because the 
misincorporated NMP aids in its own removal by stimulating back tracking and 
participating in the hydrolysis reaction (Zenkin et al., 2006b). 
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Although RNAP possesses an intrinsic hydrolysis activity, conserved external 
transcription factors exist to catalyse the hydrolysis of RNA in the event of 
misincorporation or transcription arrest in vivo (Orlova et al., 1995). The Gre factors in 
bacteria (GreA/GreB in E. coli) and their eukaryotic counterparts (TFIIS for RNAP II, 
A12.2 and C11 core subunits for RNAP I and III) provide catalytic residues for hydrolysis 
by protruding into the active centre through the secondary channel (Kettenberger et 
al., 2003, Roghanian et al., 2011, Laptenko et al., 2003, Sosunova et al., 2003). In vitro 
experiments have revealed that Gre factors replace the trigger loop when supplying 
catalytic residues to chelate Mg II and position the attacking water molecule 
(Roghanian et al., 2011). 
 
1.6: Transcription Termination 
Two independent mechanisms exist in bacteria for the termination of transcription: 
intrinsic termination and rho-dependant termination. In intrinsic termination, RNAP 
transcribes a G-C rich inverted repeat followed by a stretch of thymine residues. The 
A:U hybrid is weak and induces a pause in transcription, allowing the transcribed G-C 
rich inverted repeat to form an RNA hairpin (Gusarov and Nudler, 1999). The hairpin 
extends into the main channel, reducing the length of the RNA:DNA hybrid, clashing 
with the trigger loop and opening the β’ DNA clamp domain (Epshtein et al., 2007). As 
the β’ clamp is responsible for RNAPs stable grasp on DNA, its opening causes a release 
of the transcript and the removal of RNAP from the DNA.  
The second mechanism of transcription termination requires Rho. Rho is a 
homohexamer, with each subunit having the ability to perform ATP hydrolysis.  During 
transcription, nascent RNA is fed through the RNA exit channel and out of RNAP. Rho 
binds to the nascent RNA, in particular to cytidine rich sequences and hydrolyses ATP 
to thread the nascent RNA through its ring-like structure (Peters et al., 2009). 
Threading of RNA allows Rho to translocate up the RNA in a 5’ to 3’ direction towards 
the transcribing RNAP. Rho then interacts with RNAP to alter its conformation, 
trapping the elongation complex in an inactive state. Release of the RNA and DNA then 
ensues, thus terminating transcription (Epshtein et al., 2010). 
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Termination of transcription varies for each of the eukaryotic RNAPs, with two 
mechanisms operating to terminate RNAP II (reviewed in Kuehner et al., 2011). Protein 
coding mRNA transcribed by RNAP II undergoes cleavage and polyadenlyation at the 3’ 
end during the final stages of transcription. The termination of transcription is coupled 
to these 3’ end processing events. Briefly, the proteins required for cleavage and 
polyadenylation are recruited to the C-terminal domain (CTD) of RNAP II. After the 
transcription of the polyadenlyation signal, the mRNA is cleaved and polyadenylated at 
newly exposed 3’ end. The other outcome of cleavage is exposure of the 5’ end of the 
nascent RNA chain still bound by RNAP II. Rat1, a 5’-3’ exonuclease bound to the CTD 
proceeds to degrade the nascent RNA which results in the removal of RNAP II from the 
DNA through a collision event. The second mechanism of RNAP II termination applies 
to the transcription of non-coding genes. This mechanism occurs through the 
recruitment of the Sen1 helicase which unwinds the RNA:DNA hybrid in the active 
centre, leading the release of RNA and removal of RNAP II from DNA.  
RNAP I and RNAP III termination are simpler processes. In vitro, a stretch of thymine 
bases and the Reb1 roadblock protein bound to its corresponding DNA element 
downstream is sufficient to terminate RNAP I transcription (Lang et al., 1994). 
However, results of in vivo work has implicated pre-rRNA processing factors in RNAP I 
termination. Evidence suggests as for RNAP II, RNAP I transcripts are cleaved with 
downstream RNA remaining bound to RNAP I. This RNA is then degraded by Rat1 
exonuclease which upon contacting the RNAP I, triggers the removal of RNAP I from 
DNA (reviewed in Nemeth et al., 2013)) RNAP III termination resembles the intrinsic 
termination of bacterial RNAP in that both mechanisms utilise RNA secondary 
structure and a downstream poly U tract (Zenkin, 2014a). Upon transcribing the poly U 
tract, RNAP III backtracks and becomes catalytically inactive (Nielsen and Zenkin, 
2013). RNAP III transcribes structured RNA including tRNA. In a backtracked state, the 
nascent RNA folds into its secondary structure which brings about the removal of the 
RNAP III from the template DNA.  
It remains unclear how archaeal transcription is terminated. The limited experimental 
evidence suggests that the mechanism is similar to that of bacterial intrinsic 
termination (Santangelo and Reeve, 2006, Zenkin, 2014b). Whilst a bacterial 
termination signal featuring an RNA hairpin and a downstream thymine rich DNA 
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sequence was recognised by archaeal RNAP, the RNA hairpin was shown not to be 
essential for termination. Interestingly, archaeal transcription termination is influenced 
by the sequence of upstream DNA but the cause of this remains to be investigated.   
1.7: Evolution of multisubunit RNA Polymerases 
The β’ and β DPBB folds are conserved in all multisubunit RNAPs, leading to the 
suggestion that the two DPBB form an ancient core from which the multisubunit RNAP 
evolved (Iyer et al., 2003). The two DPBB folds are only structurally homologous and do 
not share any similarities in amino acid sequence. Despite this, it has been proposed 
that the β’ and β subunits originate from a single protein containing the DPBB fold, 
which duplicated in the last universal common ancestor (LUCA). The individual DPBB 
folds then underwent divergent evolution to loose sequence similarity and gain 
differing motifs, with β’ DPBB gaining the asp triad. Finally, the two DPBB folds split to 
form two separate subunits. (Iyer et al., 2003, Iyer and Aravind, 2012).  
Single subunit RNA dependant RNAPs (rdRNAPs) exist in a wide variety of eukaryotic 
organisms. Rather than bearing homology to other single subunit RNAPs such as T7 
RNAP, bioinformatics revealed a distant relationship to the multisubunit RNAP (Iyer et 
al., 2003). All eukaryotic rdRNAPs contain an aspartate triad and the presence of two 
DPBB domains has been confirmed by the structure of one such rdRNAP, QDE-1 
(Salgado et al., 2006, Iyer et al., 2003). Therefore RNAPs exist which contain the β’ and 
β DPBB folds on a single polypeptide. It is thought that these enzymes diverged prior 
to the splitting of the two DPBB into individual subunits (Iyer and Aravind, 2012, 
Salgado et al., 2006, Iyer et al., 2003).  
The presence of two DPBB folds and an aspartate triad has been used to identify a 
number of hypothetical, non-canonical RNAPs (Aravind et al., 2012). Patterned based 
PSI BLAST searches identified hypothetical bacteriophage encoded proteins with 
distant homology to eukaryotic rdRNAPs and multisubunit RNAPs (Iyer et al., 2003). 
One example is the YonO protein encoded by the Bacillus subtilis prophage SPβ 
(discussed in the next section). Recently, the identification of two DPBB folds has 
further suggested that the ORF6 protein of the Kluyveromyces lactis killer system is an 
RNA polymerase (Ruprich-Robert and Thuriaux, 2010). Previously, this protein was 
identified as a putative RNAP through amino acid sequence similarities (Wilson and 
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Meacock, 1988). Furthermore, when projected onto the crystal structure of RNAP II, 
the amino acid homology mapped onto the two DPBB folds suggesting ORF6 RNAP 
contains these characteristic RNAP folds (Ruprich-Robert and Thuriaux, 2010).   
In the next chapters, YonO and ORF6 RNAPs will be discussed in more detail, including 
their discovery, what is currently known about these proteins and descriptions of the 
transcription systems they are thought to operate within.   
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Chapter 2: YonO: the hypothetical RNA polymerase of the Bacillus subtilis 
prophase SPβ 
2.1. Resident prophages of Bacillus subtilis  
Bacillus subtilis is a soil dwelling, gram positive rod bacteria. Many aspects of its 
physiology have made B. subtilis a widely used model organism for the study of gram 
positive bacteria. The B. subtilis 168 strain is widely regarded as a wildtype strain. The 
chromosome of this strain and its many derivatives harbours two prophages and 7 
prophage-like elements (Westers et al., 2003, Kunst et al., 1997). Prophages are 
genomic integrations of temperate bacteriophage DNA. Prophage DNA remains in the 
host chromosome until induction stimulates the replication and release of the 
bacteriophage particle. This life cycle of temperate bacteriophages is referred to as the 
lysogenic cycle. In addition to the lysogenic life cycle, bacteriophages can also replicate 
by a lytic life cycle. In contrast to the temperate bacteriophages, lytic bacteriophages 
begin replication immediately after the injection of their DNA into the host bacteria. 
This makes the lytic life cycle the quickest mode of replication, with the T7 
bacteriophage producing approximately 180 phage particles in less than 20 minutes 
under optimal conditions (Nguyen and Kang, 2014). The two life cycles are outlined in 
Figure 2-1.  
The two prophages residing in the B. subtilis chromosome are PBSX and SPβ (Seaman 
et al., 1964, Warner et al., 1977). Spontaneous induction of the prophages can occur at 
very low frequencies (1 in 106 for SPβ), resulting in cell lysis and the release of phage 
particles (Warner et al., 1977). Induction of PBSX and SPβ is controlled by the RecA 
dependant SOS response triggered by DNA damage (Goranov et al., 2006). 
Experimentally, the DNA crosslinker Mitomycin C is used to stimulate the induction of 
the prophages (Warner et al., 1977, Seaman et al., 1964).   
PBSX is a defective bacteriophage as upon its induction, B. subtilis DNA rather than the 
PBSX genome is packaged into the phage particles. Furthermore, PBSX particles do not 
inject their DNA into susceptible B. subtilis cells. Instead, PBSX particles cause the rapid 
lysis of susceptible bacteria upon adsorption (Seaman et al., 1964). In contrast, SPβ 
forms phage particles capable of lysogenising sensitive strains (Warner et al., 1977). 
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Therefore SPβ is a functional temperate bacteriophage which stably resides in the 
chromosome of B. subtilis 168 strain.  
 
Figure 2-1: Lifecycle of bacteriophages. Bacteriophages can be classified according to 
the life cycle they under take during infection of a host bacterium. Lytic bacteriophages 
such as T7 bacteriophage replicate by the lytic life cycle. In this life cycle, the 
bacteriophage directly progresses to replication and assembly of progeny phage 
particles subsequent to injecting the host with its DNA. This is in contrast to temperate 
bacteriophages which replicate by a lysogenic life cycle. In this cycle, the 
bacteriophage DNA integrates into the host chromosome to become a prophage. The 
prophage stably resides in the chromosome and is therefore replicated during 
bacterial cell division. In the event of unfavourable conditions, such as DNA damage, 
the prophage is induced and progresses to replication, particle assembly and eventual 
host cell lysis.  
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The 7 prophage-like elements in the genome include the ICEbs1 (integrative 
conjugative element) and the SKIN (SigK intervening) element. ICEbs1 is a 20 kb mobile 
element encoding its own excisionase and integrase, allowing for its horizontal transfer 
to recipient cells through conjugation (Auchtung et al., 2005, Lee et al., 2007). The 
SKIN element is a 48 kb prophage-like element, with 3 of its operons resembling the 
early, middle and late operons of PBSX (Krogh et al., 1996). The remaining genes of the 
SKIN element are predicted to function in arsenate metabolism (Takemaru et al., 1995, 
Krogh et al., 1996). An unusual property of the SKIN element is that its insertion into 
the genome disrupts the sigK gene coding for the sigma factor σK. Upon sporulation, 
the SKIN element is excised from the mother cell chromosome by the action of a site-
specific recombinase, which itself is encoded by the spoIVCA gene on the SKIN element 
(Stragier et al., 1989, Sato et al., 1990, Kunkel et al., 1990). The excision results in the 
reconstitution of the sigK gene and expression of σK, which directs transcription in the 
sporulating mother cell (Kunkel et al., 1990, Sato et al., 1990). Despite having 
homology to PBSX, expression of SKIN element genes is not induced by the triggering 
of the SOS response by Mitomycin C (Krogh et al., 1996). This is in contrast to ICEbs1, 
whose expression is triggered by the SOS response or high cell densities (Auchtung et 
al., 2005).   
2.2: SPβ prophage of Bacillus subtilis 
SPβ has a very large 134 Kb genome that integrates into the host genome via 
recombination during lysogeny. Recombination occurs between the SPβ attachment 
site (attP) and the B. subtilis attachment site (attB) located towards the replication 
terminus of the Bacillus chromosome (Figure 2-2) (Zahler et al., 1977, Lazarevic et al., 
1999). Generally, SPβ remains stably integrated into the genome until induction of the 
phage. However, spontaneous excision of the phage does occur, leading to the 
isolation of cured B. subtilis strains. One such strain,Su3+ proved invaluable for the 
initial characterisation of SPβ. Su3+ was susceptible to lysogenisation by SPβ, providing 
investigators a means to investigate SPβ induction and lysogenisation (Warner et al., 
1977).    
The whole sequence of the prophage DNA uncovered the organisation of the genome. 
187 ORFs have been predicted. The majority of the proteins (~75%) encoded by the 
187 ORFs on SPβ have unknown functions (Lazarevic et al., 1999). Putative functions 
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have been assigned to encoded proteins based on their amino acid sequence 
similarities. The ORFs have been organised into three clusters based on their 
orientation on the genome, as shown in Figure 2-2. Cluster I and III are directed 
towards the origin of replication. Cluster II is transcribed in the direction away from 
the origin. Cluster III contains many short ORFs predicted to function in DNA 
replication and metabolism (Lazarevic et al., 1999). Therefore, it has been posited that 
Cluster III contains the operons transcribed early during the induction of SPβ. Cluster II 
contains ORFs encoding for proteins with homology to the lytic enzymes of PBSX 
(Lazarevic et al., 1999). Additionally, homologues of PBSX tail fibre proteins are 
encoded in Cluster II. Tail fibre proteins are structural proteins of the phage particle. 
Tail fibre proteins are expressed at the end of phage particle maturation along with 
lytic enzymes which degrade the cell wall of the host bacterium. Therefore Cluster II 
contains the late operons. 
 
Figure 2-2: Genome organisation of SPβ. Top: Integration of SPβ genome into the B. 
subtilis chromosome. Upon infection of a B. subtilis cell, the circular SPβ genome 
integrates into the host chromosome by homologous recombination between the attP 
and attB attachment sites on the SPβ and B. subtilis genomic DNA, respectively. 
Clusters I, II and III are shown in red, green and blue. In the circularised form, Cluster II 
is orientated in the opposite direction of Clusters I and III. Bottom: Genome 
organisation of SPβ prophage. Homologous recombination and subsequent 
integration of SPβ duplicates the attachment site, giving attL and attR either side of 
SPβ. Upon integration, Cluster II is the only cluster to be coded on the plus DNA strand.       
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Unlike Cluster II and III, Cluster I and the genes it contains are not categorised based on 
when they are expressed during SPβ induction (i.e. early or late). A number of the 
proteins encoded by SPβ DNA are expressed during the prophage state. Examples of 
such proteins are found encoded on Cluster I.  B. subtilis cells harbouring SPβ produce 
the bacteriocin sublancin 168 (Paik et al., 1998). Sublancin 168 has bactericidal activity 
on a broad range of gram positive organisms including Staphylococcus aureus. 
Sublancin 168 is encoded by the sunA gene in Cluster I (Lazarevic et al., 1999, Paik et 
al., 1998). Immediately downstream lies an operon coding for the specific sublancin 
168 exporter along with the enzymes required for sublancin synthesis. The ability to 
kill other competing bacteria is an advantage conferred to B. subtilis cells by SPβ, 
explaining the continued maintenance of the large prophage in the B. subtilis genome. 
Beneficial proteins are not exclusively encoded by ORFs on cluster I. The SspC protein 
encoded by the sspc gene of Cluster III has been incorporated into the complex process 
of sporulation. SspC binds to DNA and offers the spore protection against UV radiation 
(Tovar-Rojo and Setlow, 1991).  
The detailed mechanism of SPβ induction by DNA damage has not been elucidated. 
Through transcriptome analysis, it has been shown that induction of SPβ and PBSX is 
dependent on RecA and LexA (also referred to as DinR in B. subtilis) (Goranov et al., 
2006). RecA mediates the SOS response in bacteria. Upon DNA damage, RecA 
stimulates the autocleavage of DinR. DinR is a transcriptional repressor of the SOS 
regulon and binds the SOS box element to prevent transcription. The nucleotide 
sequence of SPβ has revealed the locations of four SOS box sequences in the SPβ 
genome (Lazarevic et al., 1999). The SOS response and cleavage of DinR may result in 
the derepression of numerous SPβ operons and/or ORFs. An SPβ encoded protein 
synthesised as a consequence of the SOS response may inhibit an SPβ repressor 
protein, allowing the full induction of the prophage (Lazarevic et al., 1999). 
Hypothetical SPβ repressor binding sites have been identified. SPBRE (SPβ repeated 
element) are 30 bp sequences found in intragenic spaces upstream from ORFs. 8 
SPBRE are present in Cluster III. One is present upstream of the first ORF of Cluster II. 
Predicted σA promoters are located within or directly adjacent to SPBRE sequences. 
Any repressor of SPβ induction may bind to the SPBRE to occlude the σA promoter. A 
repressor of SPβ lytic growth has been identified, the c gene. Mutations in the c gene 
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prevent SPβ from lysogenising susceptible cells, with the mutant SPβ being restricted 
to lytic growth on susceptible strains (Warner et al., 1977).  A temperature sensitive 
mutation in the c gene, defined as c2, allows induction of SPβ when the lysogenic cells 
are shifted to a non-permissive temperature (Rosenthal et al., 1979). How the c gene 
protein regulates lytic growth is unknown. It also not known whether there is a 
connection between the c gene protein and the predicted SPBRE elements.  
2.3. YonO, a putative RNA polymerase of SPβ 
Single subunit RNA dependant RNAPs (rdRNAPs) function in post transcriptional gene 
silencing across a wide variety of eukaryotic organisms. In an effort to investigate the 
origins of the rdRNAP, pattern based protein data base searches (PSI – BLAST) were 
conducted to identify potential distant homologues (Iyer et al., 2003). In PSI-BLAST, the 
patterns of conservation in the amino acid alignments produced by the first PSI-BLAST 
query are used for the second database search (iteration). This process can be 
repeated multiple times, with each iteration producing amino acid alignments of 
increasingly distantly related proteins. Specifically, an 800 residue core common to 
rdRNAPs was used as the PSI-BLAST query sequence. The second iteration revealed 
distant homology between the rdRNAP core and the protein coded by the YonO ORF of 
SPβ (Iyer et al., 2003). Furthermore, a reciprocal PSI-BLAST using YonO amino acid 
sequence as the query resulted in the discovery of YonO homologues. Primarily, YonO 
homologues reside in firmicute bacteria including Bacillus and Clostridium species. 
However, distant homologues have been also been identified in cyanobacteria 
(Ruprich-Robert and Thuriaux, 2010, Iyer and Aravind, 2012).  
The homology between rdRNAP and YonO had a significant e value in the PSI BLAST 
search. However, the two proteins are only distantly related, with amino acid 
sequence similarities limited to 9 motifs and 12 invariant amino acids (Iyer et al., 
2003). Secondary structure prediction showed conservation of 20 β sheets and 16 α 
helices conserved across YonO and rdRNAPs. 3 of the 12 invariant amino acids are 
those of the aspartate triad motif, which is regarded as the RNAP active centre 
(Ruprich-Robert and Thuriaux, 2010). In addition to the aspartate triad, 7 of the 
remaining amino acids conserved in YonO also map to the active centre of rdRNAPs. 
This was shown by identifying the conserved residues in the structure of QDE-1, a well-
studied example of a eukaryotic rdRNAP from Neurospora crassa (Figure 2-3a). The 
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conservation of the aspartate triad and other residues of the rdRNAP active centre 
strongly suggests YonO is an RNAP functioning in an undetermined stage in the SPβ life 
cycle.   
The PSI-BLAST search also uncovered a very distant homology between YonO and 
rdRNAP to the multisubunit RNAP (Iyer et al., 2003). Amino acid sequence similarity 
between YonO and multisubunit RNAP is limited to the aspartate triad of β’ and a 
conserved lysine and aspartate residue of β. The aspartate triad motif shared between 
rdRNAPs and YonO has less conserved amino acids than the motif shared between 
multisubunit RNAP, with the conserved motif being DbDGD (b represents a bulky 
amino acid). In multisubunit RNAPs the conserved motif is extended to NADFDGD. 
Figure 2-3b shows a comparison of the aspartate triad in YonO, QDE-1 and β’. In 
multisubunit RNAPs, the aspartate triad is present on a loop between two β strands of 
a DPBB fold in the β’subunit. The calculated secondary structure of YonO and rdRNAPs 
predicted the aspartate triad to be buried in a region enriched with β sheets, 
suggesting the presence of a DPBB fold. Since this initial prediction, the structure of 
QDE-1 was solved. This confirmed that the aspartate triad does indeed exist on a DPBB 
fold that corresponds to that of the β’ subunit.  
The structure of QDE-1 also revealed the presence of the second DPBB fold 
corresponding to the β subunit DPBB fold. Two closely spaced lysines present in the β 
DPBB fold are extremely conserved in multisubunit RNAPs. However, amino acid 
sequence comparisons show that only the second lysine is present in YonO and 
eukaryotic rdRNAPs. The first lysine has been substituted for an extremely conserved 
arginine residue (Iyer et al., 2003, Ruprich-Robert and Thuriaux, 2010). The remaining 
YonO residues that map to the QDE-1 active centre are present on the β DPBB, giving 
further evidence that both DPBB folds are present in YonO.    
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Figure 2-3: The Distant relationship between YonO, rdRNAP and the multisubunit 
RNAP. a) Amino acid shared between YonO and rdRNAP mapped on the structure of 
QDE-1. The invariant amino acids shared amongst YonO and rdRNAPs were identified 
on the structure of the eukaryotic rdRNAP, QDE-1. Of the 12 residues, 10 were present 
on the two highly conserved DPBB folds. The DPBB folds corresponding to the β’ and β 
DPBB are coloured red and blue, respectively. The residues conserved in YonO are 
coloured according to the DPBB which they map to. Those not present on DPBB folds 
are coloured orange. B) Conservation of the aspartate triad in YonO, rdRNAP and 
multisubunit RNAPs.  Adapted from Iyer et al., 2003. Amino acid sequences 
corresponding to the β’ DPBB fold in rdRNAPs, YonO and RNAP were aligned. QDE-1 
from N. crassa was used to represent rdRNAP whilst β’ subunits of E. coli and T. 
thermophilus were used for to represent the multisubunit RNAP. The absolutely 
conserved aspartate triad is shown in red. Secondary structure predictions show that 
the aspartate triad of YonO and rdRNAP is embedded in a region enriched in β strands. 
These predictions are shown above the corresponding amino acid sequences.   
YonO has not been investigated beyond bioinformatics and so the enzymatic activity of 
this protein remains to be seen. Assuming it is an RNAP, it is not known whether YonO 
would function as an RNA dependant or DNA dependant RNAP. Eukaryotic rdRNAPs 
function in post transcription gene silencing. In addition to an RNAP, these complex 
systems require a cohort of additional proteins to bring about gene silencing (Iyer et 
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al., 2003). To date no homologues of these proteins have been identified in 
bacteriophages, suggesting that YonO does not function as an rdRNAP in a novel 
bacterial gene silencing system. SPβ is a DNA based bacteriophage, therefore it is likely 
that, despite resembling RNA dependant RNAPs, YonO utilises DNA as a template if it is 
indeed an RNAP. QDE-1 rdRNAP has been observed carrying out transcription utilising 
both RNA and DNA as a template, implying that the homology shared between YonO 
and rdRNAP does not preclude YonO from functioning as a DNA dependent RNAP 
(Aalto et al., 2010, Lee et al., 2009).      
RNA based bacteriophages are known to utilise rdRNAPs for gene expression and 
replication. All single subunit bacteriophage RNAPs, including rdRNAPs, resemble the 
‘right handed’ T7 RNAP and so do not feature an aspartate triad embedded on a DPBB 
fold (reviewed in (Ferrer-Orta et al., 2006). Therefore, YonO is potentially the first 
example of a single subunit bacteriophage RNAP equipped with the aspartate triad and 
resembling the multisubunit RNAP.   
The presence of the aspartate triad suggests that YonO carries out nucleotide 
polymerisation using the same catalytic mechanism used by all RNAPs; chelating Mg2+ 
ions and catalysing nucleophilic attack between the 3’ hydroxyl of RNA and the α 
phosphate of the substrate NTP. Besides this, nothing is known regarding YonO 
catalysis. According to amino acid sequence similarities, no other conserved 
multisubunit RNAP motifs are present in YonO, including the trigger loop. This is 
striking, as the trigger loop is critical for catalysis in multisubunit RNAPs. It is possible 
that the structure of functional motifs is conserved rather than the amino acid 
sequence.    
The distant relationship between YonO to other RNAPs raises interesting questions 
regarding its evolution and occurrence in SPβ. YonO does not have increased similarity 
to an rdRNAP of a particular eukaryotic organism (Iyer et al., 2003). This undermines 
the hypothesis that the presence of a eukaryotic related RNAP in a bacteriophage is 
due to recent horizontal transfer. Rather, YonO and rdRNAPs may represent an ancient 
intermediate in the evolution of the multisubunit RNAP. Figure 2-2 shows the 
proposed origin of YonO in relation to the evolution of the multisubunit RNAP. It is 
possible the ancestor of YonO and rdRNAP may have diverged from the multisubunit 
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RNAP ancestor after the duplication of the DPBB folds but before the individual folds 
gained differing motifs and split (Iyer and Aravind, 2012, Iyer et al., 2003, Salgado et 
al., 2006). An implication of this hypothesis is that the ancestral YonO/rdRNAP in LUCA 
was lost in Archaea but kept in eukaryotes and certain bacteria. An alternative 
hypothesis is that the YonO/rdRNAP ancestor was completely lost by LUCA but was 
preserved in ancient bacteriophages and mobile elements (Iyer et al., 2003). Assuming 
the YonO/rdRNAP ancestor functioned in RNA metabolism in the RNA world, it would 
have become redundant upon the emergence of the DNA world allowing it to be lost 
over time. However, the YonO/rdRNAP could have been reintroduced at an early point 
in the eukaryotic lineage by a horizontal gene transfer event (Iyer et al., 2003).   
In summary, it appears YonO is a putative RNAP of the B. subtilis bacteriophage SPβ 
which is only distantly related to rdRNAP and multisubunit RNAP. The identification of 
YonO led to the uncovering of eukaryotic rdRNAP-like proteins previously unseen in 
bacteriophages. Investigation into YonO and the transcription system it operates 
within could reveal an exciting, previously undescribed RNAP utilising a novel 
mechanism of catalysis. The identification of an uncharacterised single subunit RNAP is 
an exciting prospect. The discovery and subsequent characterisation of T7 RNAP 
opened up a whole new field within transcription, a field that that has been intensely 
investigated over the past four decades (Chamberlin et al., 1970). Furthermore, 
exploitation of T7 RNAP in gene expression has completely revolutionised molecular 
biology by introducing a tractable transcription system for the expression of proteins.  
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Figure 2-3: Proposed Origins of YonO and ORF6 RNAP. Based on Salgado et al., 2006. 
Two possible explanations for the origin of the multisubunit RNAP, YonO and ORF6 
RNAP are shown. The proposals are based on the conservation of two characteristic 
DPBB folds in multisubunit RNAP, rdRNAP, YonO and ORF6 RNAP (Iyer and Aravind, 
2012, Iyer et al., 2003, Salgado et al., 2006, Ruprich-Robert and Thuriaux, 2010). Left) 
The original DPBB fold existed in a pre-LUCA organism, possibly in an RNA based world. 
The coding sequence for the DPBB was duplicated, giving rise to a single protein with 
two DPBB folds. This protein may have been a cofactor to a ribozyme RNAP. The two 
DPBBs began to diversify (represented by changes in colour), gaining catalytic motifs 
such as the aspartate triad (pink star) and conserved lysine residues (orange diamond) 
over extended periods of time. In an RNA world, such a protein may have become the 
primary rdRNAP enzyme. At this point, it is theorised YonO and rdRNAP may have 
diverged. If rdRNAP and YonO were expunged from the LUCA, they may have been 
preserved in ancient bacteriophages before reintroduction into the eukaryotic lineage. 
Alternatively they may have remained in LUCA and were subsequently lost in bacteria 
and archaea. The two DPBB continued to diversify and the RNAP they constitute 
became DNA dependent as the DNA world emerged. DNA dependent, single 
polypeptide RNAPs with two DPBB folds such as ORF6 RNAP may be remnants of this 
ancestral RNAP. Eventually, prior to the LUCA split, the DPBB folds split to produce two 
subunits which are the precursors of  β‘ and β. Diversification removed all sequence 
similarity between β’ and β DPBB folds. This RNAP would be the ancestor of all 
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multisubunit RNAPs. Right) An alternative origin of RNAPs also features a duplication 
of the DPBB fold. However, unlike the previous origin, the entire coding sequence of 
the DPBB fold protein may have been duplicated rather than only the DPBB coding 
sequence. This would result in a homodimeric complex rather than a single protein 
with two DPBB folds. Over time, the amino acid sequences of the two DPBB may have 
diversified, explaining the absence of sequence similarities between β’ and β DPBB 
folds. Prior to further diversification, including the accretion of the functional domains 
identified in the multisubunit RNAP, YonO and rdRNAPs could have arisen due to the 
fusion of the two DPBB coding sequences. Between the divergence of YonO and the 
evolution of the LUCA multisubunit RNAP, a second fusion event may have occurred. 
This could explain the presence of single proteins, such as ORF6 RNAP which have 
increased sequence similarity to both RNAP subunits.    
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Chapter 3: ORF6 RNAP of the Kluyveromyces lactis Killer System 
3.1. Killer system of Kluyveromyces lactis  
Killer yeast species have been identified in many yeast genera. Killer yeast secrete 
toxins which either kill or halt the growth of yeast competing in the same 
environment. These toxins are synthesised by the killer systems (reviewed in Magliani 
et al., 1997). In most cases the killer system also grants immunity to the killer yeast. 
Generally, the killer systems are defined as the proteins of the system, including the 
toxins, and the genetic determinants encoding them. The genetic determinants of 
killer systems vary across yeast species. In most cases the genetic material of the killer 
system is extra-chromosomal and has a cytoplasmic localisation. All three identified 
killer systems of the well-studied Saccharomyces cerevisiae are encoded by three 
different double stranded RNA of cytoplasmically inherited satellite viruses (Magliani 
et al., 1997). Another yeast with a killer system encoded by cytoplasmic nucleic acid is 
Kluyveromyces lactis. However, this system is encoded by two cytoplasmic DNA 
plasmids rather than a satellite virus. 
K. lactis is a yeast species closely related to Saccharomyces cerevisiae and is 
characterised by its unusual ability to use lactose as its sole carbon source, hence its 
isolation from dairy products and nick name ‘diary yeast’ (reviewed in Schaffrath and 
Meacock (1996)). The K. lactis killer system is encoded by two linear double stranded 
DNA plasmids, pGKL1 and pGKL2 (discussed in section 2.1.1) (Gunge et al., 1981). As 
with other killer systems, pGKL1 and pGKL2 are located in the cytoplasm and encode 
the proteins of the toxin. The toxin, zymocin, is comprised of three subunits (α, β and 
γ), with the α and β subunits functioning to transport the effector subunit, γ, across 
the cell wall of susceptible yeast species (Stark and Boyd, 1986, Butler et al., 1991). The 
γ subunit of zymocin cleaves the anticodon of a subset of tRNA molecules, causing an 
arrest in cell growth (Auchtung et al., 2005) 
3.2. Linear Plasmids of the K. lactis Killer System 
pGKL1and pGKL2 are 8.9 Kb and 13.4 kb long plasmids that encode the proteins of the 
K. lactis killer system (Gunge et al., 1981, Stark et al., 1984). The plasmids were first 
identified and isolated during a search for novel yeast plasmids (Gunge et al., 1981). In 
addition to being associated to the killer phenotype, the first investigation into pGKL1 
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and pGKL2 revealed that the plasmids have a linear structure. A subsequent study, 
aimed at increasing the efficiency of plasmid purification, revealed that pGKL1 and 
pGKL2 reside in the cytoplasmic fraction (Stam et al., 1986). As the DNA replication and 
transcription machinery resides in the nucleus, the cytoplasmic localisation of the 
plasmids implies they are self-maintained (this is discussed below).   
Further analysis of the plasmids by DNA sequencing revealed additional features. Both 
plasmids are extremely AT rich, having an AT content of ~74% (Hishinuma et al., 1984, 
Tommasino et al., 1988).  Terminal inverted repeats (TIR) were identified at the 5’ ends 
of both plasmids (Hishinuma et al., 1984). However, the TIRs differ in sequence and in 
length on each plasmid. The TIRs of pGKL1 and pGKL2 are 220 bp and 180 bp in length, 
respectively. The presence of TIRs strongly suggests a protein primed mode of DNA 
replication similar to that of the adenovirus and φ29 Bacillus phage (Mcneel and 
Tamanoi, 1991). Indeed, two terminal proteins (TP) covalently bound to the 5’ termini 
of the plasmids have been observed. As with the TIRs, the two bound proteins were 
different for each plasmid, with 28 KDa and 36 KDa proteins binding the TIR of pGKL1 
and pGKL2, respectively (Stam et al., 1986). 
Sequencing allowed the identification of the open reading frames which encode for 
the proteins of the killer system (Hishinuma et al., 1984, Stark et al., 1984, Tommasino 
et al., 1988). Arrangement of the ORFs on the plasmid is very compact, with ORFs 
present on both strands of the DNA (Gunge et al., 1981). It was calculated that 95-97 % 
of the DNA sequence codes for protein (Tommasino et al., 1988). Investigating the 
proteins encoded by the ORFs on pGKL1 and pGKL2 revealed a clear organisation of 
the two plasmids based on the function of their encoded proteins. The ORFs encoding 
the zymocin subunit localised to pGKL1. Through amino acid sequence alignments, the 
hypothetical proteins of pGKL2 were given putative roles in plasmid replication and 
gene expression (see below) (Stark et al., 1990, Tommasino et al., 1988, Wilson and 
Meacock, 1988) 
3.2.1: The pGKL1 Killer plasmid 
Initially, the gene encoding zymocin was linked to pGKL1 through genetic mutations 
which led to a loss of the killer phenotype (Wesolowski et al., 1982). Sequencing 
allowed the four ORFs present on pGKL1 to be identified (Figure 3-1) (Stark et al., 
1984). The amino acid sequences of proteins encoded by ORF2 and ORF4 bore 
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similarities to the N-terminal secretion signal, leading to the conclusion that the two 
ORFs encode the toxin subunits. However, further studies indicated that the toxin 
consists of 3 subunits: α, β and γ. Amino acid sequencing of the individual toxin 
subunits revealed that ORF2 actually codes for two subunits, α and β. ORF4 encodes 
for the active toxin subunit, γ (Stark and Boyd, 1986). Genetic studies revealed that 
ORF3 is required for self-immunity to the γ subunit of zymocin (Tokunaga et al., 1987). 
However, its mode of action has not yet been determined. The amino acid sequence of 
ORF1 gives further support to the hypothesis that the killer plasmid replicate via a 
protein primed replication. ORF1p (ORF1p refers to the protein encoded by ORF1, and 
unless stated otherwise, this nomenclature will be used to refer to proteins encoded 
by pGKL1 and pGKL2) has been assigned as a pGKL1 specific DNA polymerase (DNAP) 
based on its homology to the DNAPs operating in the protein-primed DNA replication 
of φ29 and the adenovirus (Jung et al., 1987, Fukuhara, 1987).  
 
Figure 3-1: Organisation of pGKL1 and pGKL2 plasmids of the K. lactis killer system. 
Adapted from Schaffrath and Breunig, 2000. The organisation of the ORFs on pGKL1 
and pGKL2 are shown. Hypothetical or confirmed functions are displayed adjacent to 
each ORF. The ORFs are coloured according to their predicted function. Red ORFs – 
toxin and immunity function. Blue – DNA replication. Orange – transcription. Grey – 
unknown. Terminal inverted repeats (TIR) at the 5’ terminus of each plasmid are 
represented as black (pGKL1) and grey (pGKL2) boxes. Terminal proteins (TP) bound to 
the TIR are shown as green and yellow circles.     
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3.2.2: The pGKL2 Killer plasmid 
pGKL2 has been shown to be essential for the maintenance of pGKL1, as pGKL1 cannot 
be isolated from strains lacking pGKL2  (Tommasino et al., 1988). Its localisation in the 
cytoplasm, away from the nuclear replication and transcription machinery, suggested 
that pGKL2 was responsible for encoding proteins which perform replication and gene 
expression. Sequencing of pGKL2 confirmed this hypothesis, as in addition to allowing 
the identification of 10 ORFs, it showed that the majority of these ORFs encode 
proteins homologous to replication and transcription machinery.  
Initially 10 ORFs were identified on pGKL2. However, an updated search identified an 
additional ORF, raising the total number of ORFs present to 11 (Tommasino et al., 
1988, Larsen and Meinhardt, 2000). The organisation of the pGKL2 ORFs is shown in 
Figure 3-1. ORFs 2 – 10 are essential for pGKL2 maintenance. ORF1 is dispensable and 
it has not yet been determined whether or not ORF11 is required (Larsen and 
Meinhardt, 2000, Schaffrath et al., 1992). 7 ORFs have been assigned putative 
functions based on amino acid sequence similarities and limited experimental 
evidence. The proteins can be categorised based on the two distinct processes in 
which they may function. ORF2p, ORF5p and ORF10p most likely function in DNA 
replication whilst ORF3p, ORF4p, ORF6p, ORF7p may carry out transcription (Romanos 
and Boyd, 1988, Tommasino et al., 1988, Wilson and Meacock, 1988, Mcneel and 
Tamanoi, 1991, Schaffrath and Meacock, 1995, Takeda et al., 1996, Larsen et al., 1998, 
Schaffrath and Meacock, 2001, Schaffrath et al., 1997). ORF1p, ORF8p, ORF9p and 
ORF11p do not have sequence similarity to any known proteins.  
The amino acid sequences of proteins coded by pGKL2 suggests that the killer system 
utilises plasmid specific protein primed DNA replication, as ORF2p of pGKL2 was shown 
to be homologous to the DNAP encoded by ORF1 on pGKL1 (Tommasino et al., 1988). 
Additional observations support the hypothesis of plasmid specific replication 
machinery. The 5’ TIR present on pGKL1 and pGKL2 bear no sequence similarity 
(Hishinuma et al., 1984). Furthermore, the terminal proteins covalently bound to the 5’ 
TIR appear to be different. Whilst the TP bound to pGKL2 TIR has been identified as the 
protein product of pGKL2 ORF2, the ORF coding for pGKL1 TP has not been identified 
(Takeda et al., 1996). ORF2 of pGKL2 is unusual in that it codes for the TP and a DNAP. 
TP are utilised to prime DNA replication in many viruses, including the φ29 phage of B. 
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subtilis. The coding sequence of the φ29 phage TP is also present in the coding 
sequence of the φ29 specific DNAP.      
If plasmid specific replication systems do exist, then ORF5p and ORF10p encoded by 
pGKL2 are common to both systems. As with the other replication proteins of the killer 
system, ORF5p is homologous to a protein of the φ29 bacteriophage, the p5 single 
strand DNA binding (SSB) protein. During φ29 DNA replication, p5 coats the displaced 
single stranded DNA. In vitro experiments show that ORF5p functions similarly to p5 
(Schaffrath and Meacock, 1995, Schaffrath and Meacock, 2001). ORF10 encodes 
Terminal recognition factor 1 (TRF1). TRF1 specifically binds to the TIR DNA of both 
killer plasmids; however a binding consensus sequence was not identified (Mcneel and 
Tamanoi, 1991). TRF1 is possibly functionally similar to the P6 protein of φ29, which 
also binds to TIRs. However, P6 is considerably different to TRF1 in that it recognises 
and binds a specific DNA sequence. Both P6 and TRF1 are thought to be involved in the 
initiation of TP primed DNA replication.  
In summary, it is clear that pGKL1 and pGKL2 replicate independent of the nuclear 
replication machinery. The replication system operating on the plasmids closely 
resembles that of viruses, in particular the φ29 bacteriophage.                  
The presence of a cytoplasmic transcription system operating on pGKL1 and pGKL2 
was first hypothesised when nuclear transcription machinery failed to express the 
killer toxin (Romanos and Boyd, 1988, Wilson and Meacock, 1988). The whole native 
pGKL1 sequence was cloned into a circular plasmid which localises to the K. lactis 
nucleus. The constructed plasmid was then transformed into a K. lactis strain defective 
in toxin synthesis and assayed for killer activity. No killer activity was observed. 
Investigating the lack of toxin expression revealed truncated transcripts coding for α 
and β subunits of zymocin. The most fitting explanation for these observations is an 
independent, cytoplasmic transcription system for gene expression of pGKL1 and 
pGKL2 ORFs (Romanos and Boyd, 1988, Tanguy-Rougeau et al., 1990, Wilson and 
Meacock, 1988).   
The proteins accomplishing the transcription of pGKL1 and pGKL2 ORFs were identified 
through amino acid sequence homology. ORF3p, ORF4p, ORF6p and ORF7p encoded 
by their corresponding ORF on pGKL2 share similarity with proteins of previously 
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studied transcription systems (Wilson and Meacock, 1988, Schaffrath et al., 1997, 
Larsen et al., 1998). ORF3p is a 67 KDa protein which contains conserved residues from 
the three catalytic domains of the Vaccinia virus mRNA capping enzyme (Larsen et al., 
1998). In eukaryotes, 5’ 7-methylguanosine mRNA caps are necessary to stimulate 
translation and prevent degradation. Vaccinia virus resides in the cytoplasm 
throughout its life cycle and therefore utilises its own transcription system, including 
an mRNA capping enzyme (reviewed in Moss, 1990 ). In vitro assays demonstrated 
ORF3p has 5’ RNA triphosphatase and guanyltransferase activity (Tiggemann et al., 
2001). The third enzymatic activity required for mRNA capping is methyltransferase, it 
was not determined if ORF3p has this activity due to the lack of a suitable assay. 
However, amino acid homology suggests ORF3p is able to perform this activity.  
The similarities between the Vaccinia virus and the pGKL2 transcription system are not 
limited to ORF3p. ORF4p shares amino acid sequence similarity to two individual 
proteins of the Vaccinia virus, the D6R subunit of the ETF (Early Transcription Factor) 
and the NPH I (nucleoside triphosphate phosphohydrolase I) (Stark et al., 1990, Wilson 
and Meacock, 1988). Both proteins function in transcription and have DNA dependant 
ATPase activity (Broyles, 2003). The ETF recruits the Vaccinia encoded RNAP to DNA. In 
contrast to this, NPH I is a helicase involved in transcription termination. ORF4p has 
not been investigated experimentally and so it is unknown if it functions during 
initiation or termination of transcription.  
Central to any transcription system is RNAP, which catalyses the synthesis of RNA. 
ORF6 of pGKL2 encodes a large 115 KDa protein with significant homology to the 
conserved multisubunit RNAP (Wilson and Meacock, 1988). Furthermore, the small 17 
KDa protein product of ORF7 has a small region of weak homology to the β’ subunit 
(Schaffrath et al., 1997). Therefore the current consensus is that ORF6p, potentially 
complexed with ORF7p, is the RNAP of the cytoplasmic transcription system of the K. 
lactis killer system. The homology between ORF6 RNAP and the multisubunit RNAP is 
unusual and raises many questions about how the enzyme functions. ORF6 RNAP has 
amino acid sequence similarity to both catalytic subunits (β’ and β in bacteria, RPB1 
and RPB2 in RNAP II). However, not all of the conserved domains which operate in 
RNAP during transcription appear to be present in ORF6 RNAP. This, in addition to the 
absence of recognisable nuclear promoters, further implies that the killer system 
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utilises a novel, previously uncharacterised transcription system featuring an unusual 
RNAP.            
3.3: ORF6 RNAP  
ORF6 of pGKL2 encodes a 982 amino acid, 115 KDa protein. Upon searching the 
protein database with the amino acid sequence of ORF6p (referred to as ORF6 RNAP), 
Wilson and Meacock uncovered homology to the multisubunit RNAP (Wilson and 
Meacock, 1988). Unusually, ORF6 RNAP, a single polypeptide chain, has sequence 
similarity to both catalytic subunits of RNAP. At the time, this was considered unique 
as no other known single subunit RNAP bore resemblance to both β’ and β (Stark et al., 
1990). Other examples of such RNAPs are now known (Ruprich-Robert and Thuriaux, 
2010). Upon first inspection, ORF6 RNAP had three small regions of homology, one 
region (denoted region A) homologous to β and two regions (denoted region II and III) 
homologous to β’. Region III contains the essential aspartate triad motif (Wilson and 
Meacock, 1988). In 2010 a greater level of conservation between ORF6 RNAP and the 
β’ and β subunits was observed (Ruprich-Robert and Thuriaux, 2010). The homology is 
now known to extend to 250 amino acids that span the length of ORF6 RNAP.  In the 
2010 study, the authors defined 21 functional motifs present in the two large catalytic  
subunits (β’and β in bacteria) of all multisubunit RNAPs. These domains include the 
previously discussed switch region, trigger loop, bridge helix and aspartate triad (these 
domains are shown schematically in Figure 3-2). The 250 amino acids shared between 
ORF6 RNAP and the multisubunit RNAP corresponds to 11 of the 25 motifs (Figure 3-2) 
(Ruprich-Robert and Thuriaux, 2010). Approximately half of the motifs involved in 
transcription in all cellular organisms are absent in ORF6 RNAP. Incredibly, the trigger 
loop is absent from ORF6 RNAP. The trigger loop plays a pivotal role in all reactions 
catalysed by RNAP (Wang et al., 2006, Yuzenkova et al., 2010, Yuzenkova and Zenkin, 
2010, Temiakov et al., 2005). Its absence, along with the majority of the β’ motifs, 
raises interesting questions regarding the mechanism by which ORF6 RNAP carries out 
the nucleotide addition cycle and catalysis. It also raises the exciting possibility that 
ORF6 RNAP is a novel RNAP with a minimal architecture consisting of only the domains 
absolutely essential for transcription. The minimal nature of ORF6 RNAP, including its 
reduced size compared to the multisubunit RNAP, is illustrated in Figure 3-2. 
Alternatively, the functional motifs may not be conserved in the amino acid sequence 
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but may perhaps be conserved structurally. Two amino acid inserts are present in the 
ORF6 RNAP polypeptide sequence (Ruprich-Robert and Thuriaux, 2010). The residues 
in these inserts may fold to structurally resemble absent conserved motifs.  
Modelling the homology shared between ORF6 RNAP and multisubunit RNAP onto the 
structure of RNAP II revealed two DPBB folds, a conserved feature of all multisubunit 
RNAPs (Ruprich-Robert and Thuriaux, 2010). In addition to further confirming that 
ORF6 encodes an RNAP, the presence of two DPBB fold led to speculation regarding 
the origin of ORF6 RNAP. ORF6 RNAP may be a representative of an intermediate 
ancestral RNAP, an RNAP in which the two DPBB folds had partially differentiated to 
gain different functional motifs, but not split into to the individual proteins (Iyer and 
Aravind, 2012). Splitting of the DPBB folds into two proteins, further divergence and 
gain of motifs could account for the increase in functional motifs observed in the 
multisubunit RNAP. An alternative hypothesis is that ORF6 RNAP is a result of the two 
large RNAP subunits fusing together, with subsequent divergence and loss of the 
unessential functional motifs (Ruprich-Robert and Thuriaux, 2010). 
ORF6 RNAP remains totally uncharacterised beyond the analysis of its amino acid 
sequence. However, the promoter elements driving transcription on pGKL1 and pGKL2 
ORFs have been identified. Once it became clear that the leader sequences of pGKL1 
transcripts were very short (~2 - 27 nucleotides) compared to nuclear mRNA (50 
nucleotides on average), the DNA sequences upstream of each ORF were analysed 
(Stark et al., 1984). A 13 bp conserved sequence (ACT(A/T)AATATATGA), 35 bp 
upstream from the translation start codon of ORF1, ORF2 and ORF3 was identified. 
This DNA element is known as the upstream conserved sequence (UCS). An 11 bp UCS 
with reduced conservation is present 49 bp upstream of ORF4 (Romanos and Boyd, 
1988).  
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Figure 3-2: The conservation of multisubunit RNAP functional motifs in ORF6 RNAP. 
Adapted from  Ruprich-Robert and Thuriax, 2010. a) Conserved motifs of the 
multisubunit RNAP. The 21 motifs conserved motifs of the two large catalytic subunits 
(β’ and β in bacteria, Rpb1 and Rpb2 in eukaryotic RNAP II) are displayed along the 
polypeptide of their subunit. The amino acid length of each subunit is shown on the 
left. The approximate locations of the two DPBB folds are shown. b) RNAP motif 
conservation in ORF6 RNAP. The multisubunit RNAP motifs present in ORF6 RNAP are 
displayed along the ORF6 polypeptide chain. ORF6 RNAP has homology to both β’ 
(Rpb1) and β (Rpb2). The motifs homologous to β’ and β are coloured red and blue, 
respectively. c) Structural representation of RNAP motifs conserved in ORF6 RNAP. 
The motifs shown in b) were identified in the structure of the RNAP II elongation 
complex to demonstrate the minimal nature of ORF6 RNAP compared to the 
multisubunit RNAP. The motifs conserved in ORF6 RNAP are shown in ribbon 
representation and coloured as for b).  
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UCSs are also present on pGKL2 but they display marked differences to their pGKL1 
counterparts (Tommasino et al., 1988). pGKL2 UCSs are shorter (~7 bp) and display 
greater variation with a consensus of TA(A/-)TNTGA. On pGKL2, transcription starts 10 
– 17 bp downstream of the UCSs. However, the distance between the UCS and the 
translation start codon of the corresponding ORF can vary widely from 27 to 110 bp. 
Therefore, in contrast to pGKL1, pGKL2 ORFs have long 5’ leader sequences. An UCS 
precedes every ORF on pGKL1 and pGKL2, suggesting that each ORF is transcribed 
independently and not as part of an operon. Transcripts for each ORF have been 
detected, confirming this (Romanos and Boyd, 1988, Stark et al., 1984, Sor and 
Fukuhara, 1985). Positioning of the glucose dehydrogenase reporter gene or 
kanamycin resistance cassette downstream of a UCS on the pGKL1 plasmid resulted in 
detectable activity and resistance, respectively (Tanguy-Rougeau et al., 1990, Schickel 
et al., 1996). This provided direct evidence that UCSs are genuine promoter elements 
directing expression in the K. lactis killer system.   
In summary, ORF6 RNAP is regarded as the enzyme responsible for cytoplasmic gene 
expression in the K. lactis killer system. Approximately half of the conserved motifs in 
RNAP are not present in ORF6 RNAP according to amino acid sequence. Interestingly, 
one such motif is the trigger loop. Investigation into ORF6 RNAP may reveal an RNAP 
with a minimal architecture which updates our understanding of the basic 
requirements for catalysis. Alternatively, novel functional motifs may be uncovered, 
leading to the elucidation of undescribed mechanisms of catalysis. Furthermore ORF6 
RNAP utilises UCSs, novel promoter elements to initiate transcription. The 
investigation of ORF6 RNAP and UCSs may lead to the discovery of a novel 
transcription system which can be exploited for the expression of AT rich ORFs. Aside 
from studies which have shown ORF6 RNAP to be essential for plasmid maintenance, 
no experimental investigations into ORF6 RNAP have yet been published (Schaffrath et 
al., 1995b). Therefore a primary aim of this thesis is to begin the characterisation of 
the ORF6 RNAP transcription system using an in vitro approach.   
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Chapter 4: Materials and Methods  
4.1. General Methods 
4.1.1. PCR 
Each 50 µl PCR reaction contained the following: 0.5 µl DNA template (typically 100 ng 
µl-1), 1 unit of Phusion DNA polymerase (New England Biolabs), 0.4 mM of each primer, 
200 µM dNTPS mixed in High Fidelity Buffer (New England Biolabs). Sequences of all 
primers can be found in Table 4-1.  
Each PCR was carried out as follows: 
Temperature (⁰C) Time (s) Cycles 
98 30 
 
98 9 
30 variable 15 
72 30 s per kb 
72 300 
 
10 pause 
 
 
4.1.2. Growth media and Strains 
All bacterial and yeast strains used throughout this work are listed in Table 4-2. Unless 
stated otherwise, all bacterial strains were grown in Luria – Bertani (LB) medium 
supplemented with the required antibiotic which is stated in the relevant materials 
and methods. Yeast strains were grown in Synthetic Complete – uracil (SC-URA) 
medium supplemented with a specific carbon source detailed in the corresponding 
method. The composition of growth media can be seen in Table 4-3.    
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Table 4-1: Primers used in this study.  
Oligonucleotide Sequence (5' - 3') 
Annealing temperature 
⁰C 
Restriction 
Enzyme (If 
applicable) 
yonO pET28 L CATATGGCTAGCTTGAAAGGAAAAAAAGACGG 
58 
NheI 
yonO pET28 R GTAGTTCTCGAGCTAACGGTGGTTAATTC XhoI 
yonO SDM L GCTGCTGCAGTTTGACAATAACGGGAATAAGGCCTTAATTATTTC 
68  
yonO SDM R GAAATAATTAAGGCCTTATTCCCGTTATTGTCAAACTGCAGCAGC 
 
pBEST:UP L GAAATATGAAGCTTCTAGACTTGGTCTGAAAC 
60 
HindIII 
pBEST:UP R CATGTGTGGTCGACCCCCTTATTACTTTTATGC XhoI 
pBEST:DOWN L GAATATGGCGGCCGCGTGCCTTGAGCCTTACTC 
65 
NotI 
pBEST:DOWN R CACACATGGGATCCCAAGCACAAAAAGGCCTTC BamHI 
pBESTdx L GATGGATCCACTATCATTTACTTTTCC 
55  
pBESTdx R CTCGTAAACACATTCCGGCTG 
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pBEST seq L GAGACTGCTATTATTGAAGGAACTG 
  
pBEST seq R CTCCCTTATGACGATTATCTCC 
  
pBEST internal seq L GATGTGTGTCATGTCAACAGAGG 
  
pBEST internal seq R CCTCTGTTGACATGACACACATC 
  
1673 L GCGACTCCAATCTAAATAAAATTAAAG 
52  
1673 R GTTTTGAACCCTTTAAAATCACTGG 
 
1673 L + 50 GTTCAGGTATCTTTTTTGCTAGTTCTTC 52 
 
1673 R + 50 CTTCTTCATCCTCAATCGTTTTTTTG 52 
 
VM RNAP L GCATATGGCTAGCTTGAAAGGAAAAAAGACGG 
60 
NheI 
VM RNAP R CATATATGCTCGAGCTAAATGCTAACAACTTCTTTC XhoI 
ORF6C+ pYES L GTACATGATCAGAGGATCCATGATCGTCTTGGACATCC 
59 
BamHI 
ORF6C+ pYES2 R CTATACGTATGCACTCGAGTCATAAGTACATTTCGTTGC XhoI 
ORF7 pET21 L GTACGTCATATGAATGAAAATATTATTTC 53 NheI 
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ORF7 pET21 R GTAATGAACTCGAGTAAAAAGAATATTTTCTCG XhoI 
ORF6C+ pESC L 
GTCGTATGCAACTAGTAACACAATGGATTACAAGGATGACGACGATAAGATCATGATCGTCTTGGA
CATCCC 68 
SpeI 
ORF6C+ pESC R GGATGTCGAGGAGCTCTCATAAGTACATTTCGTTGCAG XhoI 
ORF7 pESC L GGATGTCGAGGGATCCAACACAATGAATGAAAATATTATTTC 
60 
BamHI 
ORF7 pESC R TGCATACGACGTCGACTAAAAAGAATATTTTCTCG SalI 
ORF6C+ pACYC L GAAATATTGGATCCGATGATCGTCTTGGACATC 
58 
BamHI 
ORF6C+ pACYC R CATATATGAAGCTTTCATAAGTACATTTCGTTG HindIII 
ORF7 pACYC L GAGCTATGCATATGAATGAAAATATTATTTC 
56 
NdeI 
ORF7 pACYC R CATATATGCTCGAGTTATAAAAAGAATATTTC XhoI 
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 Table 4-2: Strains constructed and used in this study 
Species Strain Genotype Reference 
B. subtilis 
168 (WT) trpC2 
Kunst et 
al., 1997 
ΔyonO trpC2 ΔyonO:: neoR This work 
CU1065 trpC2 SPβS 
Zahler et 
al., 1977 
ΔSPβ trpC2 ΔSPβ 
Dorenbos 
et al., 
2002 
B. vallismortis DV1-F-3 Wildtype isolate 
Roberts et 
al., 1996 
E. coli 
T7 
Express 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] 
R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-
mrr)114::IS10 
New 
England 
Biolabs 
DH5α 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
New 
England 
Biolabs 
BL21-
CodonPlu
s (DE3)-
RIPL 
F- ompT hsdS(rs
- ms
-) dcm+ Tetr gal λ (DE3) 
endA Hte (argU proL Camr) 
(argU ileY leuW Strep/Specr) 
Agilent 
K. lactis AWJ137 MATα leu2 trp1 [pGKL1+ pGKL2+] 
Kämper et 
al., 1991 
S. cerevisiae 
INVSc1 
his3Δ1/his3Δ1 leu2/leu2 trp1–289/ trp1–289 
ura3–52/ura3–52; 
Invitrogen 
YPH449 
MATa ura3-52 lys2-801amber ade2-101ochre 
trp1-Δ63 his3-Δ200 leu2-Δ1 
Agilent 
 
Table 4-3: Composition of growth media 
Media 
Concentration / 
Amount 
Component 
Luria - Bertani  
1% Tryptone 
0.50% Yeast extract 
1% NaCl 
Spizizen Minimal 
Salts 
(Anagnostopoulos 
and Spizizzen, 
1961) 
1.4% K2HPO4 
0.6% KH2PO4 
0.1% Na3C6H5O7 
MM (Minimal 
Media)  
Spizizen minimal salts supplemented with: 
1ug ml-1 FeNH4 citrate 
0.50% Glucose 
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6mM MgSO4 
0.02% Casamino acids 
MMB (Modified 
M Broth) 
1% Bacto-tryptone 
0.50% Bacto-yeast extract  
1% NaCl 
5mM MgCl2 
0.1mM MnCl2 
Nutrient Agar 
0.50% Peptone 
0.30% Yeast Extract 
2.00% Agar 
0.50% NaCl 
SC- URA  
1 x yeast nitrogen base (formedium) 
1 x  SC-URA dropout supplement (Formedium) 
2% Glucose 
SC-URA agar 
1 x yeast nitrogen base (formedium) 
1 x  SC-URA dropout supplement (Formedium) 
2% Glucose 
2% Agar  
SC-URA:gal/raf  
1 x Yeast nitrogen base (formedium) 
1 x  SC-URA dropout supplement (Formedium) 
2% galactose 
1% raffinose  
Starvation Media 
Spizizen minimal salts supplemented with: 
0.50% Glucose 
6mM MgSO4 
 
4.1.2. Molecular Cloning 
All insert DNA fragments for cloning were generated through PCR (see section 4.1.1). 
The Primers and restriction enzymes used can be seen in Table 4-1. Amplified insert 
DNA was purified using the Qiagen Gel Extraction kit, following the protocol provided. 
Plasmid and insert DNA were restricted using the appropriate restriction enzymes (see 
Table 4-1) for 1 hour at 37 ⁰C before being purified as before. For ligations, 3 times 
molar excess of insert DNA to plasmid DNA was mixed and ligated overnight at 15 ⁰C 
using T4 DNA ligase (New England Biolabs). The following day, 5 µl of ligation mix was 
transformed into 50 µl of DH5α competent E. coli cells (New England Biolabs). Cells 
were transformed according to the supplied protocol. Cells were plated on nutrient 
agar containing the selective antibiotic, either 100 µg ml-1 ampicillin or 50 µg ml-1 
kanamycin.    
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To identify positive clones, colonies were picked and grown overnight in LB 
supplemented with the selective antibiotic. Plasmid DNA was isolated using the Qiagen 
Mini Prep Kit and restricted using the same restriction enzymes used for the cloning. 
The digest was resolved on a 1% agarose gel to determine which plasmids contained 
the insert. Positive plasmids were then sent for sequencing. All sequencing was carried 
out by GATC using their standard primers or the primers used for molecular cloning. 
Resultant sequences were visualised using the software Vector NTI (Invitrogen).  
All plasmids used and constructed can be seen in Table 4. 
Table 4-4: Plasmids used and constructed throughout this work  
Plasmid  Source  
Antibiotic 
Marker 
pBEST501 Itaya et al., 1989 Kanamycin 
pBEST:U:D  This work  Kanamycin 
pET-21 Novagen Ampicillin 
pET-21: yonOSTOP This work  Ampicillin 
pET-28 Novagen Kanamycin 
pET-28: yonO This work  Kanamycin 
pYES2/NT Novagen Ampicillin 
pYES2/NT:ORF6C+ This work  Ampicillin 
pESC/URA Agilent  Ampicillin 
pESC-URA:O6C+:O7 This work  Ampicillin 
pACYC-Duet Noavgen Chloramphenicol 
pACYC:ORF6C+:ORF7 This work Chloramphenicol 
 
4.1.3. Buffers  
Composition of all buffers used can be seen Table 4-5. All chromatography buffers 
were filtered through 0.45 µm pore PVDF filters (Helena) prior to use. Where available, 
the compositions of commercial buffers are listed in Table 4-6.  
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Table 4-5: Composition of buffers. Buffers are listed in alphabetical order 
Buffer Concentration  Component  
Acetate buffer 100mM NaAcetate pH 4.8 
  10mM  MgCl2 
  500mM NaCl 
  0.10% Triton X-100 
Binding buffer 10mM  Tris - HCl pH 6.8 
  100mM NaAcetate pH 4.8 
  10mM  MgCl2 
  50mM NaCl 
Blocking buffer 200mM Tris - HCL pH 8  
  10mM  MgCl2 
  500mM NaCl 
  0.10% Triton X-100 
Breaking buffer 50mM  Sodium phosphate buffer 
  50% Glycerol 
  1mM  PMSF 
B. subtilis lysis buffer 20mM  Tris-HCl pH 8 
  2mM EDTA 
  1.20% Triton X-100 
Buffer I 10mM  Tris - HCl pH 7.2 
  10mM  MgCl2 
  1M NaCl 
  0.10% Triton X-100 
Buffer II 10mM  Tris - HCl pH 7.2 
  10mM  MgCl2 
  150mM NaCl 
  0.10% Triton X-100 
Coupling buffer 100 mM NaHCO3 pH 8.3 
  10mM  MgCl2 
  500mM NaCl 
  0.10% Triton X-100 
Developing solution 235mM  Sodium Carbonate 
  0.02% 37% w/v Formaldehyde 
Dilution buffer 10mM  Tris - HCl pH 7.4 
  0.10% Triton X-100 
Elution buffer I 100 mM Glycine pH 2 
  0.10% Triton X-100 
Elution buffer II 2M Tris-HCl pH 8 
Fixation solution 40% Ethanol 
  10% Acetic acid 
Gel Filtration buffer 
  
50mM  Tris - HCL pH 7.9  
500mM NaCl 
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Grinding buffer  
  
50mM  Tris-HCl pH 7.9 
200mM NaCl 
HEPES storage buffer 20 mM HEPES KOH pH 7.9 
  50% Glycerol 
  0.5mM EDTA 
  1mM  β mercaptoethanol 
Laemmli buffer 100 mM Tris - HCl pH 6.8 
  2% SDS 
  20% Glycerol 
  4% β-mercaptoethanol 
ORF6 RNAP Heparin buffer 
10 mM Tris-HCl pH 7.9 
5% Glycerol 
0.1 mM  EDTA 
0.1 mM DTT 
ORF6 RNAP Heparin elution 
buffer 
10 mM Tris-HCl pH 7.9 
5% Glycerol 
0.1 mM  EDTA 
0.1 mM DTT 
1M NaCl  
ORF6 RNAP Ni2+ buffer 
20 mM Tris-HCl pH 7.9 
600 mM NaCl 
5% Glycerol 
ORF6 RNAP Ni2+ elution 
buffer 
20 mM Tris-HCl pH 7.9 
600 mM NaCl 
5% Glycerol 
200mM  Imidazole pH 8 
ORF7p Storage buffer 20mM Tris - HCL pH 7.9  
  50% Glycerol 
  200mM KCl 
pESC Breaking buffer 50 mM Tris-HCl pH 7.4 
  150 mM  NaCl 
  1mM EDTA 
  1% Triton X-100 
Sensitising solution 30% Ethanol 
  4.0% 5% w/v Sodium thiosulphate 
  830mM Sodium acetate  
Silver solution 10% 2.5% w/v Silver nitrate 
  0.04% 37% w/v Formaldehyde 
Transcription Buffer  20mM Tris-HCl pH 8.5 
  40mM KCl 
  10mM MgCl2 
Tris Buffered Saline 50 mM Tris-HCl pH 7 
  150 mM  NaCl 
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Western blot buffer 
  
1 X  
Phosphate buffered saline 
(Oxoid) 
0.10% Tween 
Western blocking buffer 1 X  
Phosphate buffered saline 
(Oxoid) 
  0.10% Tween 
  5% Milk powder 
Western transfer buffer 1 X Tris- glycine (Fisher Scientific) 
  0.20% SDS 
  20% Methanol 
YonO Heparin buffer 10mM  Tris-HCl pH 7.8 
YonO Heparin elution 
buffer 
10mM  Tris-HCl pH 7.9 
  1M  NaCl 
YonO Ni2+ buffer 20mM  Tris-HCl pH 7.9 
  600mM NaCl 
YonO Ni2+ elution buffer 20mM  Tris-HCl pH 7.9 
  600mM NaCl 
  200mM Imidazole pH 8 
YonO Storage buffer 20mM  Tris-HCl pH 7.9 
  200mM KCl 
  50% Glycerol 
  1mM  DTT 
  0.1mM  EDTA  
 
Table 4-6: Composition of Commercial buffers.  
Commercial Kit Buffer Concentration  Component 
Qiagen 
Miniprep Kit 
P1 50 mM Tris - HCl pH 8 
10 mM  EDTA 
100 μl ml-1 RNase A 
P2 200 mM NaOH 
1% SDS 
N3 5 M Guanidinium chloride 
0.9 M Potassium acetate pH 4.8 
Qiagen Gel 
Extraction Kit 
QG 5.5 M Guanidine thiocyanate 
20 mM Tris - HCl pH 6.6 
PE 10 mM  Tris - HCl pH 7.5 
80% ethanol  
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4.2. Protein Methods  
4.2.1. Purification of YonO  
DNA encoding for YonO was amplified from B. subtilis genomic DNA using primers 
yonO pET28 L and yonO pET28 R and cloned into pET-28a. An overnight culture of the 
T7 express E. coli strain (New England Biolabs) carrying pET-28:yonO was used to 
inoculate 12 L of LB media at a ratio of 1:1000 and grown at 37 ⁰C until an OD600 of 0.4 
was reached. At this point the temperature was shifted to 18 ⁰C and IPTG (Melford) 
was added to a final concentration of 1mM. Cultures were grown overnight before 
being harvested by centrifugation using a Beckman JLA 8.1000 at 6000 rpm for 10 
minutes. Cell pellets were resuspended in 120 ml of grinding buffer and sonicated on 
ice by a Braun sonicator at 60% amplitude, 2 seconds on, 2 seconds off for 9 minutes in 
total. Lysates were clarified by centrifugation at 20 000 rpm using a JA25.50 rotor 
followed by filtration through a 0.45 µM PVDF filter (Merck-Milipore). Prior to FPLC, 
imidazole pH 8 was added to the lysate to a final concentration of 20 mM.  
The lysate was applied to a 5 ml His-trap Ni2+-NTA column (GE Healthcare) equilibrated 
in grinding buffer at a flow rate of 5 ml min-1 using the p900 pump on the AKTA 
Explorer FLPC (GE Healthcare). The column was washed with Ni2+ elution buffer 
containing 25 mM imidazole to remove any unbound proteins. YonO was eluted by 
washing the column with Ni2+ elution buffer containing 100 mM imidazole followed 
subsequently with 200 mM imidazole. SDS-PAGE was used to determine which elution 
fraction contained YonO.  
The elution fraction containing YonO were pooled and applied to a 5 ml HiTrap Heparin 
HP column (GE Healthcare) equilibrated in 600 mM NaCl Heparin Elution Buffer. 
Contaminating proteins were eluted by washing the column with 700 mM NaCl 
Heparin Elution Buffer. This was followed by elution using a shallow gradient of 700 
mM to 1M NaCl in Heparin Elution Buffer over 2 hours at a flow rate of 2 ml min-1. The 
elution fraction containing YonO (determined by SDS PAGE) was concentrated using a 
Centricon device with a 30 000 MW cut off (Merck-Millipore). The concentrated 
protein was clarified by centrifugation at 15 000 rpm at 4 ⁰C and applied to a Superdex 
200 gel filtration column (GE Healthcare) equilibrated in gel filtration buffer. Gel 
filtration buffer was run through the column at a rate of 1 ml min-1. The absorbance of 
the eluate at 280 nm revealed that YonO eluted after 70 ml of buffer had passed 
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through the column; this was confirmed by SDS PAGE. Elution fractions which 
contained YonO were pooled and concentrated as previously described. 
Purified YonO intended for use in screening for crystallisation conditions was 
concentrated to 10 mg ml-1 and applied to the condition screens. For biochemistry, 
purified YonO was dialysed into YonO storage buffer overnight and stored at -20 ⁰C.  
4.2.2. Purification of ORF6 RNAP by Ni2+ NTA chromatography 
The DNA sequence of ORF6 was codon optimised for expression in Saccharomyces 
cerevisiae. The optimised sequence, denoted as ORF6C+ was synthesised by Eurogentec 
and was provided cloned into pUC57. ORF6C+ was amplified using primers ORF6C+ pYES 
L and ORF6C+ pYES R and cloned into pYES2/NT.  
The construct pYES2/NT:ORF6C+ was transformed into S. cerevisiae strain INVSc1 using 
the standard lithium acetate protocol (Gietz et al., 1992). Positive transformants were 
selected for by plating onto SC-URA agar medium. The transformant colonies were 
purified by restreaking individual colonies on SC-URA agar medium.  
An INVSc1 transformant was grown overnight at 30 ⁰C in SC-URA medium. The 
overnight culture was used to inoculate 1.5 litres of SC-URA which was grown until an 
OD600 of 3 was reached. At this point, the culture was pelleted and washed in SC-
URA:gal/raf medium before being used to inoculate 20 litres of SC-URA:gal/raf media 
to an OD600 of 0.3. Cultures were grown at 30 ⁰C overnight before being harvested by 
centrifugation (6000 rpm for 10 minutes in Beckman JLA8.1000 rotor) at stored at -80 
⁰C until required.   
The weight of the pelleted cells was measured and cells were resuspended in 10 times 
as much pYES2 breaking buffer. The resuspended cells were French pressed twice at 35 
Kpsi. The lysate was clarified by centrifugation at 16 000 rpm for 20 minutes at 4 ⁰C in 
a Beckman JA25.50 rotor. The lysate was made to 5mM imidazole and 600mM NaCl 
and filtered through a 8µM pore filter (Whatman) before being loaded onto a 10 ml 
Ni2+ - NTA column (GE Healthcare) at a rate of 5 ml min-1 using AKTA Explorer FLPC (GE 
Healthcare). Ni2+ - NTA column was equilibrated in ORF6 RNAP Ni2+ buffer. Once 
loaded, the column was washed with ORF6 RNAP Ni2+ elution buffer containing 
increasing concentrations of imidazole (5 mM, 25 mM, 50 mM, 100 mM and 200 mM). 
The protein content of each elution fraction was visualised by SDS PAGE (sodium 
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dodecyl sulphate polyacrylamide gel electrophoresis). Peptide mass fingerprint (PMF) 
carried out by Pinnacle proteomics (Newcastle University) was used to confirm the 
presence of ORF6 RNAP in the 200 mM imidazole elution fraction. This fraction was 
concentrated using a Centricon device with a 10 000 MW cut off (Merck-Millipore) and 
made to 50% glycerol before storage at -20 ⁰C.  
4.2.3. Co-expression and purification of ORF6 RNAP and ORF7p in S. cerevisiae 
ORF6C+ and ORF7 DNA fragments were amplified from pUC57 and isolated pGKL2 using 
primer pairs ORF6C+pESC L + ORF6C+ pESC R and ORF7 pESC L + ORF7 pESC R 
respectively. pGKL2 DNA was obtained from Kluyveromyces lactis strain AWJ137 grown 
overnight in YPD media. Cells were harvested and resuspended in 250 µl of buffer P1 
of the Qiagen Miniprep kit. 100 µl of acid washed glass beads and vortexed for 5 
minutes. pGKL2 was then purified according to the Qiagen miniprep manufacturer’s 
instructions. The fragments were sequentially cloned into pESC – URA. The resulting 
construct, pESC-URA:ORF6C+:ORF7 was transformed in YPH499 S. cerevisiae strain. 
YPH499 carrying the pESC-URA:ORF6C+:ORF7 construct was grown and induced by SC- 
URA galactose as in previous section (4.2.1.1). Cells were harvested by centrifugation 
in JLA 8.1000 rotor (Beckman) at 6000 rpm for 10 minutes. Pellets were weighed and 
resuspended in 10  x volume of pESC breaking buffer and French pressed twice at 35 
Kpsi. Lysates were clarified by centrifugation at 16 000 rpm in a JA25.50 rotor. The 
lysate was made to 600 mM NaCl and the pH was adjusted to pH 7 through gradual 
addition of 1% NaOH. Lysate was filted through 0.2 µM filter (Helena Biosciences) 
before 1 ml of Anti – FLAG M2 (Sigma Aldrich) resin was added. The lysate and resin 
were incubated at 4 ⁰C for 90 minutes with gentle shaking. Resin was collected on filter 
paper disc (Whatman) by filtration through a Buckner flask. Resin was washed in a 
total of 90 ml Tris Buffed Saline pH 7 (TBS) by resuspension followed by filtration. The 
resin was resuspended in 10 ml TBS and decanted into a gravity flow column (Bio Rad). 
Once the resin had settled, protein was eluted by 6 x 1 ml aliquots of glycine pH 2. 
Eluate was collected into 2 ml microcentrifuge tubes containing 25 µl Tris – HCl pH 8. 
The protein content of the eluate was visualised through SDS PAGE followed by silver 
staining.          
 
64 
  
4.2.4. Purification of ORF7p 
pGKL2 DNA was used as template DNA for the amplification of ORF7 with primers 
ORF7 pET21 L  and ORF7 pET21 R. pET-21: ORF7 was transformed into the T7 express 
E. coli strain (New England Biolabs). All growth was done in the presence of 100 µg ml-1 
ampicillin. An overnight culture of T7 express E. coli carrying pET-21: ORF7 was used to 
inoculate 6 L of LB media at a ratio of 1:1000. Cultures were grown at 37 ⁰C with 
shaking until an OD600 of 0.4 was reached. 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG, Melford) was added to cultures which were then left to 
grow for a further 3 hours. Cells were harvested by centrifugation in a Beckman JLA 
8.1000 rotor at 6000 rpm for 10 minutes. Isolation of ORF7 p inclusion bodies was 
based on the method presented by Borukhov and Goldfarb (1993). Cell pellets were 
resuspended in 40 ml of grinding buffer supplemented with 0.2 mg ml-1 lysozyme 
(Fluka) and 0.2% sodium deoxycholate. Cells were incubated on ice for 20 minutes 
before disruption by a Braun sonicator for 3 minutes (2 seconds on, 2 seconds off) at 
60 % amplitude. Inclusion bodies were pelleted by centrifugation in a Beckman JA25.50 
rotor at 15 000 rpm for 20 minutes at 4 ⁰C. Inclusion bodies were resuspended in 40 ml 
grinding buffer with 0.2 mg ml-1 lysozyme and 0.2 % n-octyl β-D-glucopyranoside 
(Sigma Aldrich) and sonicated as before. After centrifugation, pelleted inclusion bodies 
were resuspended in 40 ml grinding buffer with 0.2 % n-octyl β-D-glucopyranoside and 
sonicated. Isolated inclusion bodies were dissolved in 30 ml 8 M urea followed by 
clarification by centrifugation for 20 minutes at 15 000 rpm. Dissolved ORF7p was 
subjected to syringe driven Ni2+ - NTA chromatography under denaturing conditions 
(8M urea). ORF7p was loaded onto a 5 ml Ni2+ - NTA column (GE Healthcare) pre-
equilibrated with 8M urea. The bound proteins were eluted from the column by 
washing with increasing concentrations of imidazole (0 mM, 25 mM, 100 mM and 200 
mM). SDS-PAGE analysis revealed that ORF7p eluted at 25 mM imidazole. Therefore, 
this elution fraction was diluted 16 x in 8M urea and dialysed overnight against ORF7p 
storage buffer.  
4.2.5. Co-expression and purification of ORF6 RNAP and ORF7p in E. coli 
ORF6C+ and ORF7 DNA fragments were amplified from pUC57 and pGKL2 using primer 
pairs ORF6C+pACYC L + ORF6C+ pACYC R and ORF7 pACYC L + ORF7 pACYC R, 
respectively. The ORF6C+ and ORF7 PCR fragments were sequentially cloned into pACYC 
duet vector. An overnight culture of T7 Express E. coli cells (New England Biolabs) 
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carrying the pACYC:ORF6C+:ORF7 construct was used to inoculate 2 litres of LB 
supplemented with 33 µg ml-1 chloramphenicol. The cultures were grown with shaking 
at 37 ⁰C until an OD600 of 0.4 was reached, at which point the cultures were shifted to 
18 ⁰C and grown overnight.  
Disruption of the cells and the following Ni2+-NTA chromatography were performed as 
described in section 4.2.1, with the following alterations. Harvested cells were 
resuspended in 40 ml of grinding buffer and the YonO Ni2+ buffer was exchanged for 
ORF6 RNAP Ni2+ buffer with a NaCl concentration of 300 mM. According to SDS PAGE, 
ORF6 RNAP was present in the 100 mM imidazole elution fraction. This fraction was 
diluted 1 in 4 with ORF6 RNAP heparin buffer and subjected to Heparin affinity 
chromatography. The diluted protein was loaded onto a 5 ml Heparin HiTrap column 
(GE Healthcare) pre-equilibrated with ORF6 RNAP heparin buffer containing 100 mM 
NaCl using the p900 pump on the AKTA Explorer FLPC system (GE Healthcare) at a flow 
rate of 2 ml min-1. Protein was eluted by washing the column with ORF6 RNAP heparin 
elution buffer containing increasing concentration of NaCl (100 mM, 300 mM, 600 mM 
and 1 M NaCl). The protein content of each elution fraction was determined by SDS 
PAGE. The elution fractions were made to 50% glycerol and stored at -20 ⁰C.      
4.2.6. SDS PAGE 
Proteins were suspended in Laemmli buffer, boiled for approximately 3 minutes and 
loaded onto a precast 4-12% SDS PAGE gel (Expedeon). SDS PAGE gels were ran in 
Rapid Run buffer (Expedoen) at 150 v for 45 minutes. Gels were stained overnight with 
the coomassie blue based Instant Blue stain (Expedeon).   
4.2.7. Silver stain of SDS PAGE gel 
Proteins were resolved on SDS PAGE as above. Gels were incubated for 30 minutes in 
fixation solution. Fixation was followed by 30 minute incubation in sensitising solution. 
The gel was washed 3 times in distilled water for a total of 15 minutes. Water was 
decanted off and the gel was incubated for 20 minutes in silver solution. After a brief 2 
minute wash with water, protein was visualised through incubation in the developing 
solution. Development was stopped after protein became visible by the removal of 
developer and washing in distilled water.  
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4.2.8. Western Blot 
Lysates were run on a 4-12% SDS-PAGE gel (Expedeon) as described above. The SDS-
PAGE gel was blotted onto Amersham Hybond – P membrane (GE Healthcare) using 
wet transfer apparatus (Bio-Rad). The membrane was equilibrated in transfer buffer 
(1X Tris-Glycine, 0.2% SDS and 20% methanol) for 10 minutes prior to blotting. The 
membrane was washed with western blot buffer before being left shaking in western 
blocking buffer for 1 hour at room temperature or overnight at 4⁰C. The blocking 
buffer was replaced with 5 ml of fresh blocking buffer (2% milk powder) containing the 
primary antibody (1 in 1000 dilution for α-YonO antibody) was left incubating at room 
temperature for 1 hour. The membrane was washed thoroughly with blot buffer for a 
total of 20 minutes before blocking buffer (2% milk powder) containing the secondary 
antibody (1 in 10000 dilution. Goat anti rabbit HRP conjugate, Sigma Aldrich) was left 
shaking with the membrane for 1 hour. The membrane was washed with blot buffer 
for 30 minutes. The ECL reaction (GE Healthcare) was carried out following 
manufactures’ instructions and exposed using an Image Quant gel doc system (GE 
Healthcare).  
4.2.7. Affinity purification of α-YonO Antibody from Serum 
YonO was expressed and purified as above. The N-terminal His tag was removed using 
thrombin cleavage capture kit (Novagen). Thrombin cleavage was performed following 
the provided manufacturer’s instructions with 1 unit of biotin tagged thrombin per 1 
mg of purified YonO (10 mg in total). Cleavage reactions were incubated at room 
temperature for 16 hours. Visible precipitation formed during incubation, this was 
removed by centrifugation. Biotinylated thrombin was removed through 
immobilisation on streptavidin agarose beads. To separate tag free and N-terminal His 
tag YonO, soluble YonO was loaded onto 1 ml Ni2+-NTA column. YonO present in the 
flow through and 0 mM imidazole wash was pooled, made to 50 % glycerol and sent to 
the Eurogentec to raise antibodies. Antibodies were raised by immunising 2 rabbits 
over 28 days. Serum from preimmune bleed, middle bleed (3 weeks after 
immunisation) and final bleed (4 weeks after immunisation) was supplied.    
Antibodies were purified by affinity chromatography with cyanogen bromide (CNBr) 
activated sepharose coupled to YonO. YonO was purified as before except Tris-HCl pH 
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7.9 was replaced with HEPES-KOH pH 7.9 in all purification buffers. Following 
purification, thrombin cleavage capture kit was used to remove the N-terminal His tag. 
Coupling of YonO to CNBr and subsequent purification was adapted from Banzhaf et al. 
(2012). 0.8g of CNBr activated sepharose (Sigma Aldrich) was poured into a gravity 
flow column (Bio-rad) and washed with 200 ml of 1 mM HCl for 15 minutes. 4 mg YonO 
was added to 10 ml coupling buffer. This was in turn incubated with the CNBr 
sepharose beads overnight with mixing. Resin was washed with 25 ml coupling buffer. 
The uncoupled active groups of the CNBr sepharose were blocked through overnight 
incubation with 10 ml blocking buffer. The following day, the resin was washed with 20 
ml of acetate buffer and 20 ml of blocking buffer. This washing was repeated a total of 
three times. The column was then washed and stored in 5 ml binding buffer. When 
required for use, the column was initially washed with 1 column volume (10 ml) of 
elution buffer I to remove weakly bound YonO and prevent contamination of 
subsequently eluted antibodies. Immediately after, 30 ml of buffer I was flowed 
through the column. 10 ml of serum from the final bleed of rabbit 2 was added to 35 
ml of diluent buffer before clarification by centrifugation at 4500 rpm for 10 minutes. 
Resin was decanted from the column into a 50 ml falcon tube and incubated with 
diluted serum for 20 hours with gentle mixing. Resin was transferred into the gravity 
flow column and the diluted serum was allowed to flow through. Column was washed 
with 20 ml of buffer I and buffer II. Antibodies were eluted by flowing 10 x 1 ml 
aliquots of elution buffer I through the column. Eluate was collected in 2 ml 
microcentrifuge tubes containing 200 µl elution buffer II. 300 µl 100% glycerol was 
added and the elution fractions were stored at -80 ⁰C. SDS – PAGE was used to 
determine the antibody content of each elution fraction. Elution fractions 2 – 3 was 
pooled and aliquoted. All antibody aliquots were stored at -80 ⁰C.  
4.2.9. Electron Microscopy 
Negative stain transmission electron microscopy was performed as previously 
described by Prof Robin Harries of the Electron microscopy research services at 
Newcastle University (Harris, 1997, Harris, 2008). 2% w/v uranyl acetate was used for 
negative staining and microscopy was performed on a Zeis EM900 electron 
microscope.        
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4.3. Bacillus subtilis Methods  
4.3.1. Transformation of B. subtilis 
Transformation procedure was based on a two-step starvation procedure 
(Anagnostopoulos and Spizizen, 1961). 300 µl of overnight culture of strain 168 grown 
in MM media at 30⁰C was inoculated into 5 ml of MM media. The culture was grown at 
37⁰C for 3 hours before an equal volume of starvation media was added. After a 
further 2 hours of growth, 200 – 300 ng of DNA was added to 600 µl of culture and 
grown for 1 hour before plating onto nutrient agar containing 2 µg ml-1 kanamycin. 
4.3.2. Isolation of Genomic DNA from B. subtilis  
An overnight culture of the relevant B. subtilis strain grown in LB at 30 ⁰C was diluted 1 
in 100 and grown at 37⁰C until an OD600 of 0.5 was reached. 2ml of culture was spun 
down at 13 000 rpm and resuspended in 180 µl B. subtilis lysis buffer. 5 µl of lysozyme 
was added and the cells were incubated at 37⁰C for 30 minutes. 25 µl of proteinase K 
was added along with 200 µl of Buffer AL from the Qigaen DNeasy kit and incubated 
for 30 minutes at 56 ⁰C with shaking. 200 µl of 100% ethanol was added and the lysate 
was applied to the Qiagen column. From this point the genomic DNA was isolated as 
per the instructions of the Qiagen DNeasy Blood and Tissue kit.   
4.3.3. Construction of a B. subtilis ΔyonO strain 
Double cross over homologous recombination was utilised to generate a ΔyonO strain. 
Using genomic DNA from strain 168 as template DNA, primer pairs pBEST:UP L + 
pBEST:UP R and pBEST:DOWN L + pBEST:DOWN R were used to amplify 2kb regions 
upstream and downstream of the yonO open reading frame, respectively. The PCR 
products were purified and cloned into the pBEST 501 plasmid. This generated the 
plasmid pBEST:U:D, which contained a neomycin resistance cassette flanked by DNA 
sequence homologous to the upstream and downstream region of the yonO open 
reading frame. The plasmid was transformed into strain 168. Transformants were 
plated onto nutrient agar supplemented with 2µg ml-1 kanamycin (Melford). Individual 
transformant colonies were purified by restreaking onto 2µg ml-1 kanamycin nutrient 
agar. PCR on genomic DNA using primers pBESTdx L and pBESTdx R was used to 
confirm the resistance cassette had integrated into the chromosome by double 
crossover homologous recombination. Additionally, sequencing using primer pairs 
pBEST seq L + pBEST seq R and pBEST internal seq L + pBEST internal seq R was used to 
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confirm the deletion of yonO. Genomic DNA from the ΔyonO strain was isolated and 
used to back cross the ΔyonO mutation into the parental strain twice.  
4.3.4. Induction of SPβ prophage from Bacillus subtilis  
The following protocol is adapted from Molecular Biological Methods for Bacillus 
(Harwood and Cutting, 1991). Overnight cultures of the relevant B. subtilis strain were 
grown at 30⁰C in MMB medium. These cultures were used to inoculate fresh MMB 
medium to an OD600 of 0.02. The cultures were grown at 37⁰C until they reached mid 
log phase (approximately 0.5 OD600). To induce SPβ, Mitomycin C (Melford) was added 
to a final concentration of 0.5µg ml-1. Lysis of induced cells occurred at approximately 
2 hours post induction.  
4.3.5. B. subtilis lysates for western blot 
B. subtilis cells were grown and induced by Mitomycin C. At the required time point, 
cells were harvested by centrifugation at 9000 rpm for 5 minutes. Pellets were frozen 
in liquid nitrogen and stored at -20 ⁰C. Pellets were resuspended in grinding buffer. 
The volume of grinding buffer was one tenth of the volume of cells harvested, typically 
5 ml. Cells were then sonicated using a Braun sonicator at 60% amplitude, with 2 
seconds on, 2 seconds off, for a total of 4 minutes. The lysates were clarified by 
centrifugation for 5 minutes at 14 000 rpm. The protein concentration of the lysates 
was determined using Bradford reagent. The protein concentration was then used for 
equal loading of the samples on an SDS PAGE gel. The western blot and probing of the 
membrane were carried out as described in section 4.2.6.   
4.3.6. Isolation of total RNA from B. subtilis for RNAseq 
Fresh MMB media was inoculated with cultures of B. subtilis grown in MMB media 
grown overnight at 30 ⁰C. Cultures were grown at 37 ⁰C until mid-log phase (0.5 OD600) 
was reached, at which point the cultures were split in half. To one half, SPβ was 
induced by the addition of Mitomycin C at final concentration of 0.5 µg ml-1. The other 
half of the culture was not induced. 60 minutes post induction, cultures were 
harvested by centrifugation at 14 000 rpm in a Table top centrifuge and the pellets 
were frozen in liquid nitrogen. To extract total RNA from cell pellets, the Total RNA 
Plus kit (Norgen) was used as per the manufactures instructions.  
To determine the quality of isolated total RNA, an RNA 6000 nano chip and Bioanalyser 
2100 (Agilent) were used to the manufacture instructions. For RNAseq, total RNA was 
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sent to Primbio in the United States. Once there, rRNA was depleted prior to library 
construction. Sequencing was carried out using Ion torrent technology (Life 
technologies). 
4.3.7. Isolation of SPβ particles  
Method adapted from Molecular Biology Methods for Bacillus (Harwood and Cutting, 
1991). To produce SPβ phage particles, B. subtilis strain 168 was grown to 0.5 OD600 
before Mitomycin C induction of SPβ (see previous section). After lysis ~120 minutes 
after induction, the cultures were centrifuged at 13000 rpm for 2 minutes. The 
supernatant, containing phage particles, was then filtered using a syringe driven 0.45 
µM PVDF filter (Merck-milipore).   
The SPβ sensitive strain, A100A was grown until mid-log phase (0.5 OD600). 0.3ml of 
A100A culture was then incubated for 2 minutes at room temperature with 0.1ml of 
isolated SPβ particles. 3ml of MMB overlay agar (MMB media plus 0.5% agar) medium 
was added before plating out onto bottom agar (MMB plus 2% agar). Plates were 
incubated overnight at 37 ⁰C before being inspected for plaque formation.  
4.4. X-ray Crystallography Methods     
4.4.1 Initial Screening for Crystallisation Conditions 
Screening for crystallisation conditions was carried out using MRC 2 well sitting drop 
96 well plates (Molecular Dimensions). 80 µl of each screen condition was dispensed 
into the reservoirs of the 96 well plate using a multichannel pipette. The standard set 
of crystallisation screens included JSCG, Proplex, MIDAS, Index, Morpheus, Structure 
and AmSO4 screen. All screens except Index and AmSO4 were obtained from Molecular 
Dimensions. Index and AmSO4 screens were purchased from Hampton Research and 
Qiagen, respectively. 100 nl and 200 nl of 10 mg ml-1 YonO was dispensed by the 
Mosquito robot (TTP Labtech) into each well of the MRC 96 well plate and mixed with 
100 nl of reservoir solution. All subsequent screenings were carried out with purified 
YonO at a concentration of 10 mg ml-1. Once dispensed, 96 well plates were sealed and 
equilibrated overnight at 20 ⁰C. Formation of crystals was visualised using a Leica 
microscope. Crystals of interest were harvested using a Hampton loop and were 
cryoprotected in saturated ammonium sulphate before storage in liquid nitrogen. 
Harvesting of crystals was performed by our collaborator, Dr Arnaud Baslé. 
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4.4.2. Determination of Crystal Quality 
All harvested crystals had their diffraction tested by synchrotron radiation on the IO4-1 
beamline at Diamond Lightsource synchrotron in Oxfordshire by Dr Arnaud Baslé.  
4.4.3. Optimisation of Crystallisation Conditions 
The conditions of the CoCl2 custom 96 well plate optimisation screen can be seen in 
Figure 7-1b. The screen was mixed from concentrated stock solutions (1M HEPES pH 
7/7.5, 1M MES pH 6/6.5, 3M (NH4) SO4, 2M NaCl) and dispensed into a deepwell block 
by an automated Biomek robot (Beckman – Coultier). The custom screen was then 
used as previously described (section 4.4.1).  
4.4.4. Gel filtration calibration  
Gel filtration calibration of the Superdex 200 16/60 column was carried out as 
described in the High Molecular Weight Gel Filtration Calibration Kit (GE Healthcare). 
Standard proteins were loaded on the column and their elution volumes recorded 
Figure 4-1a). The elution volume (VE), the void volume of the column (VO) and the total 
volume of the column (VC) were used to calculate Kav using the formula: Kav=
VE-VO
VC-VO
 . Kav 
values were plotted against Log10 of the corresponding molecular weight of the 
standard proteins to give a calibration curve.  
To calculate approximate molecular weight of YonO eluting off Superdex 200 16/60 
column at 70 ml and 60 ml, Kav values were determined and the equation of the 
calibration curve trend line was used to determine the log10 molecular weight of eluted 
protein.     
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Figure 4-1: Calibration of Superdex 200 gel filtration column. a) Kav values of Protein 
standards. Protein standards were loaded on Superdex200 16/60 column and elution 
volumes were recorded. Elution volumes were used to calculate Kav values (see text 
for formula). b) Gel filtration calibration curve. Kav values of protein standards were 
plotted against the log10 of their molecular weight. The equation of the trend line is 
shown. c) Calculation of molecular weight of eluted YonO. Gel filtration elution 
volume of YonO monomer and potential oligomer were determined and used to 
calculate Kav values. Using the equation of the calibration curve trend line, the Log10 
molecular weight of eluted YonO was determined. From this, the molecular weights 
were obtained.     
4.4.5. Post crystallisation Optimisation of Crystal Diffraction 
4.4.5.1. HC1 Dehydration of Crystals 
Unless stated otherwise, crystals for dehydration were generated by dispensing 300 nl 
and 600 nl of purified YonO into each well of an MRC 2 well plate and mixing with 300 
nl of the corresponding reservoir solution. The CoCl2 and AMSO4 screens were used for 
generation large crystals (≥100 µM) for dehydration. The plates were sealed and 
allowed to equilibrate at 20 ⁰C overnight.  
For dehydration of crystals at the Diamond Light Source, the cryostream on the IO4-1 
beamline was removed and replaced by the HC1 dehumidifier. To equilibrate the HC1 
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dehumidifier, the screen condition for each crystal to be tested was dropped onto a 
Hampton loop and loaded onto the goniometer. The HC1 relative humidity was then 
increased or decreased to find the humidity which allowed for a constant drop size, at 
which point the humidifier was equilibrated.  The drop size was monitored using the 
camera loaded onto the beamline and the HC1 control software.  
Once the HC1 dehumidifier was equilibrated, a YonO crystal was harvested in a 
Hampton loop and loaded directly onto the goniometer. The crystal was then 
dehydrated by lowering the humidity for a given time, after which the diffraction was 
tested.    
4.4.5.2. In situ screening of dehydration conditions 
In situ screening and testing of diffraction at Diamond Light Source was carried out by 
Dr Arnaud Baslé. The method below was based on that of Douangamath et al. (2013). 
Purified YonO was dispensed into a CrystalQuick X-ray plate (Molecular Dimensions) 
and mixed with reservoir solution at a ratio of 2:1. 200 nl and 140 nl of YonO was 
dispensed in the wells of CrystalQuick X-ray plate (Molecular Dimensions) by a 
Mosquito robot and mixed with 100 nl and 70 nl of reservoir solution, respectively. 
Condition G12 (100 mM MES pH 6.5, 1.8 M Ammonium sulphate) of the Ammonium 
Sulphate Screen (Qiagen) was used for the reservoir. Crystals were grown by overnight 
incubation at 20 ⁰C. Dehydration was achieved through vapour diffusion with a 96 well 
dehydration screen. The dehydration screen was added to the reservoirs of the 
CrystalQuick plate after YonO crystals had formed and dehydration was allowed to 
proceed overnight at 20 ⁰C. The CrystalQuick plate was loaded onto the IO4-1 
beamline. Crystals from each dehydration condition were tested for increased 
diffraction.    
 
4.5. In vitro Transcription Methods 
4.5.1. Assembled Elongation Complexes 
Assembled complexes were set up as previously described (Korzheva et al., 1998, 
Sidorenkov et al., 1998, Yuzenkova et al., 2010, Zenkin et al., 2006b). All reactions were 
set up in a final volume of 10 µl. All oligonucleotides were synthesised by IDT 
technologies, sequences of which are displayed in the corresponding Figures. Template 
74 
  
DNA strands were modified to bear a biotin tag at the 5’ terminus. For each 
transcription reaction 1 pmol of template DNA strand was incubated with 0.5 pmol of 
corresponding RNA for 5 minutes at 45 ⁰C in the presence of transcription buffer. 
Unless stated otherwise, MgCl2 was present in the transcription buffer at a final 
concentration of 10 mM. Once formed, the DNA:RNA hybrids were allowed to cool at 4 
⁰C for 20 minutes. 5 pmol of RNA polymerase (YonO, ORF6 RNAP or E. coli core RNAP) 
was added to the hybrid and incubated at 30 ⁰C (ORF6 RNAP) or 37 ⁰C (YonO and E. coli 
core RNAP) for 5 minutes. If required, a 5 time excess of non-template DNA strand was 
added (5 pmol) and the complexes were incubated for a further 5 minutes at 30 ⁰C or 
37 ⁰C.  
To visualise RNA generated during the transcription reaction, the RNA was 32P labelled 
at either the 5’ or 3’ end. For 5’ end labelling, the RNA was labelled with γ-[32P]-ATP 
(see section 4.5.2) by T4 polynucleotide kinase (Thermo Scientific) prior to assembly of 
elongation complexes. To label the RNA at the 3’ end, assembled complexes were 
allowed to incorporate an α-[32P]-NTP for 5 minutes at 37 ⁰C before complex 
immobilisation and washing.  
If the assembled complexes were to be immobilised, at this point 5 µl of either 
streptavidin sepharose beads (GE Healthcare) were added and the assembled 
complexes were immobilised to the beads by vortexing at room temperature for 5 
minutes. Prior to use, sepharose beads were equilibrated in transcription buffer. 
Streptavidin sepharose beads immobilised complexes by the 5’ biotin tag present on 
the template DNA strand. Alternatively, complexes could be immobilised to Ni2+ 
sepharose beads through the His tag present on the RNA polymerase. Once 
immobilised, unstable complexes and unassembled components were removed by 
washing the immobilised complexes with transcription buffer containing high salt (1M 
KCl) followed by washing in low salt transcription buffer (40mM KCl). 
Transcription reactions were started by the addition of NTPs and incubation at 30 ⁰C or 
37 ⁰C. The final concentration of NTPs for each experiment can be found in the 
corresponding Figure along with the incubation time. Transcription reactions were 
stopped by the addition of an equal volume of formamide containing stop buffer. 
Transcription reactions were resolved by 23% denaturing (8M urea) polyacrylamide gel 
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electrophoresis (PAGE). Gels were exposed and revealed by the Phosphorimaging 
system (GE Healthcare). ImageQuant software was used for any subsequent analysis.  
For cleavage reactions, complexes were assembled as described but in the absence of 
MgCl2. Reactions were started by the addition of MgCl2 and were resolved and 
analysed as described above. Pyrophosphorolysis was performed using immobilised 
complexes as above. Except reactions were carried out in transcription buffer pH 6.8 
and initiated by the addition of 500 µM pyrophosphate.  
4.5.2. 5’ 32P labelling of oligonucleotides 
To 32P label oligonucleotides to be used in assembled elongation complexes, 150 pmol 
of RNA/ DNA oligonucleotide (sequence displayed in the corresponding Figure) was 
mixed with 5 µl of y-[32P]-ATP and 15 units of T4 Polynucleotide kinase (PNK) in 
reaction buffer A (Thermo scientific) with a final volume of 30 µl (5 µM oligonucleotide 
final concentration). The reaction was incubated for 1 hour at 37 ⁰C. PNK was 
inactivated by heating at 65 ⁰C. Oligonucleotides were cleaned up using a Microspin 6 
chromatography column (Bio-rad) following the manufacturer’s instructions. 
To label DNA oligonucleotides used in primer extension, sequencing and to generate 
32P labelled DNA used in footprinting experiments, 12.5 pmol of DNA oligonucleotide 
was labelled in a 25 µl reaction to generate DNA oligonucleotide at a final 
concentration of 0.5 µM. DNA was cleaned up as before (See above).   
4.5.3. Transcription Initiation 
DNA for transcription initiation experiments was generated via PCR using B. subtilis 
genomic DNA as template (for primers used, see Table 4-1). Predicted start sites of 
transcription, as determined by analysis of transcript profiling (Nicolas et al., 2012), 
were amplified with an additional 100 bp of sequence either side of the predicted start 
site. Each transcription reaction was carried out in a final volume of 10 µl. For each 
reaction, 1 pmol of template DNA was mixed with 5 pmol of YonO in transcription 
buffer. To label RNA produced during transcription, 0.15 µM α- [32P]-UTP (unless 
stated otherwise) was used to start transcription along with 50 µM UTP, 500 µM ATP, 
GTP, CTP. If required, heparin was added simultaneously with NTPs to a final 
concentration of 5 µg ml-1. Reactions were incubated at 37 ⁰C and were stopped after 
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30 minutes (unless stated otherwise) by the addition of equal volume of stop buffer. 
RNA was resolved using 15% PAGE and visualised as described previously.       
E. coli RNAP transcription from the T7A1 promoter was used to generate RNA of a 
known size. The T7A1 promoter was present on a 328 bp DNA fragment that was 
biotinylated on the 5’ terminus of the template strand. For each 20 µl reaction, 1 pmol 
of core RNAP was mixed with 0.5 pmol T7A1 DNA, 5 pmol of σ70, 50 µM CAUC primer, 
10 µM ATP, 0.15 µM α-[32P]-GTP and incubated at 37 ⁰C . After 2 minutes of 
incubation, 10 µM GTP was added and reactions were incubated for a further 2 
minutes. When provided ATP and GTP, RNAP initiates transcription on the T7A1 
promoter and synthesises an 11 nt RNA. Elongation complexes were immobilised to 
streptavidin beads and washed once in high salt transcription buffer followed by 8 
washes in low salt transcription buffer. Transcription was resumed by providing the 
immobilised elongation complexes 25 µM NTPs. Reactions were incubated for 120 or 
300 seconds before being stopped by the addition of an equal volume of formamide 
stop buffer.  
4.5.4. Primer Extension 
To generate RNA for primer extension, transcription initiation reactions (described in 
section 4.5.4) were scaled up from 10 µl to 200 µl.  
2 µl of DNase I was added to reactions for 20 minutes and incubated at 37 ⁰C. RNA was 
phenol chloroform extracted and subsequently ethanol precipitated overnight. 
Precipitated RNA was resuspended in 30 µl RNase-free water.  
For primer extension, 2 µl of RNA was mixed and incubated with 1 pmol of 5’ labelled 
DNA primer for 10 minutes at 65 ⁰C. Samples were cooled on ice for 5 minutes before 
the addition of the MgCl2 to a final concentration of 20 mM. To this, 5X first strand 
buffer, dNTPS (final concentration) and 200 units of reverse transcriptase Superscript II 
(Invitrogen) were added. Primer extension was allowed to occur for 20 minutes at 37 
⁰C. Reactions were stopped by the addition of an equal volume of stop buffer and 
primer extension products were resolved by denaturing 6% PAGE and visualised using 
Phosphorimaging (GE Healthcare).  
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4.5.6. Potassium Permanganate DNA Footprinting 
5’ 32P labelled DNA was generated through PCR. To specifically label the template or 
non-template DNA strand, a 5’ 32P labelled primer was used. End labelled DNA was 
purified using the Qiagen Gel Extraction kit as per the manufacturer’s instructions. For 
each reaction, 5 pmol of YonO was mixed with 1 pmol of 5’ 32P labelled DNA in 
transcription buffer and incubated for 10 minutes at 37 ⁰C. If required, heparin was 
added to a final concentration of 5 µg ml-1 followed by 5 minutes of further incubation. 
DNA was modified by the addition of 5 mM of KMnO4 (final concentration) at 37 ⁰C. 
The reaction was allowed to proceed for 30 or 60 seconds, after which point 500 mM 
β-mercaptoethanol was added. 2 µl of 10 µg ml-1 glycogen was added before the DNA 
was extracted using phenol:chloroform:isoamy alcohol (25:24:1). DNA was ethanol 
precipitated and dissolved in 90 µl of water. To this, 10 µl of piperidine was added and 
incubated at 90 ⁰C for 20 minutes. Piperidine was removed by chloroform and DNA 
was ethanol precipitated. Pelleted DNA was resuspended in 20 µl formamide 
containing stop buffer. Footprint products were resolved on a 6% polyacrylamide 
sequencing gel alongside sequencing reactions of the same DNA template.  
4.5.7. DNase I Footprinting  
1 pmol of 5’ 32P end labelled template DNA was incubated for 10 minutes with YonO at 
room temperature. The amount of YonO used for each reaction was varied, see 
corresponding Figure for details. For each reaction, 1 unit of DNase I (Roche) diluted in 
1 X incubation buffer provided, was added. Unless stated otherwise, reactions were 
incubated for 2 minutes at room temperature. To stop the reactions, an equal amount 
of stop buffer was added. Cleaved DNA was resolved on 6 % sequencing PAGE gel.  
4.5.8. Sanger Sequencing of DNA   
For each DNA template sequenced, 4 reactions were set up. Each reaction was 
comprised of 2.5 mM MgCl2, GoTaq flexi buffer, 0.1 pmol template DNA, 0.1 pmol 5’ 
32P labelled DNA primer, 0.5 units of GoTaq DNA polymerase. To each individual 
reaction, a dideoxynucleotide (ddNTP) termination mix was added. Four ddNTP mixes 
were used, one for each nucleotide. ddATP, ddGTP, ddCTP and ddTTP were present in 
the respective sequencing reactions at final concentrations of 0.6 mM, 80 µM, 0.3 mM 
and 0.9 mM, respectively. The three remaining dNTPs had final concentrations of 10 
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µM. The reactions were loaded into the thermocycler and sequencing reactions were 
performed with the following programme: 
  Temperature (⁰C) Time (s) Cycles 
94 120   
94 30 
30 55 30 
72 30 
72 120   
10 pause   
 
An equal volume (8 µl) of formamide containing stop buffer was added to each 
sequencing reaction. The products of the sequencing reactions were resolved on a 6% 
PAGE gel in denaturing conditions and visualised by phosphorimaging.  
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Chapter 5: Preliminary Characterisation of YonO, a Putative RNA 
polymerase of SPβ prophage 
5.1. Introduction 
YonO was first identified as an RNAP through distant homology to the eukaryotic 
rdRNAP (Iyer and Aravind, 2012, Iyer et al., 2003). The homology included the 
aspartate triad which is essential for catalysis and conserved amongst all eukaryotic 
rdRNAP and multisubunit (Iyer et al., 2003, Sosunov et al., 2005). Whilst YonO and 
rdRNAP share additional conserved amino acids and motifs, the only similarity 
between YonO and multisubunit RNAP is the presence of the triad and two predicted 
DPBB folds. None of the additional domains that participate in transcription, including 
the trigger loop, appear to be conserved in YonO. Therefore YonO has been designated 
as a bacteriophage rdRNAP maintained in the B. subtilis genome that functions in an as 
yet undetermined stage of the SPβ life cycle (Iyer and Aravind, 2012, Iyer et al., 2003).  
YonO is a hypothetical protein and all current understanding of its function and 
structure has been derived purely from bioinformatics analysis. It remains to be seen if 
YonO possesses nucleic acid polymerisation activity. Proof YonO is a functional enzyme 
would raise a wide range of questions, including how it accomplishes transcription 
despite an apparent lack of catalytic domains and the impact of an additional RNAP on 
the transcriptome of B. subtilis.  
5.2. Aims 
The aim of this work was to determine if YonO is a catalytically active enzyme capable 
of nucleotide polymerisation. If polymerising activity is shown, we will begin the 
characterisation of YonO. 
5.3. Expression and purification of YonO 
In order to conduct in vitro characterisation of YonO, purified YonO was required. To 
this end, yonO was amplified from B. subtilis genomic DNA and cloned into the pET-28 
expression vector. Cloning into pET-28 introduced an N-terminal His tag and allowed 
for IPTG induced over expression by T7 RNAP. The E. coli T7 expression strain carrying 
the pET-28: YonO construct was grown until mid-exponential phase and induced with 1 
mM IPTG. Induced cells were grown for a further 3 hours at 37 ⁰C before being 
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harvested. From visual inspection of the cell debris of lysed cells, it was clear expressed 
YonO protein had formed inclusion bodies. To prevent inclusion body formation, E. coli 
cells were shifted to 18 ⁰C and grown overnight upon induction of YonO expression by 
IPTG. The pelleted cell debris of disrupted cells showed that a decrease in temperature 
for expression was successful in preventing the formation of inclusion bodies.  
Expressed YonO bore a His-tag allowing for its purification from lysates by Ni2+-NTA 
chromatography (Figure 5-1a). To elute non-specific proteins bound to the column, the 
concentration of imidazole in the chromatography buffer was increased to 25 mM. The 
remaining protein bound to the Ni2+-NTA column, including YonO, was eluted by 100 
mM and 200 mM imidazole. SDS PAGE analysis of the protein content of the 100 mM 
and 200 mM imidazole elution fractions revealed YonO eluted off the column at both 
concentrations. The majority of YonO was present in the 100 mM imidazole elution 
fraction. Therefore, the protein in this fraction was concentrated and purified further 
by heparin affinity chromatography (Figure 5-1b). Heparin is a DNA analogue and can 
be used for the affinity purification of DNA binding proteins such as RNAP. Once 
loaded onto the column, YonO bound tightly to the Heparin HiTrap column as 800 mM 
NaCl was required for elution. After Heparin affinity chromatography, the purity of 
YonO was determined by SDS PAGE (Figure 5-1b). This showed that after the two 
chromatography steps, YonO was purified to apparent homogeneity.   
In addition to in vitro experiments, purified YonO was to be used for crystallisation 
screening. Gel filtration is a common final purification step for proteins designated for 
crystallisation as it increases the homogeneity of the protein sample by ensuring all 
protein is of an equal molecular weight and no oligomers are present. Therefore, YonO 
was loaded onto a Superdex 200 gel filtration column. The elution fractions were 
pooled and concentrated. Purified YonO was divided into two aliquots; one was 
dialysed against storage buffer and used for in vitro characterisation, whilst the other 
was used for crystallisation trials (see chapter 7).  
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Figure 5-1: Purification of YonO. a) Ni2+NTA chromatography. The T7 express E. coli 
strain carrying the pET-28: yonO construct was induced with 1 mM IPTG and grown 
overnight at 18 ⁰C. Cells were disrupted by sonication and lysates were loaded on the 
Ni2+-NTA column. The Column was washed with increasing concentrations of imidazole 
to elute proteins. Primarily, YonO was eluted by 100 mM imidazole and was collected 
in elution fractions 1 – 5. Protein content of elution fractions were analysed by SDS 
PAGE. Lanes 2 – 4 were loaded with 1 µl of protein. Lanes 5 – 10 were loaded with 10 
µl of protein. MW refers to the molecular weight ladder. b) Heparin affinity 
chromatography. 100 mM imidazole elution fractions (Ni2+ fraction) were pooled and 
loaded onto 5 ml Heparin HiTrap column. The column was washed with 500 mM and 
700 mM NaCl YonO heparin elution buffer to remove non-specific proteins. The 
remaining proteins were eluted by increasing the NaCl concentration to 1M over a 
gradient. The protein content of elution fractions was visualised by SDS PAGE, which 
showed YonO was eluted by approximately 800 mM NaCl. All lanes were loaded with 
10 µl of protein. c) Superdex 200 gel filtration. YonO in heparin elution fractions was 
concentrated to 10 mg ml-1 and loaded onto the Superdex 200 16/60 column. 2 ml 
elution fractions were collected throughout gel filtration, those containing protein 
were analysed by SDS PAGE. YonO eluted after 70 ml of gel filtration buffer had flown 
through the column. 5 µl of protein was loaded in all lanes.     
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5.4. In vitro characterisation of YonO  
5.4.1. Artificially Assembled Elongation Complexes 
Frequently in vitro transcription experiments are performed using elongation 
complexes (EC) which were derived from transcription initiation at a well characterised 
promoter such as T7A1 promoter of the T7 coliphage. This technique requires prior 
identification of promoter elements and detailed knowledge of transcription initiation 
and so is not applicable for the investigation of a novel RNAP. These limitations can be 
bypassed by the artificial assembly of elongation complexes (Sidorenkov et al., 1998). 
Artificial elongation complexes are assembled from a single stranded RNA primer and 
DNA oligonucleotides (Figure 5-2). The RNA primer is complementary to template DNA 
strand and so forms an RNA:DNA hybrid. RNAP is able to bind this hybrid and extend 
the RNA primer upon the addition of NTPs and Mg2+.  To increase the stability and to 
fully resemble promoter derived elongation complexes, the non-template DNA strand 
fully complementary to the template strand is included in the assembly of elongation 
complexes. Artificial elongation complexes are indistinguishable from those derived 
from a promoter (Sidorenkov et al., 1998, Yuzenkova and Zenkin, 2010). 
The standard GA36 scaffold (scaffold refers to the oligonucleotides bound by RNAP) 
used throughout this work is shown below. GA refers to the first two nucleotides to be 
incorporated upon provision of NTPs and 36 denotes the length of the template DNA 
strand. RNA13, so called due to its 13 nt length, hybridises with GA36 template DNA 
strand to give a hybrid of 9 bp. The 4 nt at the 5’ end of RNA13 are not complementary 
to GA36 to mimic the disengaged transcript.  
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Figure 5-2: Artificially Assembled Elongation Complexes. a) GA36 scaffold. The 
sequences of the oligonucleotides in the GA36 scaffold used throughout are work is 
shown. The non-template strand is fully complementary to the template strand. The 
Transcription bubble is formed by incorporating the non-template DNA after RNAP has 
bound the hybrid. b)  Immobilised assembled elongation complex. Shown is a 
schematic representation of an artificially assembled elongation complex. The 
elongation complex is immobilised to streptavidin coated sepharose bead through 5’ 
biotin tag on template strand DNA.  
To visualise elongation complexes and transcription, RNA13 can be 32P labelled at the 
5’ or 3’ end. 5’ 32P labelling of RNA is performed prior to complex assembly by 
incubation with T4 Polynucleotide Kinase and γ-[32P]-ATP. 3’ end labelling can be 
achieved through the incorporation of α-[32P]-NMP by assembled ECs.   
5.4.2. RNA Polymerase activity of YonO elongation complexes 
Assembled elongation complexes can be immobilised onto a solid phase, such as 
streptavidin sepharose beads, through a biotin tag present on the 5’ end of template 
strand DNA. Immobilising elongation complexes allows them to be washed with 
transcription buffer to remove unassembled oligonucleotides, RNAP and 
unincorporated α-[32P]-NTP. The stringency of the washing is governed by the ionic 
strength of the transcription buffer. Washing immobilised complexes with high ionic 
strength (1M KCl) removes unstable complexes to leave only stable, specific complexes 
suitable for in vitro transcription. As mentioned above, the non-template DNA strand is 
included during the assembly of elongation complexes to increase their resemblance 
to promoter derived complexes. Furthermore, the non-template DNA strand is 
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required for stability. When the non-template DNA strand is omitted during assembly, 
immobilised bacterial elongation complexes are destroyed by high salt conditions 
(Sidorenkov et al., 1998).        
To determine if YonO possesses RNAP activity, as predicted by the conservation of the 
aspartate triad, YonO was incubated with the GA36 scaffold to assemble elongation 
complexes. In accordance with the length of the RNA primer (13 nucleotides), 
elongation complexes assembled on the GA36 scaffold will be referred to as EC13. The 
RNA13 component of the scaffold was 5’ 32P labelled to allow us to observe RNA 
polymerisation. The assembled complexes were immobilised to streptavidin beads and 
washed with either low ionic strength (40 mM KCl) or high ionic strength (1 M KCl) 
transcription buffer. The complexes were then provided with a high concentration of 
NTPs (500 µM) and incubated for 30 minutes at 37 ⁰C.  
 
Figure 5-3: Determination of YonO RNAP activity. a) Sequence of GA36 scaffold. The 
GA36 scaffold used to form YonO EC13. EC13 was detected though 5’ 32P labelling of 
RNA13 (indicated by red asterisk) prior to assembly. b) Immobilisation of YonO 
elongation complexes. Assembled complexes were immobilised onto streptavidin 
beads and washed with low salt (40 mM) transcription buffer. Subsequently, the 
complexes were incubated for 30 minutes at 37 ⁰C in the presence of 500 µM NTPs. c) 
Kinetics of YonO RNA polymerisation. Elongation complexes formed in the absence of 
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the non-template DNA strand. Transcription was initiated as for Figure 5-3b but 
reactions were allowed to proceed for the indicated length of time. d) The aspartate 
triad is essential for YonO RNAP activity. EC13 was assembled in the absence of the 
non-template DNA strand using the YonO D537N D538N mutant and incubated for 
1800 seconds at 37⁰C in the presence of 500 µM NTPs. Wildtype (WT) YonO EC13 were 
formed as a control. All of the above reactions were terminated by the addition of 
formamide containing stop buffer and resolved by 23% denaturing PAGE.    
During the assembly of elongation complexes, RNAP is required to prevent loss of the 
RNA primer in the washing stages. In the above experiment (Figure 5-3b, lane 2), 
RNA13 was not lost during washing of the immobilised YonO elongation complexes 
with low salt transcription buffer. This shows that YonO is capable of binding the 
RNA:DNA hybrid to form a stable elongation complex, which is characteristic of an 
RNAP. Upon incubation with NTPs, full length (run off) transcripts were synthesised as 
a result of YonO elongating RNA13 to the end of the template DNA. The inclusion of 
the non-template DNA strand during complex assembly resulted in a small loss of 
RNA13 during washing (Figure 5-3b, compare lanes 2 and 5). However, this is also 
observed in the formation of bacterial elongation complexes and occurs due to the 
non-template DNA strand competing with RNA13 for the binding of the template DNA. 
If the non-template DNA strand does succeed in hybridising to the template DNA, the 
RNA13 is subsequently lost during the washing stages of complex assembly. The 
remaining elongation complexes which have successfully incorporated the non-
template DNA strand exhibit much greater stability and resemble promoter derived 
complxes. 
Interestingly, the washing of YonO EC13 comprised of only RNA13 hybridised to the 
template DNA with high salt did not lead to the loss of RNA13 (not shown). This 
indicates that the stability of YonO elongation complexes is not determined by the 
non-template DNA. This contrasts to bacterial RNAP, which does require the binding of 
the non-template DNA strand for the assembly of highly stable elongation complexes 
(Sidorenkov et al., 1998).  
Previously, the immobilised YonO EC13 were allowed to transcribe for 30 minutes. As 
all RNA13 was fully extended during that time, this did not provide information 
regarding the speed of YonO polymerisation. Therefore, the extension of RNA13 by 
YonO EC13 was followed over time (Figure 5-3 c). After 10 seconds of incubation in the 
presence of 500 µM, YonO EC13 synthesised full length transcripts, revealing that 
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YonO, like other RNAPs, is a rapid and processive enzyme (Figure 5-3c, lane 2). Despite 
this efficient polymerisation, unextended RNA13 was present for approximately 2 
minutes. This suggests YonO EC13 was initially paused upon assembly. The pausing of 
YonO ECs appears to be a general property, as it was observed with various other 
assembled elongation complexes. The synthesis of full length transcripts within 10 
seconds suggests that once the pause was overcome, YonO was able to rapidly 
transcribe to the end of the template.     
To determine if the predicted aspartate triad is catalytic, two residues (D537 and 
D539) of the YonO aspartate triad were mutated to asparagines by site directed 
mutagenesis. The mutated YonO was expressed in E. coli and purified via Ni2+ - NTA 
chromatography. The substitution of two aspartates greatly diminished YonO 
transcription, as only 1 -4 nucleotides were incorporated after 30 minutes of 
incubation at 37 ⁰C with a high concentration of NTPs (500 µM). Comparison to the 
activity of wildtype YonO (Figure 5-3d, lane 2 and 3) confirms that the aspartate triad is 
essential for the RNAP activity of YonO. The incorporation of 1 - 4 nucleotides by a 
mutated YonO is similar to E. coli RNAP; asparagine substitution of all three asp 
residues was required to completely abolish transcription (Sosunov et al., 2005) .   
The above experiments confirm that YonO, despite only a distant relationship to the 
other known RNAPs, is a highly processive and rapid RNAP.  
5.4.3. YonO is a strict DNA Dependant RNA Polymerase  
The previous experiment showed that YonO can accomplish transcription in a DNA 
dependant manner. This is contrary to the previously published bioinformatics analysis 
of YonO, which through amino acid sequence similarities predicted YonO functions as 
an RNA dependant RNAP (rdRNAP) (Krogh et al., 1996, Iyer et al., 2003, Iyer and 
Aravind, 2012). To investigate if RNA or DNA templates are preferred by YonO, a 
scaffold featuring an RNA primer (RNA10) hybridised to an RNA template (RNA21) was 
used to form YonO elongation complexes (referred to as rEC10) alongside the 
previously used EC13.   
Upon incubation with NTPs, YonO rEC10 extended RNA10 to the end of the RNA21 
template (lane 2 and 3, Figure 5-4). However, YonO was not processive on the RNA21 
template. Only a minority of YonO rEC10 produced full length transcripts after 10 
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minutes of incubation and the ladder pattern of resolved transcripts indicates YonO 
paused at every position on the RNA template. This was in contrast to YonO EC13, 
which extended RNA13 in 2 minutes and rapidly transcribed to the end of the template 
with minimal pausing. E. coli RNAP assembled into rEC10 displayed comparable activity 
to YonO rEC10 (lane 5). However, E. coli rEC10 had increased processivity on the RNA 
template, with more complexes transcribing to reach the end of the template. 
Furthermore, E. coli rEC10 was quicker on an RNA template than YonO, with more 
complexes extended in 2 minutes (compare lanes 3 and 6). Examples of E. coli RNAP 
and RNAP II utilising an RNA template have been reported previously (Gildehaus et al., 
2007, Lehmann et al., 2007, Wassarman and Saecker, 2006). The pronounced 
transcription on a DNA template, along with unprocessive transcription on an RNA 
template comparable to E. coli RNAP, strongly suggests YonO is a DNA dependant 
RNAP.     
YonO had a clear preference for extending RNA using a DNA template. In addition to 
RNAP, DNA polymerases (DNAP) are able to extend RNA hybridised to a DNA template 
through incorporation of dNMPs. To confirm that YonO is not a DNAP, the ability of 
YonO EC13 and rEC10 to extend RNA through incorporation of dNMPs was 
investigated. As an additional experiment to determine the DNAP activity of YonO, 
complexes (dEC13) using a scaffold comprised of a DNA primer (DNA13) hybridised to 
the GA36 DNA template strand were assembled and provided with dNTPs or NTPs. 
When supplied with a high concentration of dNTPs, YonO dEC13 was completely 
inactive. It was, however, able to utilise NTPs to extend DNA13 but the extension was 
incredibly slow and unprocessive. YonO EC13 supplied with dNTPs was able to extend 
RNA13 but again, the extension was poor, with only 2 – 4 dNMPS being incorporated 
after 2 minutes of incubation. Increased incubation did not result in substantial further 
incorporation of dNMPs, suggesting YonO had stalled and was unable to transcribe 
further along the template. An inability to efficiently extend RNA or DNA through 
incorporation of dNMPs shows YonO does not possess DNAP activity.  
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Figure 5-4: Investigating the RNA dependant RNAP and DNA polymerase activity of 
YonO. a) Scaffold sequences. Sequences of the RNA21, GA36 and dGA36 scaffolds are 
shown. Elongation complexes and transcription was followed through 5’ 32P labelling of 
RNA/DNA primer (shown by red asterisk). b) Determining RNA dependant activity of 
YonO. YonO and E. coli core RNAP rEC10 and EC13 complexes were formed with 
RNA21 and GA36 scaffolds, respectively. Transcription was initiated by the addition of 
500 µM NTPs and allowed to proceed for the indicated times. c) Determining DNA 
polymerase activity of YonO. YonO and E. coli dEC13 complexes were formed with the 
dGA36 scaffold which gave a DNA:DNA hybrid. Transcription was initiated by addition 
of 500 µM NTPs or dNTPs. d) and e) RNA primed DNA polymerase activity of YonO. 
RNA21 and GA36 scaffolds were assembled into EC10 and EC13 as before, except 
transcription was initiated by provision of 500 µM dNTPS. All reactions were 
terminated by the addition of stop buffer. Transcripts were resolved on 23 % PAGE gel 
and visualised through phosphorimaging.    
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To compare YonO to a well-studied RNAP, E. coli dEC13 complexes were assembled. 
Unexpectedly, E. coli dEC13, when supplied with either NTPs or dNTPs was comparable 
to E. coli EC13. In the presence of NTPs, E. coli dEC13 fully extended DNA13. The 
reaction was quick, with all complexes extended in 2 minutes of incubation. E. coli 
dEC13 extended DNA13 by incorporating 3 to 5 dNMPs. Whilst dNMP incorporation by 
E. coli dEC13 was slow and unprocessive, it was comparable to dNMP incorporation by 
EC13. Together, these results suggest E. coli RNAP is able to utilise a DNA:DNA hybrid 
in a similar manner to an RNA: DNA hybrid. The rapid extension of DNA through 
incorporation of NMPs likely arises through the DNA:DNA hybrid mimicking the 
RNA:DNA hybrid sufficiently enough to be utilised by E. coli RNAP. Furthermore, 
through incorporation of NMPs, the DNA:DNA hybrid would transition to a RNA:DNA 
hybrid. Subsequent, downstream transcription would resemble canonical, DNA 
dependant transcription. In vivo, E. coli RNAP would not be recruited to a DNA:DNA 
hybrid reducing the significance of this observation. It does, however, suggest that 
YonO has increased stringency in hybrid binding compared to E. coli RNAP.     
In conclusion, through altering the nature of nucleic acid scaffolds (RNA/DNA primers 
combined with RNA/DNA templates) and the substrate (NTPs/dNTPs), we have shown 
YonO is a DNA dependant RNAP and not an rdRNAP or DNAP. Rapid synthesis of full 
length transcripts by YonO was strictly dependant on RNA hybridised to template DNA 
hybrid and NTP substrates. Whilst YonO did elongate RNA in an RNA template 
dependant manner, it failed to do so in a rapid and processive manner characteristic of 
a nucleic acid polymerase.   
 
5.4.4. Determination of Optimum Hybrid Length  
Throughout transcription, elongation complexes maintain a constant hybrid length. 
The hybrid length is a determinant of the processivity and stability of the elongation 
complex. Previously, structural and biochemical data were used to show a hybrid 
length of 9 bp and 8 bp were maintained by E. coli and T7 RNAP, respectively 
(Sidorenkov et al., 1998, Temiakov et al., 2002, Bochkareva et al., 2012, Vassylyev et 
al., 2007a). To investigate the hybrid length preferred by YonO elongation complexes, 
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alternative RNA primers were used in conjunction with the GA36 template DNA strand 
to give hybrids ranging from 5 to 10 bp in length (Figure 5-5a). As the template DNA 
remained constant, we were able to label all active elongation complexes through 
incorporation of α-[32P]-GMP to make EC14 complexes. In addition to labelling the 
complexes, the efficiency of incorporating α-[32P]- GMP would show the effect of 
varying the hybrid length. To observe the influence of hybrid length on elongation, 
complexes were further supplied with 100 µM ATP, the next nucleotide to be 
incorporated according to the DNA template.  
 
Figure 5-5: Influence of hybrid length on YonO elongation complexes. a) Scaffold 
sequences. The sequences of scaffolds assembled into elongation complexes are 
shown. The hybrid length is shown and the sequences of the hybrid are in red. b) 
Influence of the hybrid length on YonO elongation complexes. YonO EC13 were 
formed and labelled by incorporation of α-[32P]-GTP. To observe extension, EC14 was 
incubated with 100 µM ATP for the indicated time before reactions were stopped and 
transcripts resolved by 23% denaturing PAGE.    
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The greatest incorporation of α-[32P]-GMP was seen in EC13 with a hybrid of 8 – 10 bp 
(lanes 13 – 24, Figure 5-5b). However, a 10 bp hybrid promoted pausing of the 
complexes as after 300 seconds, a significant percentage of complexes remained 
unextended when supplied with 100 µM ATP. As only active elongation complexes 
were labelled through incorporation of α-[32P]-GTP, the inability of EC14 with a 10 bp 
hybrid to extend may be indicative of pausing due to an overextended hybrid upon the 
incorporation of α-[32P]-GTP.  
A hybrid less than 8 bp led to reduced incorporation of α-[32P]-GMP, with the least 
incorporation occurring in EC13 with a 5 bp hybrid. This suggests YonO elongation 
complexes prefer an 8-9 bp hybrid. Unexpectedly, incubation of EC14 with 100 µM ATP 
showed YonO readily misincorporates. All complexes misincorporated ATP for CTP 
within 5 seconds of incubation to give EC16. EC16 rapidly extended RNA16 to become 
EC17 through incorporation of AMP, the next nucleotide be incorporated according to 
the template sequence (refer to scaffold sequences in Figure 5-5a). The hybrid length 
appeared to influence misincorporation. When the hybrid length was reduced to 7 bp 
or less, additional misincorporation occurred during labelling of complexes (lanes 1, 5 
and 9) and after 10 minutes incubations (lanes 4, 8 and 12). This additional 
misincorporation may be due to an alteration in the translocation state of the 
elongation complex. Whilst a reduced hybrid is not preferred, most likely due to its 
poor stability, the shortened hybrid may cause the complexes to favour a post-
translocated state (Sidorenkov et al., 1998). In this state, the complexes could possess 
an increased propensity to both incorporate and misincorporate. As this is speculation, 
additional work is required to explore this possibility further.   
Together, these results suggest YonO is similar to E. coli RNAP and T7 RNAP in that a 
hybrid length of 8-10 is optimal for transcription whilst suggesting YonO is an error 
prone RNAP.  
5.4.5. Rate of Transcription 
A prominent characteristic of RNAP is the rapid rate at which it accomplishes 
polymerisation. To see if YonO is comparable to a typical multisubunit RNAP in this 
regard, EC14 elongation complexes (3’ labelled by incorporation of α-[32P]-GTP by 
EC13) were allowed to transcribe in the presence of 1 µM NTPs (Figure 5-6). In 
previous experiments, saturating concentrations of NTPs were used. At this 
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concentration, the rate of YonO and E. coli RNAP elongation is too high to make 
informative comparisons. A much reduced concentration of NTPs would drastically 
slow the rate of polymerisation.  
As mentioned previously, it appears YonO pauses on the EC14 scaffold. This conclusion 
was arrived at due to the presence of unextended RNA14 at saturating NTP 
concentrations, despite active ECs transcribing to the end of the template within 5 
seconds. As only active complexes are labelled through the incorporation of α-[32P]-
GTP, the unextended RNA14 suggests that upon incorporation of a single nucleotide, 
active YonO ECs pause. Upon the provision of all NTPs, the YonO ECs which overcome 
the pause rapidly transcribe to the end of the template with little pausing elsewhere, 
even in low NTP concentrations (1 µM). This was in contrast to E. coli RNAP EC, which 
at this concentration of NTPs had a tendency to pause after the extension of EC14. The 
differential pausing reflects differences between the two enzymes in recognising the 
template DNA sequence (Bochkareva et al., 2012).      
The propensity for YonO to pause on  artificially assembled complexes prevented 
accurate determination of the rate of polymerisation. However, calculation of the rate 
of polymerisation (Kobs) of YonO ECs exhibiting pausing (Kobs = 0.018 s
-1) showed that 
YonO was as fast as non-paused E. coli RNAP (Kobs = 0.016 s
-1). As a fraction of the YonO 
ECs used for the calculation of Kobs were paused, the accurate rate of YonO 
polymerisation would be expected to be higher. Therefore, combined with YonO 
transcribing to the end of the template, this shows YonO is more processive and 
potentially faster than E. coli RNAP.  
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Figure 5-6: YonO is a fast and processive RNAP. a) Scaffold sequences. The sequence 
of the GA36 scaffold used to form the initial YonO and E. coli EC13 complexes is shown. 
G* indicates the incorporation of α-[32P]-GMP by EC13 to label ECs. b) Comparison of 
YonO and E. coli elongation. YonO and E. coli EC13 complexes were assembled and 
labelled by incubation with α-[32P]-GTP to form EC14. EC14 were immobilised and 
washed to remove unincorporated radiolabelled nucleotides. YonO and E. coli EC14 
complexes were incubated with 1 µM NTPs for the indicated times at 37 ⁰C. Reactions 
were stopped by addition of stop buffer and resolved by 23% PAGE. C) Rate of YonO 
elongation. The observed rates (Kobs) of elongation were calculated by non-linear 
regression using Sigma Plot. The curve is the fitting of the kinetic data to a single 
exponential equation.   
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5.4.6. Pyrophosphorolysis activity of YonO 
RNAP catalyses pyrophosphorolysis, the direct reverse reaction of phosphodiester 
bond synthesis. In pyrophosphorolysis, cleavage of phosphodiester bonds is dependent 
on a pyrophosphate (PPi) molecule, which chelates Mg II in addition to performing the 
nucleophilic attack on the phosphodiester bond (Sosunov et al., 2003). 
Pyrophosphorolysis occurs by RNAP in a pre-translocated state. However, the 
previously used EC13 are stabilised in the post-translocated state. By assembling 
elongation complexes (EC15) with an extended RNA primer (RNA15) (Figure 5-7), RNAP 
is permitted to oscillate on the template DNA between pre-translocated, post-
translocated and 1 bp back tracked states (Roghanian et al., 2011). EC15 complexes 
were incubated in the presence of Mg2+ and PPi. After 30 minutes of incubation, 
RNA15 was degraded resulting in a ladder of shortened transcripts, thus revealing 
YonO is capable of catalysing pyrophosphorolysis (Figure 5-7).  
 
Figure 5-7: Pyrophosphorolysis by YonO elongation complexes. EC15 was formed 
(sequence shown), immobilised and incubated with 500 µM pyrophosphate at 37 ⁰C 
for 30 and 60 minutes. Pyrophosphorolysis was visualised by 5’ 32P labelling of RNA15. 
To prevent intrinsic hydrolysis activity, reactions were buffered to pH 6.5. Reactions 
were stopped, resolved on 23 % denaturing PAGE gel and visualised by 
phosphorimaging.  
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5.4.7. Hydrolysis by YonO 
In addition to synthesising RNA, multisubunit RNAPs have been shown to catalyse the 
hydrolysis of phosphodiester bonds at the 3’ end of the RNA chain (Orlova et al., 1995, 
Zenkin et al., 2006b). This intrinsic activity contributes to the fidelity of transcription by 
allowing the removal of wrongly incorporated nucleotides (misincorporation). 
Hydrolysis of RNA requires elongation complexes to be in a 1 bp backtracked state. The 
previously used EC13 are stabilised in the post-translocated state, preventing the 
backtracking of elongation complexes required for hydrolysis. By assembling 
elongation complexes (EC15) with an extended RNA primer (RNA15) (see Figure 5-8), 
RNAP is permitted to oscillate on the template DNA between pre-translocated, post-
translocated and 1 bp back tracked states (Roghanian et al., 2011). In EC15, the 3’ NMP 
of RNA is complementary to the corresponding position on the template strand DNA. 
However, a mismatch between the 3’ NMP of RNA15 and the template DNA would 
stabilise the 1 bp backtracked state, as opposed to the pre and post-translocated 
states, and stimulate hydrolysis (Zenkin et al., 2006b). Therefore, in a parallel 
experiment, the DNA sequence of the template strand was altered to introduce an A:A 
mismatch upon hybridisation with RNA15 during mismatch elongation complex 
(mEC15) assembly.   
To determine if YonO is able to perform hydrolysis, assembled EC15 and mEC15 were 
incubated in the presence of Mg2+. After two hours of incubation, neither YonO EC15 
nor mEC15 accomplished RNA hydrolysis. In comparison, E. coli EC15 and mEC15 
demonstrate the stimulation of hydrolysis by a 3’ mismatch, with hydrolysis occurring 
after 60 seconds by the mEC15. The ability of RNAP to hydrolyse RNA varies between 
organisms, with RNAP II of S. cerevisiae having very slow hydrolysis (Nielsen and 
Zenkin, 2013, Izban and Luse, 1992, Reines, 1992). Despite this, the 120 minutes 
incubation of EC15 and mEC15 was thought to be sufficient to detect any potential 
hydrolysis by YonO. Therefore, this experiment strongly suggests that YonO does not 
possess the ability to remove misincorporated nucleotides through hydrolysis.  
96 
  
 
Figure 5-8: Determination of YonO hydrolysis activity. a) Sequences of 
oligonucleotides in EC15 and mEC15. Elongation complexes were followed by 5’ 32P 
labelling of RNA15, shown by red asterisk. mEC15 3’ end RNA A:A mismatch was 
introduced through alteration of DNA sequence. b) Correct and mismatch elongation 
complexes to determine YonO hydrolysis activity.  EC15 and mEC15 complexes   were 
immobilised and washed before incubation with 10 mM Mg2+ for the indicated lengths 
of time. Reactions were stopped by the addition of formamide stop buffer and were 
resolved by 23% denaturing PAGE. Transcripts were visualised by phosphorimaging.      
5.4.8. Misincorporation by YonO 
Maintaining high fidelity during transcription is essential for correct gene expression. 
Intrinsic hydrolysis by RNAP and the action of Gre proteins and their S factor analogues 
in eukaryotes and archaea corrects for the incorporation of the incorrect nucleotide. 
Prior to removal of misincorporated NMPs, the major determinant of fidelity is the 
discrimination of incorrect substrates such as non-complementary NTPs or dNTPs by 
RNAP during the nucleotide addition cycle (Yuzenkova et al., 2010). Previous 
experiments have suggested that YonO is prone to misincorporation. To investigate 
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this further, YonO and E. coli RNAP EC13 were assembled. Active elongation complexes 
were labelled through the incorporation of α-[32P]-GTP to give EC14. To observe 
misincorporation, EC14 was provided with each of the 4 nucleotides (ATP, CTP, GTP 
and UTP).   
In EC14, the next correct nucleotide to be incorporated according to the template was 
AMP. As expected, YonO and E. coli EC14 rapidly incorporated AMP to produce RNA15 
within 10 seconds, (lanes 1 -4, Figure 5-9 b and c). After 10 minutes of incubation, 
YonO misincorporated AMP to synthesise RNA16. RNA16 was rapidly extended to 
RNA17 through the correct incorporation of AMP    (lane 4, Figure 5-9b). For the 
remaining nucleotides, YonO displayed increased misincorporation compared to E. coli 
EC14. Multiple misincorporation events occurred upon incubation with CTP (Figure 5-
9b, lane 13 – 16). These events can be explained upon analysis of the template 
sequence. Following ATP, the next nucleotides to be incorporated are CMP, AMP and 
CMP. After misincorporation of CMP to produce EC15, all EC15 complexes correctly 
incorporate CMP, resulting in EC16. Misincorporation of CMP instead of AMP, followed 
by correct incorporation of CTP is repeated again, thus explaining the synthesis of 
RNA18. Misincorporation of GTP, UTP and CTP instead of ATP does occur by E. coli 
RNAP EC14. However, the reactions are slow with only a small fraction of complexes 
misincorporating after 10 minutes of incubation.  
To see if misincorporation is a general characteristic of YonO, an alternative scaffold 
was used to generate a different misincorporation event. Elongation complexes were 
assembled with the GC36 scaffold and labelled as before through the incorporation of 
α-[32P]-GTP, giving EC14. The GC36 scaffold was identical to GA36 scaffold used 
previously except EC15 is formed through the incorporation of CMP, rather than AMP 
(refer to Figure 5-9d for sequences). Upon incubation with the correct NTP (CTP), YonO 
quickly synthesised RNA16 within 5 seconds by incorporating 2 CMP nucleotides. After 
5 minutes of incubation, RNA18 was synthesised through the misincorporation of CTP 
for ATP, followed by correct incorporation of CMP. When supplied with a non-
complementary nucleotide (ATP, GTP and UTP), YonO EC14 misincorporated to 
synthesise RNA15 (ATP and GTP) and RNA16 (UTP). Out of the non-complementary 
nucleotides, UTP had the fastest rate of misincorporation, with RNA15 synthesised 
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within 5 seconds. Increased incubation led to further misincorporation of UTP, with all 
EC14 being converted to EC15 or EC16 after 5 minutes of incubation. 
The extent of YonO misincorporation can be seen by comparison to the E. coli RNAP 
EC14 supplied with each nucleotide. As with YonO, E. coli EC14 correctly incorporated 
CTP to synthesise RNA16 but no further extension was observed throughout the time 
course of the experiment. When incubated with non-complementary nucleotides, E. 
coli EC14 only misincorporated UMP. Unlike YonO, misincorporation was limited to the 
extension of RNA14 by one UMP. Furthermore, misincorporation of UMP was slow as 
approximately half of EC14 remaining unextended after 5 minutes of incubation. The 
remaining nucleotides, ATP and GTP were misincorporated by E. coli RNAP EC14. 
However, the reactions were incredibly slow with RNA15 only being detected after 5 
minutes of incubation.  
In conclusion, the misincorporation of non-complementary NTPs by YonO elongation 
complexes shows YonO is more error prone than multisubunit RNAP. Comparing 
misincorporation on the GA36 and GC36 scaffolds, it is apparent YonO is less efficient 
at discriminating between differing purines and differing pyrimidines. On the GA36 
scaffold, misincorporation of GTP, a purine, instead of ATP occurs at a faster rate than 
misincorporation of the pyrimidines, UTP or CTP. The same observation was made 
during misincorporation on the GC36 scaffold. The fastest rate of misincorporation was 
UTP rather than CTP. In this regard, the pattern of YonO misincorporation is 
comparable to E. coli EC14, albeit at much faster rates (Yuzenkova et al., 2010).  
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Figure 5-9: Misincorporation by YonO elongation complexes. a) GA36 scaffold. 
Sequence of GA36 oligionucleotide scaffold used to assemble EC13. Complexes were 
labelled through incorporation of α-[32P]-GTP (shown in red) to form EC14.b) 
Misincorporation by YonO GA36 EC14. EC14 was incubated with 100 µM of ATP, GTP, 
UTP or CTP at 37 ⁰C for the indicated times. c) Misincorporation by E. coli core RNAP 
GA36 EC14. As for Figure 5-9b except complexes were assembled with E. coli core 
RNAP. d) GC36 scaffold. Sequence of GC36 oligionucleotide scaffold used to assemble 
EC13. Note the next NTP to be incorporated after GTP is CTP, not ATP as with GA36 
scaffold. EC14 was formed as before. e) and f) Misincorporation by YonO and E. coli 
GC36 EC14, respectively. EC14 was incubated with 100 µM ATP, GTP, UTP and CTP as 
before. All reactions were stopped after the indicated time by addition of stop 
solution. Transcripts were resolved on 23 % PAGE gel and visualised by 
phosphorimaging.          
 
5.5. Discussion 
YonO was successfully purified by utilising an N-terminal His tag. Despite greatly 
facilitating the purification of recombinant proteins, there is a chance that a His tag will 
have a detrimental effect on protein structure or function. These negative effects are 
dependent on the position of the tag (N or C terminal end) and the folding of the 
protein. If the tagged N-terminal or C-terminal domain participates in a key structural 
fold or is embedded in the active centre, the function of the protein may be 
compromised. However, compared to other purification tags, the His tag is small (2 
KDa in the case of YonO) and so is less likely to interfere with protein folding or 
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function. As YonO displays proficient RNA polymerase activity with an N or C-terminal 
(not shown) His tag, it is unlikely that the function of YonO is impeded or altered by 
the presence of the His tag. 
Prior to this work, YonO was a hypothetical protein only predicted to function as an 
RNAP through distant homology to rdRNAP and the multisubunit RNAP (Iyer et al., 
2003). Through utilisation of artificially assembled elongation complexes, we have 
directly shown YonO possesses RNAP activity. The activity was dependant on chelation 
of Mg2+ ions revealing YonO, is like all nucleic acid polymerases that conduct catalysis 
through a general two metal mechanism (Sosunov et al., 2003, Steitz, 1998). The 
polymerising activity of YonO is comparable to that of E. coli core RNAP; it is both fast 
and processive. This was not expected, as the only functional module identifying YonO 
as an RNAP is the aspartate triad. No other RNAP functional domains have been 
identified in the YonO amino acid sequence. This includes the trigger loop, which plays 
a crucial role in all reactions catalysed by RNAP (Temiakov et al., 2005, Wang et al., 
2006, Yuzenkova et al., 2010, Yuzenkova and Zenkin, 2010, Zhang et al., 2010).  
Whilst the speed and processivity of YonO is similar to that of its multisubunit 
relatives, the determinants of elongation complex stability appear to differ. Unlike 
bacterial RNAP, YonO complexed with only the RNA and template DNA strand 
withstood high ionic conditions. In bacterial RNAPs, the hybrid and the presence of the 
downstream non-template DNA are major contributors to the stability of elongation 
complexes (Sidorenkov et al., 1998). The stability of elongation complexes is also 
influenced through interactions between the downstream DNA duplex and RNAP 
domains such as the clamp and jaw domains (Ederth et al., 2002, Chakraborty et al., 
2012, Gnatt et al., 2001). According to amino acid sequence comparisons, these 
domains are not conserved in YonO, which may explain why Yono does not depend on 
the non-template DNA strand for stability. Therefore, this raises the question of how 
YonO is able to maintain tight binding of the hybrid.  
The catalytic activity of YonO also raises questions with regards to the mechanisms 
employed by YonO for accomplishing transcription. These questions include how the 
substrates enter and are bound by the active centre, how YonO translocates along the 
template, and most interestingly: how YonO performs catalysis. Elongation is preceded 
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by initiation and followed by termination. Therefore, the ability of YonO to transcribe 
implies mechanisms of transcription initiation and termination exist, both of which 
remain completely undefined.  
rdRNAPs operate in the post-transcription gene silencing (PTGS) pathway occurring 
across a wide range of eukaryotic organisms including humans (Maida et al., 2009). 
Despite this, our in vitro experiments shows processive transcription by YonO is DNA 
dependant and requires NTP substrates. This, along with SPβ being a DNA based 
bacteriophage, suggests YonO does not function to produce double stranded RNA 
necessary for PTGS. Supporting this notion is the absence of identifiable PTGS proteins 
encoded in the SPβ genome (Iyer et al., 2003). One eukaryotic rdRNAP related to YonO 
is QDE-1 of Neurospora crassa. Interestingly, QDE-1 has been shown to transcribe on 
single strand DNA templates (Lee et al., 2009, Aalto et al., 2010). This is in addition to 
the previously observed transcription on a single stranded RNA template. Therefore, 
closer similarity to rdRNAP over multisubunit RNAP does not preclude YonO from 
functioning as a DNA dependant RNAP. 
The use of artificial elongation complexes has revealed additional characteristics of 
YonO. YonO appears not to be able to intrinsically catalyse the hydrolysis of 
phosphodiester bonds, even when stabilised in a 1 bp backtracked position. This is 
surprising, as in multisubunit RNAPs the same active centre catalyses both 
phosphodiester bond synthesis and hydrolysis. Intrinsic hydrolysis has been well 
detailed in bacterial RNAP and has been confirmed to be performed by RNAP II 
(Nielsen and Zenkin, 2013, Yuzenkova et al., 2010, Yuzenkova and Zenkin, 2010, Zenkin 
et al., 2006b). Hydrolysis activity is stimulated by misincorporation and has therefore 
been linked to RNAP proof reading and fidelity (Zenkin et al., 2006b). YonO was able to 
remove 3’ NMP of RNA through pyrophosphorolysis, offering a potential mechanism of 
proofreading. However, pyrophosphorolysis as a means of removing misincorporated 
nucleotides is not probable. This notion is based on all RNAPs, whilst being able to 
catalyse pyrophosphorolysis, using intrinsic hydrolysis or auxiliary factors such as Gre 
factors (bacteria) and TFIIS (RNAP II) for proofreading.  
YonO is analogous to T7 RNAP in that both enzymes do not possess hydrolysis activity 
but are capable of pyrophosphorolysis (Huang et al., 2000). Pyrophosphorolysis was 
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ruled out as a mechanism of proof reading by T7 RNAP. Addition of PPi to stalled 
elongation complexes did not result in the removal of an incorporated 3’ dNTP and 
resumption of transcription. It was concluded fidelity of T7 RNAP transcription was 
governed solely by highly stringent substrate selection (Huang et al., 2000). SPβ and 
other DNA based bacteriophages that utilise their own RNAP for gene expression will 
have less tolerance to decreased fidelity of transcription. Increased errors during 
transcription would result in truncated or mutated proteins that would not function 
correctly. Ultimately, this would limit the bacteriophages ability to successfully 
replicate. This is in contrast to RNA based bacteriophages that utilise rdRNAPs for 
replication. In these circumstances, lower rates of fidelity could be tolerated. Lower 
rates of transcriptional fidelity can even be advantageous, as it results in increased 
variation in the genome and therefore increased rates of evolution.      
Despite in vitro experiments presented here demonstrating that YonO is more error 
prone that other RNAPs, the rate of YonO incorporation was faster compared to 
misincorporation. This implies that at high substrate concentrations, YonO is able to 
maintain fidelity through substrate selectivity. By testing misincorporation of each 
nucleotide in place of ATP and CTP, it does appear YonO is able to distinguish well 
between purines and pyrimidines, with GTP being misincorporated instead of ATP at a 
faster rate than CTP or UTP.  The in vivo impact, if any, of error prone YonO 
transcription needs to be investigated. Despite RNAP having intrinsic proof reading 
activity, transcription factors exist to perform transcript hydrolysis upon 
misincorporation (Roghanian et al., 2011). No bacteriophage Gre homologues have 
been reported. However, only 25% of the 187 proteins encoded on SPβ have been 
assigned putative functions. The coding of a protein either distantly homologous or 
functionally analogous to Gre-like factors by SPβ cannot be entirely dismissed.    
The in vitro activity of YonO reveals the presence of a second, functional RNAP existing 
in the genome of the model Gram positive organism Bacillus subtilis. The possible 
impact YonO has upon the host transcriptome remains to be investigated. PSI BLAST 
revealed the existence of YonO homologues across a broad range of bacteriophages 
that infect other gram positive bacteria, including the medically and biotechnologically 
important Clostridium and Lactococcus species (Iyer et al., 2003). Our work confirming 
YonO has RNAP activity provides evidence that the YonO-like homologues present in a 
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wide range of gram positive bacteria may also be catalytically active enzymes. This 
makes YonO an archetype of a novel class of single subunit RNAP and further work will 
develop this potentially new field of transcription.    
As YonO is capable of RNA polymerisation, our work supports the proposal that YonO 
is a descendant of an ancient enzyme that represents an intermediate stage during the 
evolution of the multisubunit  RNAP (Iyer and Aravind, 2012, Iyer et al., 2003). Despite 
bearing closer resemblance to eukaryotic rdRNAP, YonO accomplishes transcription in 
a DNA dependant manner. Speculating, the YonO ancestor may have been the 
predominant transcription enzyme during the emergence of the DNA world.    
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Chapter 6: Investigation of Biological Function of YonO  
6.1. Introduction 
The SPβ prophage resides within the genome of the widely studied wildtype (WT) B. 
subtilis strain 168. At very low frequencies (1 in 106  cells), the prophage can be 
spontaneously induced. This results in phage development and the eventual lysis of 
cells and release of SPβ phage particles (Warner et al., 1977). Induction can be 
achieved at a much greater frequency by DNA damage. Experimentally, DNA damage 
can be brought about by the addition of Mitomycin C, a compound which induces the 
SOS response by causing DNA crosslinking (Goranov et al., 2006).     
Sequencing of the 134 KB SPβ prophage genome allowed for the prediction of 187 
putative ORFs. Subsequent analysis of the orientation of the ORFs revealed that they 
are arranged into three Clusters, termed Cluster I, Cluster II and Cluster III (Lazarevic et 
al., 1999). The majority of the proteins encoded by the ORFs of SPβ are yet to be 
ascribed a function. The proteins which have been given a function, either through 
homology or experimental evidence, have been used to categorise the Clusters based 
on the temporal expression of the genes they contain. 
Typically, bacteriophage operons are categorised according to the life cycle stage in 
which they are expressed. The bacteriophage encoded genes expressed at the 
beginning of an infection are referred to as early genes. The genes expressed at the 
midpoint and end of infection are middle and late genes, respectively. Cluster III of SPβ 
has been proposed to contain the prophage’s early genes, with many encoded proteins 
having homology to other bacteriophage proteins known to be involved in DNA 
replication. Additionally, over half of the ORFs in Cluster III encode for very short 
proteins, a feature similar to that of the early gene operons of the lytic bacteriophage 
sk1, which infects the gram positive bacteria Lactococcus lactis (Chandry et al., 1997).  
Cluster I has not been categorised based on the temporal expression of its ORFs. The 
23 ORFs of Cluster I encode proteins that function in apparently unrelated processes 
including integration of the SPβ genome into B. subtilis chromosome and production of 
the sublancin 168 bacteriocin (Lazarevic et al., 1999). The continued maintenance of 
substantial 134 KB SPβ genome in B. subtilis is potentially due to the advantages it 
confers to lysogenic strains, including the synthesis of sublancin 168.  
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Genes expressed during the late stage of phage development encode lytic enzymes. In 
addition to SPβ, B. subtilis strain 168 is lysogenic for PBSX, a defective prophage. In 
PBSX, the lytic enzyme is an N-acetymuramoyl-L-alanine amidase encoded by the xlyA 
gene (Longchamp et al., 1994, Wood et al., 1990). This gene was shown to be part of 
the late operon along with the gene xhlB, which is thought to encode a holin (Wood et 
al., 1990). Holins act to form pores in membranes, granting bacteriophage lytic 
enzymes access to the cell wall (Krogh et al., 1998, Wang et al., 2000). SPβ Cluster II 
contains the genes blyA and bhlB which have homology to xlyA and xhlB of the PBSX 
late operon, respectively. In vitro, BlyA protein was shown to have amidase activity 
(Regamey and Karamata, 1998). In addition to blyA, the yomI gene of Cluster II 
encodes CwIP. Studies have revealed that CwIP has DD endopeptidase and 
muramidase activities which are capable of degrading the B. subtilis cell wall. CwIP is 
also predicted to function as a bacteriophage tail-fibre protein (Sudiarta et al., 2010). 
The protein products of yomR, yomQ and yomP of Cluster II are also likely to act as tail-
fibre proteins (Lazarevic et al., 1999). The presence of genes encoding tail-fibre 
proteins is also characteristic of late operons. PBSX follows this pattern, with the tail-
fibre protein genes such as xkdV (XkdV shares homology to YomR) being within the 
same operon as xlyA and xhlB. The similarities shared between SPβ and PBSX strongly 
suggest that Cluster II is comprised of genes expressed at the late stage of SPβ 
development.  
yonO, the gene coding for the YonO RNAP is located at the beginning of Cluster II. 
Therefore, it is likely that YonO is expressed at the late stage of SPβ development. 
Typically, bacteriophage encoded RNAPs are responsible for the transcription of the 
late genes. Therefore, it is likely the yonO is transcribed by the endogenous B. subtilis 
RNAP. Once expressed, YonO would carry out transcription of the remaining SPβ late 
genes. Despite SPβ being first identified over 30 years ago and YonO being 
hypothesised to be an RNAP over 10 years ago, no work has been published which 
directly investigates transcription in SPβ. As mentioned above, YonO has very little 
homology to the multisubunit RNAP and no homology to any previously described 
single subunit RNAPs such as T7 RNAP. However, we have shown that YonO is a DNA 
dependant RNAP. From this, many questions regarding the role YonO plays during SPβ 
development arise including which genes, if any, are transcribed by YonO. If YonO does 
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indeed transcribe Cluster II genes, how does it initiate and terminate transcription and 
how is it regulated? Below is our attempt to begin to answer these questions.  
6.2. Aim 
The aim of this study was to investigate the role YonO plays in the development of SPβ. 
In particular, we wanted to address whether YonO is required for SPβ development 
and to determine whether YonO is indeed responsible for the transcription of Cluster II 
genes. Further to this, we aimed to determine if YonO is capable of transcription 
initiation and to elucidate potential promoters.     
6.3. Expression of YonO during SPβ induction  
Previously, YonO had been classified as a hypothetical protein and the only evidence of 
expression came from microarray data published online in 2012 (Nicolas et al., 2012). 
The European-wide Bacillus systems biology collaboration, BaSysBio, investigated the 
response to environmental conditions at a transcriptomic level in B. subtilis (Nicolas et 
al., 2012). The results were made accessible online in the form of a searchable 
database. By searching this database, it was apparent that the greatest expression of 
yonO occurred between 45 and 90 minutes after treatment with Mitomycin C. Taking 
into account that SPβ is known to be induced by Mitomycin C, the expression of yonO 
in this condition is to be expected.  As this data only shows expression at the level of 
transcription, we sought to confirm that YonO protein is present during SPβ induction 
by western blot.  
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Figure 6-1: Expression of YonO during SPβ induction. Wildtype and ΔyonO cells were 
grown to mid – log phase and treated with 0.5 µg ml-1 Mitomycin C. Cells were 
harvested every 20 minutes after treatment. Samples were disrupted by sonication 
and equal amounts of lysate (5 µg of protein) were resolved by SDS PAGE. YonO was 
detected by probing the PVDF membrane with anti – YonO polyclonal antibodies. 
Expression of YonO (indicated by red arrow) begins at 40 minutes, with maximum 
expression occurring after 60 minutes of induction. Additional bands are due to cross 
reactivity between the primary antibody and proteins present in B. subtilis lysate.     
To allow visualisation of YonO expression by western blot, polyclonal α-YonO 
antibodies were generated by providing purified YonO to the commercial company 
Eurogentec. YonO was inoculated into two rabbits over the course of 28 days, after 
which the serum was collected. From the provided serum, we purified polyclonal 
antibodies against YonO by affinity chromatography using cyanogen bromine activated 
sepharose resin covalently crosslinked to YonO.  
For a negative control for YonO expression in induced WT cells, a ΔyonO strain was 
generated. To do so, the coding region of yonO was replaced by homologous 
recombination with a neomycin resistance cassette. WT and ΔyonO cells were treated 
with Mitomycin C and harvested every 20 minutes over a time course of 100 minutes. 
Probing with α-YonO antibodies revealed that YonO was indeed present in the lysates 
of wild type cells treated with Mitomycin C. YonO expression begins approximately 40 
minutes post induction, with maximum occurring between 40 and 60 minutes. YonO 
expression is maintained throughout the remainder of the time course. At 
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approximately 120 minutes after Mitomycin C treatment, cell lysis occurs. The 
observed appearance of YonO is in agreement with the microarray data of Nicolas et 
al, which shows expression of yonO gene occurs between 45 and 90 minutes after 
treatment with Mitomycin C (Nicolas et al., 2012). The additional bands present on the 
western blot are due to cross reactivity of the primary antibody with proteins present 
in the B. subtilis lysate. The bands are uniform across both wildtype and ΔyonO strains 
and are present in all time points, revealing they are not YonO degradation products. 
The uniformity of the additional band allowed us to conclude the lysates were equally 
loaded.  
During the above experiments, we did not observe a difference in the growth of 
wildtype and ΔyonO strains (not shown). Furthermore, both wildtype and ΔyonO 
strains lysed approximately 120 minutes after treatment with Mitomycin C. Both 
observations were to be expected. Deletion of SPβ and other prophage elements in 
the B. subtilis genome was shown not to have an impact on growth or physiology of B. 
subtilis cells (Westers et al., 2003). As discussed above, PBSX is also induced upon 
treatment of cells with Mitomycin C which results in the expression of lytic enzymes 
including the XlyA amidase (Longchamp et al., 1994). Therefore, the lysis of ΔyonO cells 
cannot be used to determine if YonO is essential for SPβ development.  
6.4. Requirement of YonO for SPβ development  
When induced, PBSX is capable of causing host cell lysis (Seaman et al., 1964). This 
prevented us from using lysis of Mitomycin C treated cells to determine if YonO is 
required for SPβ induction. Therefore, to determine if YonO is essential for SPβ 
development and phage particle release, a strain sensitive to SPβ lysogenisation was 
used. Strain 1A100 is a derivative of the Su3+ strain, an isolated strain spontaneously 
cured of SPβ and therefore susceptible to lysogenisation by SPβ particles (Zahler et al., 
1977, Warner et al., 1977). When treated with Mitomycin C, wildtype B. subtilis cells 
lyse. As SPβ development is triggered by Mitomycin C, SPβ particles are present in the 
lysates of wildtype cells. When incubated with an SPβ cured strain such as 1A100, the 
SPβ particles lysogenise the cured cells resulting in small turbid plaques on a lawn of 
cured cells. The plaques are a result of inefficient lysogenisation of cells by the SPβ 
particles. The SPβ particles which do not lysogenise the cured cells undergo the lytic 
life cycle.  
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The lysate derived from lysis of WT cells was briefly incubated with A100A cells and 
plated. After overnight growth, small turbid plaques appeared in the lawn of 1A100 
cells as a result of SPβ lysogenising the susceptible strain (Figure 6-2). In contrast, no 
plaques were observed when lysate from induced ΔSPβ strain was incubated and 
subsequently plated with strain 1A100. When plated with strain 1A100, the lysate from 
ΔyonO strain also did not produce any plaques. The inability of ΔyonO strain to 
produce SPβ particles capable of lysogenising 1A100 strain indicates that YonO is 
essential for SPβ particle development which would be expected if YonO is a 
bacteriophage RNAP.   
 
 
 
Figure 6-2: YonO is essential for SPβ production in vivo. Wildtype, ΔSPβ and ΔyonO 
strains were induced by Mitomycin C and subsequent lysates were tested for the 
presence of SPβ particles capable of forming plaques in a lawn of SPβ sensitive cells 
(Strain 1A100). Only lysates from the wildtype strain produced plaques, suggesting 
YonO is required for the production of SPβ in induced cells.      
6.5. Identification of Genes Transcribed by YonO 
In vitro, YonO displays efficient RNA polymerase activity. This, in combination with its 
expression during SPβ induction and apparent essentiality strongly suggests YonO is an 
SPβ specific RNAP functioning during the induction of the prophage.  
Whilst YonO appears to be essential for SPβ development, the genes it transcribes 
remain unidentified. To address this, total transcriptome analysis (RNAseq) was 
performed on WT and ΔyonO strains. Comparison of the WT and ΔyonO 
transcriptomes during bacteriophage induction would reveal the genes under the 
control of YonO. Wildtype and ΔyonO strains were grown to mid-log phase (0.5 OD600) 
and SPβ was induced with Mitomycin C. Western blot data revealed YonO is present in 
WT cells 60 minutes after induction. Additionally, SPβ induction was observed 60 
Wildtype ΔSPβ ΔyonO 
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minutes after Mitomycin C treatment in previously published microarray data 
(Goranov et al., 2006). Therefore, cells were harvested 60 minutes after treatment 
with Mitomycin C. In parallel, wildtype and ΔyonO cells without treatment were 
harvested along with biological replicates for all samples. Total RNA was extracted 
from the cells and subjected to next generation sequencing. The commercial company 
PrimBio performed all subsequent handling of total RNA and RNA sequencing. Total 
RNA contains rRNA which strongly skews RNAseq due to its abundance. Therefore, 16S 
and 23S rRNA was depleted prior to library preparation. Library preparation involved 
the ligation of adaptors and sample specific barcodes to the RNA followed by reverse 
transcription and purification of cDNA. Sequencing primers hybridise to the adaptor 
sequences whilst barcode sequences allow for multiplexing, the simultaneous 
sequencing of multiple samples. The sequencing reads were aligned to the B. subtilis 
reference genome and quality controlled via read metrics such as mapping quality and 
alignment score. For each annotated gene, a normalised expression value was 
calculated. The expression of each gene in the two different strains (wildtype and 
ΔyonO) and each condition (+/- Mitomycin C treatment) was compared, giving fold 
changes in expression. This data was provided by PrimBio.  
Comparing the changes in gene expression of the wild type strain, with and without 
Mitomycin C treatment, the wide ranging impact of Mitomycin C could be seen (Figure 
6-3). Primarily, Mitomycin C treatment induces the SOS response through DNA damage 
(Goranov et al., 2006). One aspect of the SOS response is the activation of the 
nucleotide excision repair machinery, comprised of UvrA, UvrB and UvrC (reviewed in 
Lenhart et al, 2012).  Mitomycin C treatment led to an approximate 9 fold increase in 
the transcription of the uvrA and uvrB genes. A 4 fold increase in uvrC was observed. 
The pattern of lower induction of uvrC compared to uvrA and uvrB correlates with 
previous transcriptomic data (Au et al., 2005).  
The prominent effect of Mitomycin C treatment is the induction of resident prophages 
PBSX, SPβ and the ICEbs1 mobile element through activation of the SOS response 
(Goranov et al., 2006, Auchtung et al., 2005). The RNAseq data correlated well with 
previously published data (Goranov et al., 2006, Seaman et al., 1964, Warner et al., 
1977). Upon Mitomycin C treatment, expression of PBSX, SPβ and ICEbs1 genes was 
greatly increased as shown in Figure 6-3. Despite possessing homology to the late 
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operon of PBSX, the SKIN element was not induced by Mitomycin C. This observation is 
consistent with a previously reported absence of β-galactosidase activity in Mitomycin 
C treated cells with lacZ fusions to the SKIN late operon (Krogh et al., 1996). The 3 
genes upstream of ICEbs1 displaying increased expression in response to Mitomycin C 
correspond to ybfE, ybfG and ybfG. The proteins encoded by these genes are 
uncharacterised but bioinformatics have shown that they contain peptidoglycan 
binding and hydrolase domains.   
Looking closer at the induction of SPβ in response to Mitomycin C, RNAseq revealed 
that genes of Cluster II and III underwent increased expression whilst Cluster I did not. 
No Cluster I genes exhibited a significant fold change in expression when WT cells 
treated with and without Mitomycin C were compared. Referring to the BaSysBio 
database supported this observation (Nicolas et al., 2012). SunT, a representative gene 
of Cluster I, had equal expression levels in cells treated with Mitomycin C for 45 
minutes and the negative control.   
 
Figure 6-3: Fold changes of expression across the B. subtilis genome in response to 
Mitomycin C. The fold changes in expression of individual genes in WT cells, with and 
without Mitomycin C treatment (blue diamond) were plotted. The KEGG BSU accession 
number for each gene was used to plot along the X axis, showing the fold changes 
across the genome. The fold changes of expression between WT and ΔyonO cells 
treated with Mitomycin C were plotted in parallel (red square). Negative values 
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correspond to a decrease in expression. The regions along the genome corresponding 
to PBSX, SPβ and ICEbs1 have been indicated.  
To determine which genes are under the control of YonO, expression levels of wildtype 
and ΔyonO cells treated with Mitomycin C were compared. There were no fold 
changes in Cluster I and III expression (Figure 6-3). The RNAseq revealed a large 
disparity between the wildtype and ΔyonO strains with regards to the expression of 
Cluster II genes after Mitomycin C treatment, with comparisons of expression levels 
revealing large fold changes. The fold changes were negative; indicating Cluster II 
genes were not expressed in the induced ΔyonO strain and suggesting that YonO is 
responsible for the transcription of Cluster II. Furthermore, the overall strength of 
YonO expression appears to be greater than that of the endogenous, host RNAP. This 
conclusion was arrived at by comparing the normalised expression values generated 
from the RNAseq data. Using the expression of rpoC (gene encoding for β’ subunit) as 
an example of a gene highly expressed by the host RNAP, this gene has a normalised 
expression value of 0.56. This is in stark contrast to the expression value of the yomI 
gene of SPβ Cluster II, which has a normalised expression value of 9.9. It is appreciated 
the rpoC expression value was generated from cells treated with Mitomycin C. Cells 
treated by Mitomycin C are subjected to DNA damage and undergoing the SOS 
response. Therefore, additional work will be required to accurately compare the in vivo 
expression strength of YonO to other RNAPs such as the bacterial RNAP and T7 RNAP.   
yonO is predicted to be the middle gene in an operon comprised of yonP, yonO and 
yonN (Figure 6-4) based on transcription profiles constructed from the high resolution 
BaSysBio microarray data (Nicolas et al., 2012). In the transcription profiles, sudden 
increases and decreases of transcription, referred to as upshifts and downshifts, were 
used to define transcription units. yonP, yonO and yonN were shown to be on the 
same transcription unit which indicates they belong to a single operon, the expression 
of which would be driven by a single promoter upstream of yonN (Figure 6-4). All three 
genes display greatly increased expression upon Mitomycin C treatment in the 
wildtype cells. However, in ΔyonO cells treated with Mitomycin C, only yonP 
expression was comparable to wild type cells. There was no expression of yonO and 
yonN expression was reduced. This observation supports the prediction these three 
genes belong to an operon. In the ΔyonO strain, the yonO coding sequence has been 
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replaced with the kanamycin resistance cassette, which explains the complete absence 
of yonO expression in this strain. The kanamycin resistance cassette likely disrupts the 
transcription of the downstream yonN gene which would account for the reduction in 
yonN expression in the ΔyonO strain. yonO belonging to an operon with yonP, in 
combination with the observation that yonP expression is not lessened in the ΔyonO 
strain, suggests yonO is transcribed by the B. subtilis RNAP during SPβ development.  
 
Figure 6-4: Transcription profile of yonO and adjacent regions of SPβ. Data retrieved 
from BaSysBio database. Top: yonO and the adjacent Cluster II genes are shown in the 
GenBank annotation of the wildtype B. subtilis genome. Middle: Transcription profiles 
generated from microarray array data with a resolution of 22 bases. Profiles for both 
DNA strands are shown. The individual traces represent the transcription profiles for 
individual environmental conditions. Bottom: Transcription units were defined by 
sudden upshifts and downshifts of transcription, as observed in the transcription 
profiles. Upshifts and downs shifts are depicted by red triangles and red squares, 
respectively. Transcription units above the genome (black line) are those on the plus 
strand. Transcription units on the – strand are below the genome. yonP, yonO and 
yonN exist on a single transcription unit started by upshift 1672. Downstream, yonI is 
present in a transcription unit on the minus strand with the corresponding upshift 
1673 indicated by a green arrow. yonI is the sole ORF of the transcription unit and is 
therefore not expressed as part of any operon on either strand of DNA.  
The alignment of wildtype and ΔyonO RNAseq sequencing reads to the Cluster II region 
on the SPβ genome was used to generate a coverage map which can be seen in Figure 
6-5. The coverage map revealed that the Cluster II genes downstream of yonN were 
not transcribed in Mitomycin C treated ΔyonO cells. This is in contrast to induced 
wildtype cells, in which Cluster II genes were expressed. Therefore, the RNAseq 
indicates YonO is responsible for the transcription of Cluster II genes. Cluster II is 
suggested to contain late genes which are expressed towards the final stages of SPβ 
development, including lytic enzymes and bacteriophage structural proteins. Despite 
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being unrelated to any known examples, it appears YonO is similar to other 
bacteriophage encoded RNAPs in that it transcribes late genes.   
 
Figure 6-5: Coverage map of RNAseq reads aligned to the annotated SPβ Cluster II 
DNA. The sequencing reads from wildtype (WT) and ΔyonO cells treated with 
Mitomycin C were aligned to the annotated B. subtilis genome. The red underlining of 
annotated genes indicates those belonging to Cluster II. Differences between the 
reference sequence and read sequences are shown in red (thymine), blue (cytidine), 
yellow (guanidine) and green (adenine). The number of reads was plotted onto a 
logarithmic scale.     
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6.6. Investigation of Transcription Initiation by YonO  
6.6.1. Transcription initiation at the yonI predicted start site  
One aspect common to all RNAPs is an ability to begin de novo synthesis of RNA on 
double stranded DNA. Whilst all multisubunit RNAPs require transcription factors to 
achieve promoter binding and DNA melting, single subunit RNAPs such as T7 RNAP can 
initiate transcription independently. We decided to determine if YonO is capable of 
independently initiating transcription on double stranded DNA. Any transcription 
initiation by YonO would raise many interesting, fundamental questions regarding the 
mechanism in which it accomplishes promoter binding and DNA melting.  
RNAseq suggested transcription of yonI is controlled by YonO. Whilst most Cluster II 
genes appear to be transcribed by YonO, yonI is encoded on the minus strand and does 
not belong to any operons (Figure 6-4). This implies a YonO promoter could be 
upstream of the yonI coding sequence. According to BaSysBio transcription profile, 
upshift 1673 corresponds to a predicted transcription start site upstream of yonI. 
Therefore, 100 bp of DNA sequence upstream and downstream of the upshift 1673 
position was used as a template for in vitro transcription to determine if YonO can 
initiate transcription.   
To see if YonO was able to start transcription on upshift 1673 template, YonO was 
incubated with the template DNA and NTPs at 37⁰C for 30 minutes. Synthesised 
transcripts were labelled through incorporation of α-[32P]-UMP. YonO transcribed on 
the 1673 template to synthesise a transcript approximately 100 nt in length (Figure 6-
6). The length of the transcript was determined through comparison to the well-
studied tr2 terminator transcript produced by E. coli RNAP transcription initiated on 
the T7A1 template DNA, which gives transcripts 100 nt and 157 nt in length. The length 
of the transcripts indicates YonO is initiating transcription at the centre of the 1673 
DNA template, possibly at the predicted yonI start site. In vitro transcription reactions 
were also performed in the presence of 5 µg ml-1 heparin, which was added 
simultaneously with NTPs. Heparin competes with DNA to bind RNAP and remove 
complexes that result from non-specific interactions between RNAP and DNA. 
Furthermore, heparin binds to free RNAP and prevents multiround transcription.   
Despite high levels of potentially specific transcription, transcription on 1673 DNA by 
YonO was diminished in the presence of heparin. From this experiment it cannot be 
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determined if heparin destroyed unstable YonO complexes or restricted transcription 
to a single round.  
The direction of transcription on the 1673 template could not be determined in the 
previous experiment and as such, transcription initiating in the vicinity of 1673 upshift 
may occur in the reverse direction, away from the yonI gene. To determine the 
direction of transcription, 50 bp of sequence was added to either end of the DNA 
template. An increase in the transcript length would reveal the direction of 
transcription. The addition of 50 bp to the downstream end of the template resulted in 
an increase in transcript length from 100 nt to approximately 150 nt (Figure 6-7). 
Varying the incubation times from 30 seconds to 30 minutes showed the transcripts 
accumulated slowly over time due to multiple rounds of transcription. As the 
transcripts synthesised by YonO in 30 seconds are comparable to those produced in 30 
minutes of incubation in the presence of heparin, it suggests heparin reduces 
transcription by restricting YonO to a single round of transcription.  
The run off transcripts produced by transcription initiation in the vicinity of the 1673 
upshift appear to be heterogeneous (figure 6-7b). The differences in transcript length 
are mostly likely due to YonO using multiple transcription start sites at the yonI 
promoter. Alternatively, the heterogeneity may be due to minor variations in the 
overall length of the DNA template. These slight variations would have been 
introduced to the 5’ ends of the DNA template during PCR amplification due to errors 
at the 5’ end of the oligonucleotide primers. These errors would have been introduced 
during the 3’ to 5’ synthesis of the oligonucleotides.  
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The main conclusion to be drawn these two experiments is that YonO initiates 
transcription on double stranded DNA in a factor independent manner. Transcription 
factors are obligatory for multisubunit RNAPs to initiate transcription. To our 
knowledge, YonO is the first homologue of the multisubunit RNAP capable of 
transcription initiation without the need for accessory factors. This observation raises 
many questions, as initiation of transcription independent of other factors implies 
YonO has a previously undescribed method of recognising and melting duplex DNA. 
The experiments suggest YonO initiates transcription in the vicinity of the 1673 upshift, 
the predicted yonI transcription start site. Furthermore, YonO transcribes with a 
downstream direction towards the yonI coding sequence suggesting YonO is indeed 
responsible for transcription of yonI. 
 
Figure 6-6: Transcription initiation by YonO on upshift 1673 DNA. DNA containing 
upshift 1673, the predicted yonI transcription start site, was used as a template for 
YonO transcription initiation. YonO was incubated with DNA before the addition of 
NTPs (500 µM ATP, GTP, CTP, 50 µM UTP and 0.15 µM α-[32P]-UTP). Transcription 
reactions were incubated for 30 minutes at 37 ⁰C and the synthesised transcripts were 
118 
  
resolved by 15% denaturing PAGE. 100 nt transcripts synthesised by E. coli RNAP 
elongation complexes terminating at the tr2 terminator on T7A1 template DNA were 
used to measure the length of transcripts synthesised by YonO. 
 
Figure 6-7: Direction of transcription on the upshift 1673 template DNA. a) Upshift 
1673 DNA templates. Upshift 1673 template DNA was extended on either side by 50 
bp to give 1673 + L and 1673 + R templates. The lengths of DNA (in bp) are shown 
below each template, with the additional 50 bp indicated by the dashed line.  b) 
Direction of YonO transcription on the 1673 template. YonO was incubated with each 
template and transcription was initiated by the addition of NTPs (500 µM ATP, GTP, 
CTP, 50 µM UTP and 0.15µM α-[32P]-UTP). Reactions were allowed to proceed for up to 
30 minutes at 37 ⁰C before the addition of formamide containing stop buffer. 
Transcripts were resolved by 15% denaturing PAGE.  
6.6.2. Primer extension to confirm transcription initiation at the predicted yonI start 
site  
To determine if YonO is initiation transcription at the predicted yonI start site, primer 
extension was carried out on transcripts synthesised from 1673 template DNA using 5’ 
32P labelled primer 1673 R. Primer 1673 R was complementary to the 3’ end of 
transcripts produced by downstream run off transcription, as shown in Figure 6-7. In 
order to calculate the DNA sequence corresponding to the transcription start sites, 
dideoxy chain terminator sequencing of 1673 template DNA was also carried out using 
primer 1673 R. The site of the 1673 upshift was identified in the sequencing lanes. 
According to primer extension, transcripts were produced from the initiation of 
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transcription at the 1673 upshift (red arrow in Figure 6-8). However, there is not an 
over-abundance of primer extension products from the 1673 upshift, despite this 
transcript being the most synthesised in the in vitro transcription reaction. The primer 
extension suggests transcription also started approximately 20 bp downstream from 
upshift 1673 (shown by black arrow, Figure 6-8), possibly indicating multiple start sites 
are utilised for transcription of yonI. According to the BaSysBio transcription profile, 
there is only one transcription start site upstream of yonI. However, since the 
resolution of the tiled microarray is 22 bases, an additional start site in such close 
proximity to upshift 1673 may not have been identified. A radioactive signal migrating 
with upshift 1673 transcripts can be seen in all lanes. This signal is even present in the 
absence of YonO as so is likely due to a contaminant carried over from the synthesis or 
5’ 32P labelling of the primer.  
Looking at Figure 6-6, In vitro transcription on the 1673 template also produced short 
transcripts. Consistent with this, primer extension suggests there are additional 
transcription start sites on the 1673 template that are near to the start codon of yonI. 
The yonI start codon is shown in the sequencing of 1673 template DNA in Figure 6-8b.  
In summary, the primer extension does suggest YonO initiates transcription at upshift 
1673. However, the presence of additional bands indicative of transcription start sites 
downstream of upshift 1673 prevent us from concluding that upshift 1673 is a definite 
YonO transcription start site.  
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Figure 6-8: Primer extension to determine YonO transcription start sites. a) 
Schematic of primer extension. The 1673 DNA template shown, featuring the putative 
yonI transcription start site was used to generate transcripts (shown in red) for primer 
extension. Transcription reactions were also carried out in the presence of 5 µg ml-1 
heparin. 5’ 32P labelled Primer 1673 R (shown in black) used for extension was 
complementary to all RNA produced by run off transcription downstream of the yonI 
promoter. b) Primer extension of 1673 derived transcripts. cDNA products of primer 
extension were resolved on a 6% denaturing PAGE gel alongside dideoxy terminated 
DNA sequencing of 1673 using primer 1673 R. The sequences of upshift 1673 and the 
start codon of yonI are shown. The red and black arrows indicate RNA synthesised by 
transcription starting at upshift 1673 and approximately 20 bp downstream, 
respectively.  
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6.6.3. KMnO4 footprinting to observe DNA melting at the predicted yonI transcription 
start site  
During initiation, RNAP holoenzyme binds to the promoter DNA to form a closed 
promoter complex. Through the action of σ70, the promoter DNA is melted and the 
template strand is positioned into the active centre of RNAP. Melted DNA bound by 
RNAP is referred to as the open promoter complex. The formation of open promoter 
complexes can be observed by KMnO4 foot printing. In this technique, the thymine 
bases in the melted DNA are modified by KMnO4 and subsequently cleaved by 
treatment with piperidine. The pattern of cleaved DNA, resolved by denaturing PAGE, 
can be interpreted to determine the position of open promoter complexes on the DNA 
template.   
Therefore, KMnO4 footprinting of YonO incubated with the 1673 template was 
performed to determine if YonO is able to melt DNA and form a stable open promoter 
complex at the predicted yonI transcription start site. To detect the cleaved DNA, the 
5’ end of the 1673 DNA template strand was 32P labelled through PCR using 5’ 32P 
labelled primer 1673 R.       
Surprisingly, given the efficient transcription on the 1673 template, comparisons of 
KMnO4 footprints in the presence and absence of YonO revealed no DNA melting 
occurred (Figure 6-9a). Heparin was added to investigate the stability of any potential 
YonO open promoter complexes. Since open promoter complexes were not seen, 
heparin did not alter the footprint. The absence of evidence for DNA melting in the 
KMnO4 footprint implies that YonO open promoter complexes are highly unstable and 
transient. This characteristic was unexpected and is in contrast to the multisubunit 
RNAP which forms stable open promoter complexes that can be observed through 
KMnO4 footprinting (Nechaev et al., 2000). An exception to this is the RNAP of T. 
aquaticus. KMnO4 footprinting fails to detect T. aquacticus RNAP open promoter 
complexes suggesting the complexes are unstable (Andrey Kulbachinskiy, personal 
communication). It has also been proposed T7 RNAP open complexes are unstable, 
with evidence suggesting the initiating nucleotides are needed for stabilisation of open 
complexes (Villemain et al., 1997). Therefore, YonO may be similar to T7 RNAP and T. 
aquaticus RNAP in that its open promoter complexes are highly unstable and transient.   
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Even in the absence of YonO, the DNA template was modified by KMnO4, resulting in 
cleavage by piperidine. This gave background signal, making the identification of DNA 
cleavage due to YonO open promoter complex formation difficult. To reduce this 
background in future experiments, the modification of melted DNA by KMnO4 could be 
probed by primer extension rather than piperidine cleavage. A 5’ 32P primer annealed 
to the 3’ end of the KMnO4 modified DNA strand can be extended by DNA polymerase. 
However, primer extension is halted as the DNA polymerase encounters the modified 
DNA. Upon resolving the primer extension products by denaturing PAGE, the site of 
open promoter complex formation can be determined.  
6.6.4. DNase I footprint to observe YonO closed promoter complex formation 
Since we were unable to detect open promoter complex formation, we investigated 
YonO’s ability to bind the 1673 template and form closed promoter complexes by 
DNase I footprinting. Protein bound DNA is protected from endonucleolytic cleavage 
by DNase I. Resolving the cleavage products by denaturing PAGE gives a footprint 
pattern which reveals the position of protein binding on the DNA. To visualise the 
cleavage products, 1673 template DNA was 32P labelled at the 5’ terminus of the non-
template strand. YonO was incubated with 1673 template DNA at room temperate 
prior to the addition of DNAse I. The incubation temperature can influence the binding 
of YonO to the template DNA; a reduced temperature (room temperature) would slow 
the disassociation of YonO from the template and increase detectable protection 
against DNase I. Titrating the concentration of YonO revealed a very weak protection 
of the DNA from endonucleolytic cleavage. A detectable reduction in DNA cleavage 
was only observed when YonO was at a 20 times excess over DNA (lane 4, Figure 6-8b). 
This shows that YonO is only capable of weakly binding to the double stranded DNA. 
From this experiment alone, it cannot be concluded that this weak binding is non-
specific. However, given the protection from DNase I was not limited to a discrete 
region of the DNA template; this appears to be the case.  
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Figure 6-9: DNA footprinting of YonO on upshift 1673 DNA. a) KMnO4 footprint. YonO 
was incubated with 1673 DNA 5’ 32P labelled on the template strand for 10 minutes at 
37 ⁰C. KMnO4 was added and reactions were allowed to proceed for the indicated time 
before addition of β-mercaptoethanol and piperidine treatment. YonO and KmnO4 
were omitted for negative controls. Dideoxy DNA sequencing on the 1673 was 
performed using 5’ 32P labelled primer 1673 R. Reactions were resolved on 6 % 
denaturing PAGE gel and visualised by phosphorimaging. Sequence of upshift 1673 
(red) on the template strand is shown. b) DNase I footprint. YonO was incubated with 
1673 DNA (labelled as before) for 10 minutes at room temperature. YonO was mixed 
with 1673 DNA at a ratio of 1:1, 5:1, 10:1 and 20: 1. DNase I was added for 2 minutes 
at room temperature. Reactions were stopped by addition of stop buffer and resolved 
on 6 % denaturing PAGE gel. To identify sites of DNA protection, dideoxy DNA 
sequencing reactions were loaded. The arrow indicates a preferential DNase I cleavage 
site.   
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6.7. Discussion 
Whilst showing YonO is a functional enzyme, in vitro experiments did not shed light on 
the involvement of YonO in SPβ induction. Previously, YonO was classified as a 
hypothetical protein and the only evidence for it expression was microarray data 
(Nicolas et al., 2012). Here we have directly shown that YonO is expressed during 
development of SPβ. Furthermore, our RNAseq data suggests YonO is responsible for 
transcription of the SPβ late genes. As it is completely unrelated to T7 RNAP, these 
results suggest that YonO is a novel type of bacteriophage RNAP.  
Bacteriophages vary widely in their strategies used for gene expression. Many 
bacteriophages manipulate the host bacterium’s RNAP for the expression of their early 
and middle genes before utilising their own RNAP to express late genes. The work 
presented here suggests that SPβ falls into this category of bacteriophages, with YonO 
being employed for the expression of the SPβ late genes. In this regard, SPβ is 
comparable to the highly studied T7 coliphage.  
An alternative method of gene expression is the total hijacking of the host RNAP for 
the transcription of all bacteriophage genes. T4 coliphage is a well-studied example of 
a bacteriophage which does not encode its own RNAP. The biology of T4 
bacteriophage is reviewed extensively in Miller et al., 2003. To enable the complete 
control of the host RNAP, T4 bacteriophage encodes a wide range of additional 
proteins which target the host RNAP to the bacteriophage promoters at the correct 
times during infection. For instance, to express its late genes, T4 encodes for its own σ 
factor. However, this alone is not sufficient and so T4 encodes many more proteins 
that contribute to the expression of late genes. These include proteins that mimic σ 
factors and bind the host RNAP to prevent the transcription of host genes and a DNA 
clamp which facilitates in the opening of late promoter DNA duplexes. This clamp itself 
is loaded onto DNA by a heterodimer whose proteins are also encoded by T4. All of 
this is in stark contrast to the T7 bacteriophage, which accomplishes late gene 
expression by simply encoding for its own RNAP. This simple and economical method 
of gene expression is one advantage conferred to bacteriophages by possessing their 
own RNAP, as the bacteriophage is not encumbered with genes coding for the host 
RNAP hijacking machinery. 
125 
  
Another significant advantage of encoding an RNAP is the bypassing of host RNAP 
regulation. Host RNAPs are subjected to a multitude of regulations and processes that 
impact on transcription. These include regulation of transcription initiation, elongation 
speeds, and termination by factors such as Rho. Even in the absence of these external 
regulations, multisubunit RNAPs are impeded by events such as pausing and 
backtracking that are brought about by the template DNA sequence (Bochkareva et al., 
2012). As bacteriophage RNAPs are not affected by these regulations, they are free to 
rapidly transcribe long operons. Indeed, the T7 RNAP has a much greater rate of 
elongation than the multisubunit RNAP of its host (Tahirov et al., 2002). Previous 
experiments (shown in chapter 5) suggest YonO is also faster than multisubunit RNAPs, 
with a potentially lower Km too. If this is indeed the case, this would provide an 
additional advantage, as YonO could still achieve rapid transcription in low NTP 
conditions. 
The conclusion that YonO is essential for SPβ development and is required for Cluster II 
transcription is based on Cluster II not being comprised of a single operon. A single 
operon under the control of one promoter upstream of yonP would be disrupted by 
the replacement of yonO with a kanamycin cassette, explaining the complete absence 
of Cluster II gene expression in ΔyonO. The transcription profile calculated from the 
BaSysBio microarray data does not support this. Rather, it suggests yonO is only in an 
operon with yonP and yonN. yonI of Cluster II is coded on the minus stranded and does 
not belong to any operon. The fold changes calculated from RNAseq data indicate yonI 
is only expressed in wildtype cells, not in ΔyonO, in response to Mitomycin C. This 
further supports the conclusion YonO is required for the transcription of Cluster II 
genes. However, to allow us to confirm that YonO is definitely responsible for Cluster II 
expression, a scarless ΔyonO strain will be constructed. In this strain, transcription of 
Cluster II would not be disrupted by the insertion of a kanamycin resistance cassette.  
In addition to a scarless ΔyonO mutant, the conclusion that YonO is essential for SPβ 
induction and transcription of Cluster II could also be verified by complementation 
experiments. In these experiments, a copy of the yonO gene under the control of an 
inducible promoter would be introduced into a ΔyonO strain through homologous 
recombination elsewhere on the chromosome. If YonO is indeed responsible for 
Cluster II transcription, the simultaneous induction of YonO expression and SPβ in this 
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strain would result in the restoration of Cluster II transcription and SPβ particle 
production. The state of Cluster II transcription could be observed by analysis of the 
transcripts at either a single gene level (Northern blot or qPCR) or at the transcriptomic 
level (RNAseq). Furthermore, the production of SPβ particles could be assayed by 
incubating the lysates of the induced cells with an SPβ sensitive strain, as performed in 
section 6.4.   
It was reasoned a YonO promoter would be upstream from the yonI coding sequence 
as yonI is independent from all other Cluster II genes and according to RNAseq, is 
transcribed by YonO. Therefore, the DNA surrounding upshift 1673, a predicted 
transcription start site was used as template DNA to determine if YonO is able to 
initiate transcription. Surprisingly, YonO was able to initiate transcription on double 
stranded DNA. Furthermore, YonO initiated transcription in the vicinity of the 
predicted yonI and transcribed downstream towards the yonI coding sequencing. 
Whilst supporting the notion that YonO initiates transcription at the predicted start 
site, primer extension also suggested the existence of multiple start sites downstream 
of upshift 1673. Therefore, further work is needed before it can be concluded that this 
is a genuine YonO transcription start site.       
As YonO is capable of initiating transcription, future work will also involve determining 
the promoter sequence recognised by YonO. In addition to confirming that YonO is 
required for expression of Cluster II genes, future RNAseq experiments will contribute 
to identifying transcription start sites and promoter elements. The first nucleotide of a 
transcript retains its triphosphate moiety. Therefore, transcription start sites can be 
identified with RNAseq by selecting transcripts featuring 5’ triphosphates during library 
construction (Sharma et al., 2010). Assuming YonO transcription start sites are 
identified, comparisons of the upstream DNA sequences may allow for the 
identification of promoter elements. As YonO has been observed initiating 
transcription at the predicted yonI transcription start site, this too can be utilised for 
the identification of promoter elements. An in vitro approach allows control over the 
transcription reaction and so the DNA sequence upstream of the yonI transcription 
start site could be modified. By observing the effects the modifications have on 
transcription, the yonI promoter may be identified.  Furthermore, these alterations to 
the template DNA would allow us to delineate the specific sequence of the promoter.  
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Given its relationship to the multisubunit RNAP, YonO initiating transcription on 
double stranded DNA was not expected. As discussed previously, multisubunit RNAPs 
are dependent on transcription factors for initiation. In addition to recognising and 
melting promoter DNA, transcription factors are required for the binding of 
nucleotides, initial catalysis and promoter escape (Kulbachinskiy and Mustaev, 2006, 
Sainsbury et al., 2013). Therefore YonO independently initiating transcription raises 
many fundamental questions that will form the basis of future work. One of the major 
questions to be answered is how YonO, a 100 KDa protein, is able to independently 
initiate transcription whilst the 500 KDa multisubunit RNAP cannot. In being able to 
bind and melt duplex DNA independent of other factors, YonO is analogous to T7 
RNAP. T7 RNAP utilises two structural motifs, the specificity loop and the intercalating 
hairpin to accomplish these tasks. Residues of the specificity loop recognise the T7 
promoter DNA whilst the intercalating hairpin separates the DNA strands (Yin and 
Steitz, 2002, Cheetham and Steitz, 1999). It is possible two structural motifs analogous 
to the specificity loop and intercalating hairpin exist in YonO. Bioinformatics has 
predicted YonO contains a zinc ribbon (Iyer and Aravind, 2012). Zinc ribbons are 
utilised by many proteins that interact with nucleic acids. The N-terminal domain of 
the β’ subunit contains a single zinc ribbon, whilst the corresponding domain in 
eukaryotes and archaea contains two (Iyer et al., 2003). Based on its position in the 
structure of the RNAP holoenzyme, it has been hypothesised that this zinc ribbon 
participates in promoter binding (Murakami et al., 2002a, Vassylyev et al., 2002). 
Therefore, it is plausible to suggest the zinc ribbon of YonO may also contribute to 
promoter binding.   
Another potential similarity between YonO and T7 RNAP is an inability to form stable 
open promoter complexes. Despite DNase I footprinting suggesting YonO binds 1673 
DNA, albeit weakly, KMnO4 footprinting suggested YonO does not form stable open 
promoter complexes. In vitro studies suggest that whilst DNA melting by T7 RNAP is 
rapid, formation of open promoter complexes is thermodynamically unfavourable 
(Bandwar and Patel, 2001, Villemain et al., 1997). Furthermore, the transition from a 
closed to a stable open promoter complex by T7 RNAP is stabilised by the presence of 
the NTPs complementary to the +1 and +2 positions on the template DNA (Stano et al., 
2002). Speculating, YonO may be similar to T7 RNAP in transcription initiation as rapid 
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DNA melting and a requirement for the initiating NTPs would account for our inability 
to detect DNA melting by YonO. Alternatively, a previously unidentified transcription 
factor may contribute to stabilisation of open conformation of DNA melted by YonO. 
Only 25% of proteins encoded on SPβ have homology to known proteins (Lazarevic et 
al., 1999). Therefore, SPβ encoding its own specific transcription factor cannot be ruled 
out.     
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Chapter 7: Attempts to Determine the Structure of YonO  
7.1. Introduction  
Structural studies of RNAP have contributed greatly to the field of transcription. Since 
1999, a great number of structures have been published, providing answers to many 
important biological questions regarding transcription. The first high resolution 
structure of the core multisubunit RNA polymerase from Thermus aquaticus was 
published in 1999 by Zhang et al. (1999). Previously, cryoelectron microscopy had 
revealed that RNAP has an overall shape similar to that of a crab claw (Darst et al., 
1989). The high resolution structure, elucidated by X-ray crystallography, confirmed 
this to be true (Cramer et al., 2001, Zhang et al., 1999). Furthermore, the structure 
confirmed and explained a vast amount of previous biochemical and genetic data. One 
such example is the elucidation of the location of the active centre. In the structure, 
this motif mapped to the centre of the enzyme and was shown to be chelating a Mg2+ 
ion, thus revealing the location of the active centre within the enzyme and confirming 
that the aspartate triad motif is responsible for chelating Mg I (Zhang et al., 1999, 
Zaychikov et al., 1996). Furthermore, Mustaev et al utilised Fe2+ hydroxyl cleavage to 
identify 9 distinct sites of β’ and β which contact Mg I (Mustaev et al., 1997). Mapping 
of the 9 sites showed they spanned across the primary amino acid sequence of the two 
subunits (Zhang et al., 1999). The crystal structure of RNAP revealed that the 9 sites 
are within 20 Å of Mg I in the ternary structure thus confirming the previous 
biochemical data.   
The explanation of previous biochemical data is a single example of how the structure 
of RNAP has advanced the field of transcription. The structures of RNAP have provided 
insights into all aspects of transcription, including initiation, elongation, substrate 
binding, and mechanism of catalysis (for a recent review, see Martinez-Rucobo and 
Cramer (2013) ). Therefore, since YonO is very distantly related to the multisubunit 
RNAP and lacks most of the essential domains, we sought to elucidate its structure at 
an atomic level.  
7.2. Aims 
The aim of this work was to determine the structure of YonO by X-ray crystallography. 
To this end, a collaboration was established with Dr Arnaud Baslé of the Structural 
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Biology Lab (SBL) at Newcastle University. Unless stated otherwise, David Forrest 
performed all cloning, protein expression, purification and crystallisation. Dr Baslé 
provided expertise on all aspects of crystallisation, harvested crystals and performed 
data collection at the Diamond Light Source synchrotron.  
7.3. Screening for Crystallisation Conditions 
Highly purified, concentrated protein is required for crystallisation screens. The three 
step purification of YonO bearing an N-terminal 6x His-tag by Ni2+ - NTA 
chromatography, Heparin affinity chromatography and gel filtration resulted in YonO 
purified to near homogeneity (discussed previously in Chapter 5).  
YonO was concentrated to 10 mg ml-1 and trialled for crystallisation by equilibration 
against a standard set of commercial crystallisation screens. The standard set of 
screens included JSCG+, Proplex, MIDAS, Index, Morpheus, Structure screens. Details 
of these screens can be found in the material and methods. Each screen is comprised 
of 96 different crystallisation conditions, with each condition being dispensed into a 
reservoir of a MRC 2 well sitting drop 96 well plate (the layout of an MRC 2 well sitting 
drop plate is shown in Figure 7-1a). Adjacent to each reservoir on the MRC plate are 
two wells into which purified YonO was dispensed and mixed with the corresponding 
condition from the reservoir. Two wells allow variation in the ratio of protein and 
reservoir solution. In accordance with typical crystallisation screens, YonO was mixed 
with reservoir solution at a ratio of 1:1 and 2:1. The plates were sealed and 
equilibration was allowed to proceed overnight at 20 ⁰C. Approximately 16 screening 
conditions were positive, giving bipyramidal crystals of varying sizes. To determine if 
the crystals diffracted to a sufficient resolution (≤3.5 Å) for structure determination, 
crystals were harvested by Dr Baslé. Harvested crystals were cryoprotected in 
saturated (NH4)2SO4 and flash cooled in liquid nitrogen. Typically, crystals are 
cryopreserved at 100 K to reduce radiation damage during data collection. The crystals 
were tested for diffraction by loading onto the in-house X-ray generator. All crystals 
diffracted poorly, with the resolution limited to ~7-8 Å.    
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7.4. Optimisation of YonO Crystallisation  
7.4.1. Optimisation of YonO screening condition  
Optimisation of crystallisation conditions is routinely performed to improve the size 
and diffraction quality of crystals. To allow optimisation of YonO crystallisation 
conditions, the constituents of the 16 positive screening conditions were compared. It 
was determined that CoCl2, NaCl and (NH4)2SO4 encouraged the formation of crystals in 
pH ranging from 6.5 to 7.5.     
Based on the initial crystallisation conditions, a custom optimisation screen (CoCl2 
screen) was designed which varied the concentrations of the precipitant ((NH4)2SO4), 
salts (NaCl and CoCl2) and buffer pH (Figure 7-1b). The screen was mixed and 
dispensed into an MRC 2 well sitting drop 96 well plate by a Beckman BioMek NX2 
automation workstation. After YonO was dispensed into the MRC plate and 
equilibrated overnight at 20 ⁰C, screens were inspected manually. Whilst crystals 
formed in a range of conditions, a greater number of conditions in the lower right hand 
quadrant of the screen (conditions E6 – E12, F6 – F12, G6 – G12 and H6 – H12, Figure 
7-1c) resulted in large bipyramidal crystals. This indicated that whilst the conditions for 
YonO crystallisation are flexible to a degree, pH 6 and the presence of CoCl2 promotes 
fewer nucleation events and therefore encourages the formation of larger crystals. In 
all positive screen conditions, the precipitant was (NH4)2SO4. Therefore, the 
commercial AmSO4 screen was also trialled. As with the custom screen, overnight 
equilibration led to the formation of large bipryamidal crystals in a wide range of 
conditions. 
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Figure 7-1: Optimisation of YonO crystallisation. a) MRC 2 well sitting drop 96 well 
plate. Each position on the 96 well screen is comprised of a reservoir and two wells. 
Protein is dispensed into the wells and mixed with the reservoir solution. YonO was 
dispensed at a ratio of 1:1 (top well) and 2:1 (bottom well). The side view 
demonstrates vapour diffusion between the protein and reservoir. b) CoCl2 custom 
screen. A custom screen was designed to optimise the conditions of YonO 
crystallisation based on the constituents of the reservoirs from the initial 
crystallisation. c) Optimised YonO crystallisation.  YonO formed large bipyramidal 
crystals in many of the CoCl2 and AmSO4 screen conditions. Two examples are shown 
along with the corresponding crystallisation condition and screen.  
Crystals from the CoCl2 and AmSO4 screens were harvested as previously described. 
Crystals were transported to the Diamond Light Source synchrotron (DLS) for 
diffraction data collection. Synchrotron radiation is more intense than that produced 
by an in-house X-ray generator and can therefore provide higher resolution diffraction 
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data. Despite this, each of the crystals diffracted with a resolution of approximately 7-8 
Å.  
7.4.2. Discovery and crystallisation of a possible YonO tetramer 
During Ni2+-NTA chromatography, YonO eluted from the column at two concentrations 
of imidazole (100 mM and 200 mM). The majority of YonO eluted at 100 mM imidazole 
and so this elution fraction was chosen for further purification by Heparin affinity and 
gel filtration.  However, the YonO eluting at 200 mM imidazole during Ni2+-NTA 
chromatography was also further purified using heparin affinity chromatography. 
Interestingly, loaded YonO eluted off the Heparin Hi-trap column at two 
concentrations of NaCl. As before, YonO eluted at 800 mM NaCl. However, SDS PAGE 
revealed YonO also eluted off the column at 1M NaCl (Figure 7-2a). Based on the 
heparin chromatography chromatogram, the 800 mM and 1M NaCl elution fractions 
are referred to as peak 1 and peak 2, respectively. This presence of peak 2 was specific 
to the YonO eluted by 200 mM imidazole during Ni2+-NTA chromatography. Peak 2 
suggests a minority of YonO exists in a conformation with increased affinity for 
heparin. Oligomerisation of YonO would explain an increased affinity. As gel filtration 
resolves proteins according to their molecular weight and shape, YonO samples from 
peaks 1 and 2 were independently loaded onto a Superdex 200 16/60 gel filtration 
column. As in previous gel filtration, YonO in peak 1 eluted off the column in an elution 
volume of 70 ml (Figure 7-2b). Peak 2 on the other hand, eluted off the column quicker 
with an elution volume of 60 ml. This showed YonO in peak 2 had an increased 
molecular mass. Since peak 2 only contained purified YonO (Figure 7-2c), the increase 
in molecular weight suggests YonO is capable of oligomerisation.  
To investigate the prospect of oligomerisation further, the molecular weight of peak 2 
YonO was calculated by gel filtration. To allow the calculation of molecular weight, the 
Superdex 200 column was calibrated using the elution volumes of protein standards 
with known molecular weights. The elution volumes of the standard proteins were 
used to calculate the Kav constant, which represents the proportion of resin pores 
available to a given protein. The Kav constants of the standard proteins were plotted 
against the log of their molecular weight to generate a calibration curve. From the 
calibration curve, it was calculated that YonO eluting off the gel filtration at 60 ml had 
a molecular weight of 413 KDa. YonO has a predicted molecular weight of 98 KDa (100 
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KDa with an N-terminal His tag), suggesting that YonO from peak 2 behaves as a 
tetramer.  
The smaller form of YonO eluting at 70 ml (peak 1) had a calculated molecular weight 
of 135 KDa. The predicted molecular weight of YonO is 98 KDa. Therefore, the 
calculation of molecular weight suggests that the abundant form of YonO, the form 
used previously for crystallisation and in vitro studies, is monomeric. Negative stained 
transmission electron microscopy was used to confirm that YonO in peak 1 exists as a 
single, monomeric protein. At 130 000 x magnification, no aggregation or oligomers 
were observed (Figure 7-2d). The discrepancy between calculated and predicted 
molecular weights of monomer YonO can be explained by the physical shape of the 
YonO protein. The passage of a protein through a gel filtration column is influenced by 
its shape. Accurate calculation of a proteins molecular weight is dependent on the 
protein being globular, as the standard proteins used for the calibration are of a 
globular nature. Therefore YonO not being globular would lower the accuracy of the 
calculated molecular weight. Furthermore, the calibration curve is not linear and any 
small variations can reduce the accuracy of the calculated molecular weight. The N-
terminal His tag only contributes approximately 2 KDa to the overall mass of YonO and 
so it is unlikely this influenced the estimation of the molecular mass of YonO and its 
oligomer. These limitations restricted us to only being able to estimate the molecular 
weight of YonO and its oligomerised state by gel filtration.  
It was thought the YonO tetramer may form crystals with an alternative morphology to 
the bipryimadal crystal seen previously. One approach to obtaining higher resolution 
diffraction data is to alter the screening conditions to find those that allow for the 
formation of different crystal morphologies. In differing morphologies, the spatial 
organisation of the protein within the crystal is likely to be different and diffraction 
may be improved. Therefore, the tetramer was trialled for crystallisation by overnight 
equilibration against the standard set of screens, the custom CoCl2 screen and the 
AmSO4 screen. As with the YonO monomer, many conditions of the CoCl2 screen 
allowed for the formation of crystals (Figure 7-2e). However, the tetramer crystals 
exhibited a range of morphologies. Crystals from the screens were harvested by our 
collaborator, Dr Arnaud Baslé, and were subjected to high energy synchrotron 
radiation. None of the tetramer crystals gave X-ray diffraction less than 7 Å.   
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Figure 7-2: Purification and crystallisation of YonO tetramer. a) Heparin affinity 
chromatography of YonO. YonO partially purified by Ni2+-NT chromatography was 
applied to a heparin column. Blue trace is absorbance of eluate at 280 nm. Red trace is 
NaCl concentration as a % of 1M. YonO was eluted from the column at ~80% (800 mM) 
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NaCl (peak 1) and at 100% (1M) NaCl (peak 2). b) Gel filtration of YonO heparin peaks 
1 and 2. Heparin peaks 1 (blue trace) and 2 (red trace) were individually applied to a 
Superdex 200 column. Chromatography traces were overlayered. Peak 1 and 2 eluted 
at ~70 ml and ~60 ml, respectively. c) SDS-PAGE comparison of heparin peaks 1 and 2. 
d) Electron microscopy of purified YonO. Purified YonO was adsorbed on a carbon 
support and negatively stained using uranyl acetate. Protein was viewed at 130 000 x 
magnification. Microscopy was performed by Dr Robin Harris. e) Crystals formed by 
YonO from heparin peak 2. After gel filtration, YonO eluted in heparin peak 2 was 
concentrated and trialled for crystallisation. Crystals shown are from equilibration 
against the custom CoCl2 screen. Specific screen condition are displayed in the top 
right. 
7.5. Optimisation of YonO Crystal Diffraction 
Many crystallography project fail due to an inability to find the correct conditions 
which promote protein crystallisation. In this case however, despite obtaining large 
(≥100 µM) crystals, we were unable to obtain high resolution X-ray diffraction data. 
There are many techniques which have been developed to address this problem, a 
number of which were attempted to increase the resolution of diffraction obtained 
from YonO crystals. 
7.5.1. Microseeding to Produce Alternative Crystal Morphologies  
The formation of a crystal occurs in two separate phases. The first step, nucleation, is 
the event in which, as the conditions become supersaturating (due to vapour diffusion 
against salt and a precipitant), proteins come out of solution by interacting to form a 
small well-ordered aggregate called a nuclei that has the potential to develop into a 
crystal. For the formation of crystal, additional protein is incorporated into the nuclei 
in a well-ordered manner. This growth is considered the second phase of crystal 
formation. The two phases of crystal growth are often encouraged by differing 
conditions. Nucleation requires a supersaturating state to bring about nucleation 
events. This is in contrast to growth, which requires a reduced saturating state to 
encourage protein to incorporate into a pre-existing crystal in a slow ordered manner, 
rather than forming new nuclei. Conditions which are too saturated result in 
unordered precipitation or unusable microcrystals.  
Often the separation of nucleation and crystal growth phases can be beneficial. One 
condition may promote nucleation and not growth and vice versa. The technique of 
microseeding can address this (reviewed in Bergfors, 2003). Crystals can be grown in a 
previously trialled condition, harvested and physically broken. The broken pieces of 
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crystal (referred to as microseeds) can act as preformed nuclei in new crystallisation 
screens, onto which fresh protein can be incorporated to form new crystals (Bergfors, 
2003, Ireton and Stoddard, 2004, D'arcy et al., 2007). The use of microseeds can 
bypass the nucleation stage and potentially result in crystals with different properties 
such as morphology and diffraction.  
To this end, monomeric YonO was purified and screened against the CoCl2 screen to 
produce large crystals. Crystals were crushed in the well of the 96 well plate, 
suspended in the corresponding reservoir solution and broken into fragments by 
vigorous vortexing with a seed bead. Crystallisation screens were set up as before 
except that microseeds were added to the wells of each screen in addition to freshly 
purified YonO.   After overnight equilibration at 20 ⁰C, crystals were observed in many 
of the conditions. Strikingly, crystals of many different morphologies formed (Figure 7-
3). These were harvested and tested for diffraction using the in house x-ray generator. 
Salt crystals produce a very characteristic diffraction pattern; the diffraction resolution 
is high and the diffraction spots are far apart. All of the microseed crystals harvested 
gave diffraction patterns characteristic of salt.  
 
Figure 7-3: Microseeding of crystallisation screens. Microseeds were added to the 
wells of crystallisation screens in addition to fresh YonO protein and reservoir solution. 
Equilibration was performed overnight at 20 ⁰C. Above, four examples of resultant 
crystals are shown. The condition and screen name are shown along with the scale bar.     
 
 
E8. JCSG + 
C5. Morpheus D11. JCSG + 
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7.5.2. Additive Screening  
Crystallisation can be aided by the presence of an additive in the reservoir solution. 
The term additive refers to any compound added which may alter the crystallisation 
process of a given protein, with examples being ZnCl2 (salts), glucose (carbohydrates) 
and ethanol (organic compounds). An additive may alter crystallisation by stabilising 
the protein, reducing movement of mobile domains or by influencing protein-protein 
interactions. It is hoped that these alterations increase the order within the crystal 
which would increase the resolution of the collected diffraction data. An example of 
this is the addition of spermidine to the reservoir solution during crystallisation of the 
distant YonO homologue QDE-1 (Laurila et al., 2005).  
For additive screening, a single condition known to produce crystals of YonO was 
chosen. This condition, G9 of the custom CoCl2 screen (see Figure 7-1b for CoCl2 
composition) was dispensed into every reservoir of a MRC 2 well 96 well plate. Each 
reservoir was supplemented with an additive from the 96 well additive screen. The 
screen was then set up as previously described and equilibrated overnight. Many 
crystals formed across the screen (Figure 7-4). However, all crystals observed were 
bipyramidal and the additives resulted in a decrease of crystal size and an increase in 
nucleation events.  The largest crystals were harvested (Figure 7-4) and tested at 
synchrotron for diffraction. None of the additives had a positive effect on diffraction 
resolution, with diffraction being limited to 7 – 8 Å.           
 
Figure 7-4: Additive screening for improved crystal diffraction. Condition G9 of the 
custom CoCl2 screen (100 mM MES pH 6, 10 mM CoCl2 and 1.7 M (NH4)2SO4) was 
used as the reservoir solution in a 96 well screen. To each reservoir, an additive was 
added prior to overnight equilibration with YonO. Small bipyramidal crystals formed in 
B4 
G2 H1
1 
D3 
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many conditions. Shown in this Figure are the largest crystals formed in the presence 
of an additive in conditions B4 (G9 + 100mM KCl), D3 (G9 + 10 mM spermine 
tetrahydrochloride), G2 (G9 + 3% hexanediol) and H11(G9 + 4% 2,2,2-trifluoroethanol).  
7.5.3. Removal of N-terminal His tag  
Out of the purification tags available, the hexahistidine tag (His-tag) is most frequently 
used for protein purification. In particular, it is favoured for the purification of proteins 
destined for crystallisation screens. This is due to its small size, 1 KDa, which rarely 
impedes on the structure of a protein or its crystallisation (Smyth et al., 2003). 
Nevertheless, it is accepted that the presence of a His-tag can occasionally be 
detrimental to crystallisation as their flexibility allows them to interfere with protein – 
protein interactions (Dale et al., 2003). Therefore, there is a possibility that the N-
terminal His-tag present on YonO prevented the ordered crystal packing required to 
form diffracting crystals.   
To address this, YonO was cloned into the expression vector pET-21, with a TAA stop 
codon preventing the inclusion of a C-terminal His-tag from the vector. Despite the 
lack of a tag, YonO was purified to apparent homogeneity though the use of a heparin 
column, for which YonO has a very high affinity, with approximately 800 mM NaCl 
being required for elution of YonO from heparin.  Western blot with anti-His tag 
primary antibodies was used to confirm the purified YonO was tag-free (Figure 7-5a)  
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Figure 7-5: Crystallisation of tag free YonO. a) Western blot to confirm absence of 
His-tag on YonO. Tag free YonO was expressed and purified by heparin affinity 
chromatography and gel filtration. 5 and 10 pmol of purified YonO, either tag free or 
with an N-His tag were resolved by SDS – PAGE and transferred onto PVDF membrane. 
Membrane was probed using anti-His-tag antibodies and visualised using HRP-
conjugated anti-mouse antibodies. b) Tag free YonO forms bipyramidal crystals. 
Purified tag free YonO was trialled for crystallisation by overnight equilibration with 
the standard set of crystallisation screens. Drop sizes of 100 nl was used with ratios of 
1:1 and 2:1 (protein: reservoir). Shown are two representative conditions (displayed in 
top right) which gave bipyramidal crystals.   
 
Tag-free YonO was trialled for crystallisation by equilibration against the standard set 
of screens (see section 7.3.1), the AmSO4 screen and CoCl2 screen. As before, 
bipyramidal crystals formed after overnight equilibration (Figure 7-5). The diffraction 
of the crystals was limited to 7 Å. Despite not increasing the diffraction, tag-free YonO 
crystals did allow us to conclude that the His-tag is not responsible for the poor 
diffraction observed throughout the crystallisation trials. Tag free YonO was purified to 
near 100% purity without Ni2+-NTA chromatography. Additionally, the absence of the 
His-tag did not have a detrimental effect on the diffraction quality of crystals. 
Therefore, all subsequent crystallisation trials were conducted using tag free YonO. 
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7.5.4. Use of Artificial Transcription Scaffolds to Stabilise YonO RNAP  
Despite optimisation, microseeding and additive screening, the conditions permissive 
for the growth of crystals with high resolution diffraction remained elusive. A possible 
explanation for this is intrinsic flexibility of YonO during crystallisation. RNAPs contain 
mobile domains. In the multisubunit RNAP, the clamp domain swings down to grip the 
downstream DNA (Chakraborty et al., 2012, Cramer et al., 2000, Cramer et al., 2001). 
The notion that YonO contains similarly mobile domains is plausible, as it was observed 
that QDE-1, a distant homologue of YonO, is able to adopt open and closed 
conformations through movement of the head and slab domains (Salgado et al., 
2006)(Figure 7-6).   
  
Figure 7-6: Open and closed conformation of QDE-1. Taken from Salgado et al, 2006. 
The side view of a QDE-1 monomer is shown. The slab and head domains of two 
monomers belonging to the same homodimer were seen to be positioned at different 
angles. This is represented by double headed arrows between monomer A and 
monomer B. In an independent, second dimer structure, the head and slab domains 
are positioned at the same angle. Taken together this suggests the head and slab 
domains have a degree of flexibility which may correspond to the opening and closing 
of QDE-1.  
Whilst the mobility of RNAP domains was not problematic for the growth of well 
ordered, high quality crystals previously, it cannot be ruled out that potential intrinsic 
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flexibility of YonO is detrimental to crystal formation. To address this potential reason 
for poor crystal diffraction, we sought to crystallise YonO bound to a nucleic acid 
scaffold. It was hoped that upon binding to the scaffold, YonO would adopt a stable, 
rigid conformation which would allow for increased order within the crystal.   
For the determination of the Thermus thermophilus elongation complex structure, 
RNAP was assembled with a nucleic acid scaffold prior to crystallisation (Vassylyev et 
al., 2007a). This scaffold (denoted as scaffold 1) was obtained and used for the 
assembly of YonO elongation complexes (YonO EC) (scaffold 1, Figure 7-7). To confirm 
that YonO ECs were both stable and active, assembled complexes were immobilised by 
the 5’ biotin tagged template DNA strand to streptavidin beads and washed with 
transcription buffer containing low or high concentrations of salt. Only stable 
elongation complexes are resistant to high ionic strength (Sidorenkov et al., 1998). 
Upon washing the immobilised complexes with high salt transcription buffer, non-
template DNA (NTDNA14) and RNA (RNA16) was lost, showing the YonO EC were 
unstable (Figure 7-7, compare lane 1 against lane 2 and lane 6 against lane 7). The 
assembled complexes were not destabilised by low salt concentrations, as RNA16 and 
NTDNA14 were not removed after washing immobilised complexes with 40 mM KCl. 
Furthermore, complexes extended RNA16 to the end of the template in the presence 
of NTPs (Figure 7-7, compare lane 4 against lane 5 and lane 9 against 10,). However, 
not all YonO elongation complexes extended RNA16. Scaffold 1 was originally designed 
for form stable T. thermophilus elongation complexes that do not oscillate between 
the post and pre-translocated states, which would interfere with crystallisation. 
Therefore, the inability of all YonO complexes to extend RNA16 in the presence of 
NTPs can be explained by increased stability of complexes due to the sequence of 
scaffold 1 oligonucleotides (Vassylyev et al., 2007a).  
Scaffold 1 was comprised of the minimum nucleic acid strands required to form a 
stable elongation complex. The short length of the scaffold was designed to reduce the 
likelihood that either RNA or DNA extrudes from the surface of RNAP and interferes 
with crystal contacts during crystallisation (Kashkina et al., 2006). Whilst bacterial 
RNAP is able to form stable elongation complexes on this scaffold, YonO did not. The 
non-template DNA strand is known to have a stabilising effect on elongation 
complexes (Sidorenkov et al., 1998). In scaffold 1, the non-template DNA strand 
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(NTDNA14) was short, with the strand only annealing to the downstream region of the 
template DNA strand (as seen in Figure 7-7). It was reasoned that a longer non-
template strand may increase the stability of YonO elongation complexes (referred to 
as scaffold 2 which is shown in Figure 7-7). The non-template strand was extended at 
the 5’ end by 9 nucleotides (NTDNA23). The extended sequence was non-
complementary to the template strand to mimic the transcription bubble (Yin and 
Steitz, 2002). Scaffold 2 YonO ECs were assembled, immobilised and washed with 
transcription buffer containing high or low concentrations of salt. The stability of the 
complexes was improved by the presence of the longer non-template DNA strand as 
both RNA13 and NTDNA23 were present after washing scaffold 2 complexes with high 
salt buffer (Figure 7-7, compare lanes 11 and 17 to lanes 1 and 7,). The increased 
stability of scaffold 2 EC is further demonstrated by comparisons of RNA13 extension 
by scaffold 1 and 2 complexes radiolabelled at the 5’ end of the non-template strand 
(Figure 7-7, compare lane 18 to 8,). In these reactions, RNA13 extended by YonO was 
labelled through the incorporation of α-[32P]-AMP during elongation. Scaffold 2 
resulted in increased amounts of extended RNA13 which suggests more RNA13 was 
retained in assembled elongation complexes after washing with high salt buffer.   
One complication with the crystallisation of YonO is the requirement of 500 mM NaCl 
to maintain solubility of YonO at a concentration of 10 mg ml-1 (not discussed or 
shown). When determining the stability of scaffold 1 and 2 elongation complexes, 
complexes were formed in the presence of 40 mM KCl prior to being washed by 500 
mM NaCl transcription buffer. This differs to the formation of elongation complexes 
intended for crystallisation screens, which would be formed in the presence of the 500 
mM NaCl necessary for YonO solubility. Elongation complexes are only resistant to 
high ionic strength after assembly, making it possible that elongation complexes may 
not form in 500 mM NaCl prior to crystallisation trials (Sidorenkov et al., 1998). 
Nevertheless, since scaffold 2 complexes showed increased stability at high salt 
concentrations, scaffold 2 was incubated with YonO prior to overnight equilibration 
against the standard set of crystallisation screens (see materials and methods). The 
screens resulted in bipyramidal crystals, all of which, when harvested and subjected to 
synchrotron radiation, diffracted to 7 – 8 Å. It is likely that the salt concentration 
prevented elongation complex formation as predicted and that the crystals did not 
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include the nucleic acid scaffold. YonO appears to not be like other RNAPs, which 
require a much reduced concentration of salt to remain soluble at 10 mg ml-1 allowing 
EC formation at the high protein concentrations required for crystallisation (Gnatt et 
al., 2001, Kashkina et al., 2006, Vassylyev et al., 2007a).    
To attempt to reduce the salt concentration required for YonO solubility, 10 mg ml-1 
YonO in 500 mM NaCl buffer was incubated with scaffold 2 before undergoing serial 
dialysis against buffers containing decreasing concentrations of salt. It was hoped the 
presence of a nucleic acid scaffold would alter the solubility of YonO and allow high 
protein concentrations in reduced salt concentrations. This was not the case, as with 
each dialysis against a lower salt concentration, precipitation occurred.   
For the crystallisation of RNAP II elongation complexes, RNAP II was allowed to form 
elongation complexes, either through incubation with a scaffold or by transcribing on 
duplex DNA with a 3’ single stranded tail. RNAP II started transcription on the tail 
which bypassed the need for initiation factors. The sequence of the downstream DNA 
permitted synthesis of a 14 nucleotide RNA without incorporation of UMP. When 
provided all NTPs except UTP, all active RNAP II complexes paused upon reaching the 
first Adenosine in the template DNA ensuring all RNAP II complexes were 
homogenous. (Kettenberger et al., 2004, Gnatt et al., 2001). In both methods, 
elongation complexes were purified and concentrated prior to crystallisation screens. 
Whilst not attempted due to time constraints, one of these approaches may allow for 
YonO elongation complexes to be maintained in high salt conditions. After initial 
assembly in low salt and low protein concentrations, elongation complexes would be 
purified by reverse heparin chromatography or gel filtration. Subsequently YonO 
elongation complexes would be concentrated to 10 mg ml-1 and trialled for 
crystallisation. 
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Figure 7-7: Determination of optimum nucleic acid scaffold for YonO elongation complex crystallisation. YonO elongation complex stability and 
activity with three different nucleic acid scaffolds was determined. Scaffold sequences were based on that used for the crystallisation of the bacterial 
elongation complex (scaffold 1) (Vassylyev et al., 2007a). Scaffolds are numbered, with sequences below. The scaffold schematic indicates the 
position of 32P labelling (denoted by *). RNA, template DNA and non-template DNA are coloured red, black and blue, respectively. Elongation 
complexes were assembled and washed with a high (500 mM NaCl) or low (40 mM KCl) concentration of salt. Transcription was initiated by the 
addition of 100 µM NTPs. RNA in complexes labelled on the non-template DNA strand was visualised by the incorporation of α-[32P]-ATP in the 
presence of 10 µM ATP and 100 µM GTP, CTP and UTP. Reactions were incubated at 37 ⁰C for 30 minutes before being terminated by the addition of 
stop buffer and resolved by denaturing PAGE.   
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7.5.5. Lysine methylation 
In addition to flexible domains, the surface entropy of a protein also influences its 
ability to assemble into well-ordered crystals. Proteins with increased surface entropy 
display greater variation on the protein surface. This added variation adds disorder to 
the crystal as the proteins ability to form well-ordered, repeating assemblies is 
reduced. Surface lysines have high entropy and are known to reduce the available 
contacts between proteins during crystal formation (Derewenda and Vekilov, 2006). 
Analysis of crystallisation data confirmed this by showing lysine as the least favoured 
amino acid for crystal contacts (Dasgupta et al., 1997). If surface lysines are known, 
point mutation can be carried out to remove these residues and improve 
crystallisation (Lawson et al., 1991, Derewenda and Vekilov, 2006, Walter et al., 2006). 
However, if a protein is undergoing crystallisation trials for the first time, it is unlikely 
surface lysines have been identified. Methylation of surface lysines offers an 
alternative way of reducing entropy and improving crystallisation and diffraction 
(Walter et al., 2006). In addition to reducing surface entropy, methylation increases 
the available crystal contacts by introducing the possibility of hydrophobic interactions 
between proteins (Walter et al., 2006).  
Methylation was performed to see if reducing surface entropy increased diffraction of 
YonO crystals.  Purified YonO was incubated with formaldehyde and dimethylamine-
borane overnight and subsequently purified by gel filtration chromatography. 
Methylated YonO did not elute from the Superdex 200 column, indicating that YonO 
precipitated during gel filtration. Another outcome of methylating lysines is a 
reduction of solubility through the removal of the polar side chain and introducing 
hydrophobicity. Often, this can be beneficial as it can increase crystallisation of highly 
soluble proteins. Inspection of the amino acid composition of YonO revealed lysine to 
be the most abundant. It is unknown how many of these lysines are located on the 
surface of the protein. However, it has been suggested lysines are predominantly 
located to the protein surface (Derewenda and Vekilov, 2006) thus explaining the 
drastic loss of YonO solubility.  
7.5.6. Twinned Date Set and Molecular Replacement 
Typically, crystals are harvested and suspended in a cryoprotectant such as saturated 
(NH4)2SO4 before being flash cooled in liquid nitrogen. Flash cooling in liquid nitrogen 
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has multiple functions: to preserve the arrangement of solvent within the crystal, to 
prevent the formation of ice and to protect from X-ray radiation damage. However, 
cases where the act of flash cooling has caused a decrease in order and in diffraction 
resolution due to differential freezing of the protein and solvent have been reported 
(Heras and Martin, 2005, Juers and Matthews, 2001, Kriminski et al., 2002).  
To see if crystal disorder introduced by flash cooling is responsible for the poor 
diffraction of YonO crystals, diffraction was attempted at room temperature (20 ⁰C). A 
crystal, grown from tag free YonO equilibrated with condition C2 of JCSG II screen, was 
harvested and suspended in paratone-N oil. Previously, crystals were suspended in 
saturated (NH4)2SO4. However, at room temperature (NH4)2SO4 salt crystals are likely 
to form leading us to use paratone-N oil. Immediately after harvesting, the crystal was 
tested for diffraction using the in house X-ray generator. The cryo nozzle was removed 
to allow diffraction data to be collected at room temperature. Room temperature data 
collection did not lead to increased diffraction, with the crystal diffracting to 8 Å. 
Despite this, the crystal was stored in liquid nitrogen to be tested for diffraction using 
synchrotron radiation at Diamond Light source at a later date, as the increased energy 
of synchrotron radiation can improve diffraction. When exposed to synchrotron 
radiation on the IO4-I beamline, the crystal diffracted to 3 Å (Figure 7-8a). From this 
crystal, two complete data sets were collected, data set 1 and 2. Data set 1 and 2 had 
resolutions of 3 Å and 3.5 Å, respectively. The dataset statistics can be seen in Table 7-
1.  
Table 7-1: Data statistics for YonO Data sets 1 and 2.    
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Crystals are ordered repetitions of protein in three dimension space. The most basic 
building block of the crystal is the asymmetric unit. In the simplest example, the 
asymmetric unit contains one whole protein molecule. Often the asymmetric unit can 
contain multiple protein molecules, or a fraction of a protein molecule. The 
asymmetric unit is reflected, repeated and rotated in space to generate the unit cell. 
Each dataset has a space group. The space group describes the rotations and the 
symmetry operators required to generate the unit cell from the asymmetric unit. The 
unit cell is repeated in three dimensional space to build up the crystal. Data sets 1 and 
2 were given space groups P41 2 2 and C2 2 21, respectively. The Matthews coefficient 
predicts the number of protein molecules in each asymmetric unit by calculating the 
protein content (Matthews, 1968). The coefficient predicted two YonO molecules in 
each asymmetric unit. The presence of multiple protein molecules in an asymmetric 
unit does not necessarily imply biological dimerization and can be a result of the 
crystal contacts between protein molecules.  
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Figure 7-8: High resolution diffraction from a twinned YonO crystal. a) Diffraction 
pattern of YonO data set 2. An example of diffraction from the YonO bipyramidal JCSG 
II C2. The diffraction image is taken from data set 2. The blue rings demark the 
diffraction resolutions. b) Crystallographic Twinning. Adapted from Rupp, 2010. 
Twinning involves the formation of different, overlapping domains in the same crystal. 
In this simple example, two domains have formed (red and blue) related with a 90 ⁰ 
rotation. Upon X-ray diffraction, two overlapping diffraction patterns are generated. 
For specific types of twinned data, depending on the operating space group, it is 
possible to resolve the two diffraction patterns using a mathematical twin operator. 
However, for the YonO data set 1 and 2, with space groups P4 1 22 and C2 2 21, 
respectively, it was not possible.   
Upon analysis of data sets 1 and 2, it was revealed that both datasets were twinned. In 
a twinned crystal, the protein has arranged into two different overlapping lattices 
(Figure 7-8b). Upon X-ray diffraction, the two different crystal organisations results in 
two overlapping diffraction patterns. Two overlapping diffraction patterns can prevent 
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reliable determination of the space group and result in complications in downstream 
data processing. Dataset 1 had a twin value of 44%, meaning approximately half of the 
crystal was ordered differently. This is classed as a perfect twin. Data set 2 displayed 
less twinning, having a twin value of 22%. For certain space groups it is possible to 
deconvolve the two overlapping diffractions using a twin operator, which describes the 
relationship between the two overlapping crystal patterns. However, for the specific 
space groups formed by YonO, no such twin law exists.  
Despite twinning reducing the accuracy of the data set, molecular replacement was 
attempted using data set 2 to solve the structure of YonO. Briefly, molecular 
replacement involves using data from a previously solved structure of a homologous 
protein to help determine the structure of a second protein. The data of the known 
structure is rotated and translated in three dimensional space to find a fit to the data 
of the protein under investigation. The nearest homologue with a known structure is 
QDE-1. Molecular replacement using the program Phaser with the QDE-1 structure did 
not result in a fit (Mccoy et al., 2007). A less stringent molecular replacement approach 
is to use individual structural domains of QDE-1 to find a fit as this would take into 
account any differences in domain orientation and positioning between YonO and 
QDE-1. QDE-1 was divided into three domains: head and neck, catalytic, and slab 
domains. Molecular replacement was then repeated with each domain, but again,  no 
solutions were found. Molecular replacement requires amino acid sequence identity of 
30 % or above. The homology between YonO and QDE-1 is poor. Two iterations of 
pattern based PSI-BLAST are required to identify homology between YonO and QDE-1. 
This substantial lack of sequence homology explains the inability of molecular 
replacement to solve the structure of YonO.  
7.6. Dehydration of YonO crystals to Reproduce High Resolution Data Set  
Twinning is thought to be stochastic; therefore we sought to reproduce the conditions 
which gave a crystal diffracting to 3 Å. A strategy for the consistent, reproduction of 
diffracting crystals would be a significant step forward in determining the structure of 
YonO. Data sets 1 and 2 were obtained from a crystal formed through equilibration 
against C2 condition of the JCSG II screen. The crystal was preserved in paratone-N oil 
and tested for diffraction on the in house x-ray generator at room temperature before 
being flash cooled and transported to synchrotron. It was suggested that exposure to 
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air prior to cryoprotecting in paratone-N oil resulted in the dehydration of the crystal. 
Dehydration, the removal of solvent from within a crystal is a well employed method 
for increasing the diffraction quality of crystals (Heras and Martin, 2005) 
7.6.1. Dehydration by HC1 Dehumidifier  
The optimisation techniques attempted previously focus on altering the crystallisation 
of YonO to improve diffraction. A second, alternative approach is to improve 
diffraction through post-crystallisation techniques (Heras and Martin, 2005).  One of 
the most investigated post-crystallisation technique is crystal dehydration. 
Approximately 50% of a protein crystal is solvent; therefore solvent plays an important 
role in the ordering of protein. If a crystal displays poor diffraction, it is possible to 
reduce the solvent content by controlled exposure to air or vapour diffusion against 
increased concentrations of a desiccant such as a salt. A potential outcome of reducing 
the solvent content is an increase in crystal packing and order in the crystal (shown 
schematically in Figure 7-9). This in turn can have a positive impact on the quality of 
diffraction. To reproduce the crystallisation process, crystals were harvested and 
suspended in paratone-N oil before being exposed to the air for a defined length of 
time. The time of air exposure was not known and so it was varied from 30 – 165 
minutes, with a crystal being flash cooled every 15 minutes to stop dehydration. The 
crystals were tested for diffraction at DLS but as before, all crystals only diffracted to 
~7Å.  
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Figure 7-9: Effect of dehydration on crystal packing. Adapted from (Awad et al., 
2013). Shown is a crystal simplified to two dimensions comprising of a protein dimer. 
Dimer subunits are coloured green and blue. For this example, the protein dimer is 
QDE-1 (accession: 2J7N (Salgado et al., 2006)).  In a hydrated crystal, solvent exists 
(white space in-between dimers) in between repeating protein units. Dehydration of 
crystals removes this solvent, increasing the crystal packing and order within the 
crystal (shown by red arrows).  
Accurate and reproducible dehydration can be achieved through the use of the HC1 
humidity control instrument at Diamond Light Source synchrotron (Sanchez-
Weatherby et al., 2009). HC1 features a nozzle which can be mounted into the 
synchrotron beamline apparatus. Once mounted, HC1 projects an airstream over the 
crystal. The relative humidity of the airstream can be controlled, allowing reproducible 
dehydration. HC1 was installed onto the IO4-I beamline in place of the cryostream. 
Prior to dehydrating a crystal, the HC1 was equilibrated to find the relative humidity of 
the reservoir solution used in crystallisation. At the relative humidity of the reservoir 
solution, the hydration state of the reservoir solution drop remained constant. This 
relative humidity value was then used as the starting point for dehydration 
experiments. The crystal which gave high resolution diffraction grew when YonO was 
equilibrated against condition C2 of the JCSG II screen. Since the initial diffraction from 
this crystal was poor, it was reasoned the specific composition of this condition was 
not responsible for the increased diffraction. Therefore, whilst crystals grown against 
C2 JCSG II were used for HC1 experiments, crystals formed using the CoCl2 and AmSO4 
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screens were also dehydrated. Overnight equilibration against the CoCl2 and AmSO4 
screens consistently produced large ≥100 µm bipyramidal YonO crystals.  
Initially, crystals from the CoCl2 screen were dehydrated. A crystal from A10 condition 
of the CoCl2 screen was mounted into the beamline and the diffraction was tested at 
96 %, the equilibrated relative humidity of the reservoir solution. The crystal gave 
diffraction in the region of 7 – 8 Å. The HC1 control allows the relative humidity to be 
lowered with a defined gradient. Initially, the humidity was lowered in large 
increments with steep gradients. The relative humidity was lowered to 86 % with a 
gradient of 2 % min-1. The diffraction of the crystal remained constant at 7 – 8 Å 
showing the dehydration did not improve diffraction. Further reductions of humidity 
did not increase diffraction. At 45 % relative humidity the diffraction was completely 
lost, with crystals being completely dehydrated.    
The humidity at which the diffraction can be improved may have a narrow range that 
was missed by lowering the relative humidity in large increments. Therefore, crystals 
from the C2 JCSG II condition were dehydrated with small reductions in humidity. The 
reduction of humidity from 92.5 % to 90 % did not increase the diffraction of YonO 
crystals.  
An additional variable is the length of time a crystal is exposed to dehydrating 
conditions. Previously, diffraction was tested upon reaching the desired relative 
humidity. To determine if prolonged exposure to a given relative humidity can increase 
diffraction, crystals were exposed to a constant relative humidity before being tested 
for diffraction. Crystals from the A8 condition of the AmSO4 plate were tested for 
diffraction at 93 % relative humidity. The crystal diffracted to 7 – 8 Å. However, after 5 
minutes at a constant relative humidity of 93 %, the diffraction was completely lost 
indicating crystals deteriorated over time.  
For HC1 dehydration, crystals are not suspended in cryoprotectant as data collection 
was carried out at room temperature. However, the YonO crystal that previously 
diffracted to 3 Å was preserved in paratone-N oil. Therefore, diffraction was tested on 
crystals from the B4 condition of the AmSO4 screen suspended in paratone-N oil. 
Resuspending the crystal in paratone-N oil prior to testing the X-ray diffraction 
increased the life span of the crystals, as 7- 8 Å diffraction was not lost over time.  The 
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crystal from which 3 Å data was collected was stored in liquid nitrogen prior to data 
collection at synchrotron. Therefore the B4 AmSO4 crystals were removed from the 
beamline, stored in liquid nitrogen and retested for diffraction when the HC1 was 
removed from the synchrotron and replaced with the standard cryostream. Despite 
replicating the conditions which resulted in 3 Å data collection, the above efforts did 
not result in the collection of high resolution data from B4 AmSO4 crystals.  
7.6.2. Dehydration through vapour diffusion and In situ data collection   
Controlled dehydration of crystals can also be achieved through vapour diffusion 
against a reservoir solution with an increased concentration of precipitant such as NaCl 
or polyethylene glycol (Schick and Jurnak, 1994). The increased precipitant acts as a 
desiccant, withdrawing the water from the crystal. Alternatively, new salts previously 
not present in the reservoir solution can be added to function as desiccants. The 
dehydration is reproducible as the concentration of the desiccants can be controlled 
along with the time and temperature of dehydration.  
Dehydration by the HC1 was time consuming as each crystal was mounted manually. In 
situ plate screening allows for high throughput testing of crystals at the synchrotron. In 
situ plate screening involves the direct loading of the 96 well crystallisation plate onto 
the synchrotron beamline. Multiple crystals in each condition can be rapidly tested for 
high quality diffraction without harvesting or cryoprotection, both of which can be 
damaging to the crystal. Recently, a 96 well plate based dehydration screen combined 
with in situ plate screening was described (Douangamath et al., 2013). The screen 
allowed for the simultaneous testing of 96 different salt concentrations to determine 
the optimum concentration for dehydration. Briefly, a 96 well plate screen was set up 
with only one reservoir solution known to allow for the formation of crystals. Once 
crystals had formed, a dehydration screen was added to the reservoir solution. The 
diffraction properties of the dehydrated crystals were then determined. The 
equipment required for the in situ dehydration screening is available at Diamond Light 
Source. Therefore, our collaborator (Dr Arnaud Baslé) performed the screen using 
purified tag-free YonO equilibrated against condition G11 from the AmSO4 screen. 
Analysis of previous crystallisation screens identified this condition as consistently 
producing large (≥100 µM) bipyramidal crystals. The dehydration screen was 
comprised of four desiccants: ethylene glycol, polyethylene glycol 200 (PEG 200), LiCl 
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and NaCl (Wheeler et al., 2012). Across the screen ethylene glycol and PEG200 was 
increased from 0 to 50%, covering relative humidities of 100 - 80 % (ethylene glycol) 
and 100 - 90% (PEG200). Both LiCl and NaCl were increased from 0 to 2.5 M, covering 
relative humidities of 100 – 95 %. Details of the screen can be found in materials and 
methods. The screen was added to the reservoirs and dehydration was allowed to 
proceed overnight. The plate was loaded onto the IO4-I beamline and diffraction was 
tested. For each desiccant trialled a dehydration point was determined. The 
dehydration point is a desiccant concentration. Above this concentration, the crystal 
becomes too dehydrated and diffraction is lost. Below the dehydration point, the 
desiccant does not have an effect on the hydration state of the crystal. Ethylene glycol 
and PEG200 had a dehydration points between 20 – 22.5 % and 17.5 – 20 %, 
respectively. LiCl and NaCl had dehydration point of 2.25 M. None of the relative 
humidities across the dehydration screen increased the diffraction of the crystals.  
The dehydration thought to be responsible for increased X-ray diffraction of the YonO 
crystal was not controlled. Dehydration through air exposure is hard to reproduce 
(Heras and Martin, 2005) as many variables are in operation during air exposure 
including length of exposure, humidity and temperature. Despite using two alternative 
methods of controlled dehydration, we were unable to replicate the formation of 
crystals with high diffraction. 
7.7. Crystallisation of the YonO homologue VM RNAP 
Homologous proteins are a potential solution to proteins which form poorly diffracting 
crystals. It is highly probable two closely related proteins are structurally very similar; 
meaning the structure of a second protein homologous to YonO could provide insights 
into the structure. Any structural variation between YonO and a homologue would 
likely be restricted to the surface of the protein. This is beneficial as the surface of the 
protein strongly influences the crystallisation process. A homologue of YonO may make 
different surface contacts leading to improved crystal packing and diffraction. BLASTp 
revealed the closest homologue to YonO is a hypothetical protein from Bacillus 
vallismortis, with the two proteins having 91% identity. The YonO homologue protein 
will be referred to as VM RNAP (Vallismortis RNAP). Analysis of the hypothetical 
proteins encoded alongside VM RNAP revealed the presence of phage like proteins. It 
is unknown if the bacteriophage is a functional. B. vallismortis is very closely related to 
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B. subtilis (Roberts et al., 1996). The two species can only be distinguished through 
their cell wall fatty acid composition and DNA sequence. The B. vallismortis strain was 
obtained from the Bacillus Genetic Stock Centre (BGSC) and the gene encoding VM 
RNAP was cloned into the pET-28 expression vector. VM RNAP was expressed and 
successfully purified to apparent homogeneity using the purification strategy 
developed for YonO, demonstrating the close similarities between YonO and VM 
RNAP. VM RNAP was trialled for crystallisation using the full collection of available 
commercial screens. The CoCl2 screen, the custom screen developed for the 
optimisation of YonO crystallisation was also trialled. The crystallisation screens were 
left to equilibrate overnight.  Equilibration against four conditions (E4, F4, G4 and H4) 
of the PACT screen and single condition (B4) of the JCSG+ screen resulted in VM RNAP 
forming small bipyramidal crystals. The crystals were harvested and tested for 
diffraction at Diamond Light Source.  As with YonO, the diffraction was limited to 7 – 8 
Å. The purification, crystal morphology and diffraction resolution of VM RNAP were 
extremely similar to YonO. This strongly suggests that VM RNAP maybe too close (91% 
identity) to YonO to crystallise differently. Alternative homologues with reduced 
sequence identity to YonO exist in other fermicutes. The reduced similarity may allow 
for different crystallisation and improved diffraction.  
7.8. SAXS  
Whilst YonO readily crystallised, the organisation of the protein within the crystal did 
not permit diffraction of X-rays to a sufficient resolution. Alternative methods for 
determining the structure of a protein require solubilised protein rather than crystals. 
However, these techniques are not suitable for YonO; YonO is too large and too small 
for the determination of its structure by NMR and cryo-EM, respectively. Whilst it 
cannot provide a high resolution structure of YonO, small angle x-ray scattering (SAXS) 
would provide the molecular envelope revealing the overall shape of YonO. Purified 
YonO was supplied to our collaborator, Dr Abel Garcia-Pino of the VIB institute in 
Belgium who performed SAXS analysis.  
The SAXS analysis revealed YonO potentially has a ring like shape, with a central cavity. 
We have tentatively concluded that the cavity is the pathway in which downstream 
DNA enters the enzyme. In keeping with other RNAPs, it is probable the active centre is 
located at the bottom of the cavity at the centre of the enzyme. In agreement with a 
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lack of amino acid sequence homology between YonO and RNAP, the domains of RNAP 
compared to pincers of a crab claw appear to be absent in YonO. The molecular 
envelope confirmed that YonO predominantly exists as a monomer. This is in contrast 
to QDE-1, the closest homologue of YonO with a determined structure, which was 
shown to be a dimer (Salgado et al., 2006). At this low resolution, it cannot be 
concluded if the overall shape of YonO is different from that of a QDE-1 monomer 
(compared in Figure 7-10).   
      
 
 
 
 
 
Figure 7-10: SAXS analysis of YonO. SAXS analysis of YonO was performed by Dr Abel 
Garcia-pino. The resultant molecular envelope of YonO suggests it has a ring like 
structure with a central cavity which is hypothesised to be an entry channel for 
downstream and the location of the active site. However, the molecular envelope is a 
very low resolution structure and therefore it is possible the ring like structure is an 
artefact. The surface representation of QDE-1 is shown for comparison. QDE-1 does 
not have a ring like structure and the cavity is much narrower, reflecting the increased 
molecular weight of QDE-1 (160 KDa) compared to YonO (98 KDa).  
 
7.9. Discussion 
Highly pure and concentrated YonO was obtained and trialled for crystallisation. 
Through optimisation with a customised crystallisation screen and the AmSO4 screen, 
large bipyramidal crystals were reproducibly obtained. A sufficient diffraction 
resolution for structural determination is 3.5 Å and below. However, the diffraction of 
YonO crystals was limited to 7-8 Å. Low resolution diffraction often arises due to poor 
packing and order of the protein within the crystal lattice during crystallisation.  Many 
techniques are available to increase the diffraction of crystals. Initially microseeding, 
additive screening and removal of the His tag were attempted to improve YonO 
YonO 
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crystallisation and find alternative crystal morphologies. Only bipyramidal crystals 
diffracting to 7- 8 Å formed during our attempts to improve diffraction. During 
chromatography, we noticed a small percentage of YonO exists in a tetramer state. As 
it may have differing crystallisation properties including increased diffraction, the YonO 
tetramer was trialled for crystallisation. Despite forming crystals with a different 
morphology, diffraction of tetramer crystals was also limited to 7- 8 Å. Although not 
investigated, the YonO tetramer was not considered to be biologically relevant due to 
the small percentage of YonO protein existing in this state.     
A single crystal did diffract to 3 Å, a sufficient resolution for structure determination. 
Two data sets were obtained from this crystal, both of which displayed twinning. The 
structure of QDE-1, the nearest homologue to YonO was used with data set 2 to 
attempt to solve the structure via molecular replacement but this was unsuccessful. 
Molecular replacement requires stronger homology than that between QDE-1 and 
YonO, explaining its failure to solve the structure. It was reasoned that the increased 
diffraction was due to dehydration of the crystal as a result of uncontrolled exposure 
to air during the testing of diffraction at room temperature. Attempts to repeat the 
growth of diffracting crystals with controlled dehydration were unsuccessful. It was 
estimated the crystal was exposed to air for 40 minutes. During that time, a number of 
variables were acting upon the crystal including exposure to the air, humidity and 
temperature. Reproduction of all the conditions which led to an increase in diffraction 
would be incredibly difficult. It could be suggested that the growth of a highly 
diffracting crystal during crystallisation was stochastic. The initial diffraction of the 
twinned crystal was poor when tested on the in-house X-ray generator, arguing against 
this notion.   
High resolution diffraction of a crystal is dependent on the highly ordered organisation 
of the protein within the crystal lattice. Therefore, the inability of YonO to form well 
diffracting crystals can be attributed to disorder within the crystal. The organisation of 
a protein in a crystal is governed by the surface of the protein and any intrinsic 
flexibility. High surface entropy of a protein is detrimental to crystallisation as it 
introduces variation into the protein population (Dale et al., 2003). This variation 
reduces the proteins ability to form well-ordered assemblies within the crystal. The 
reduction of surface entropy is one of many strategies to improve diffraction and 
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crystallisation (Derewenda and Vekilov, 2006). Surface lysine residues are a source of 
entropy and are not favoured for crystal contacts (Dasgupta et al., 1997). The 
methylation of YonO surface lysines to reduce entropy resulted in precipitation, this is 
explained by the introduction of hydrophobicity on the most abundant amino acid in 
YonO (Walter et al., 2006).   
Flexible domains of a protein can decrease ordered assembly of proteins in a crystal 
(Dale et al., 2003). A heterogeneous protein population, due to alternative 
conformations as a result of flexibility, will form crystals with increased disorder. Such 
crystals will diffract poorly. RNAP does have intrinsic flexibility, with the large clamp 
domain closing to make contacts with downstream DNA (Cramer et al., 2001). It is 
plausible to think YonO features mobile domains. Supporting this is the observation of 
different conformations in the structure of the YonO homologue QDE-1 (Salgado et al., 
2006) Attempts to stabilise YonO in a single conformation through binding a nucleic 
acid scaffold failed due to high salt concentrations preventing YonO from forming 
stable elongation complexes. A rudimental approach to reducing protein flexibility 
prior to crystallisation is limited in situ proteolysis (Dong et al., 2007, Wernimont and 
Edwards, 2009). At trace concentrations, proteases such as trypsin can cleave flexible 
domains and loops on the surface of the protein. The digested protein is then more 
amenable to ordered crystallisation, as potential sources of variation have been 
removed. However, a major limitation of this technique is the potential removal of 
domains required for structural integrity or flexible domains of interest and so this 
approach was not used.  
To bypass crystallisation, the stage preventing the determination of the high resolution 
structure of YonO, SAXS analysis was performed. SAXS provided a low resolution image 
of YonO showing a ring like structure with a cavity designated as a putative DNA 
channel and active site. T7 RNAP and multisubunit RNAPs have structures resembling a 
right hand and crab claw, respectively. The shape of YonO as revealed by SAXS does 
not suggest that it has a structure similar to either of these polymerases. Additionally, 
SAXS revealed YonO exists in solution as a monomer unlike its distant homologue, 
QDE-1, which was shown to be a homodimer. The QDE-1 monomer has a claw 
structure, with the main channel running in-between the prominent head and slab 
domains. SAX data for QDE-1 is not available however; a surface representation of the 
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crystal structure suggests it is possible that at a low resolution QDE-1 may resemble a 
ring. Therefore, the ring-like structure of the YonO molecular envelope may be due to 
an inability of SAXS to resolve YonO domains analogous to the head and slab domains 
of QDE-1. Alternatively, YonO may indeed have a ring-like shape indicating a previously 
undescribed RNAP structure. 
In this study, we have been unable to reproducibly obtain crystals that diffract at a 
suitable resolution for structure determination. A crystal structure of YonO would 
allow us to investigate the possibility of a ring-like shape as suggested by SAXS. 
Furthermore, it would shed light on the mechanisms employed by YonO to accomplish 
transcription and facilitate future in vitro characterisation by allowing structure based 
mutagenesis of YonO. Therefore, future work will include continued efforts to obtain 
the structure of YonO by X-ray crystallography.  
An emerging way to address the problems arising from a protein’s intrinsic flexibility is 
the use of the heavy chain only antibody variable fragments (VHH fragments) derived 
from camelid species (Griffin and Lawson, 2011). VHH fragments have aided in 
determination of structures by binding proteins and stabilising their conformations, 
thereby reducing protein heterogeneity and promoting increased order within the 
crystal lattice (Loris et al., 2003). The failure of proteins to make stable crystal contacts 
during crystallisation can also result in poorly diffracting crystals. This too can be 
addressed with VHH fragments, which are able to form stable contacts amongst 
themselves (Loris et al., 2003). Therefore, VHH antibodies against YonO will be 
obtained and trialled in crystallisation screens by our collaborator Dr Abel Garcia-Pino. 
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Chapter 8: ORF6 RNA Polymerase of the Kluyveromyces lactis Killer System  
8.1: Introduction 
As discussed in section 3, the inability of the nuclear transcription machinery to 
recognise and express genes present on the K. lactis killer system plasmid, pGKL1, was 
the first evidence of a cytoplasmic transcription system specific for the K. lactis killer 
system (Romanos and Boyd, 1988, Stam et al., 1986). Further evidence came from 
heterologous expression of an antibiotic marker cloned in frame downstream of UCS1 
promoter on pGKL1 (Tanguy-Rougeau et al., 1990).  
The amino acid sequence of the 115 KDa protein encoded by ORF6 on pGKL2 was 
shown to be homologous to the β’ and β subunit of RNAP (Ruprich-Robert and 
Thuriaux, 2010, Wilson and Meacock, 1988). Therefore, the ORF6 protein was 
identified as the RNAP central to the cytoplasmic transcription system specific for the 
K. lactis killer plasmids. Further analysis revealed approximately half of the functional 
motifs conserved across RNAP in all domains of life were absent in ORF6 RNAP 
(Ruprich-Robert and Thuriaux, 2010). Therefore, in addition to being of interest due to 
its cytoplasmic location and functioning in a previously uncharacterised transcription 
system, ORF6 RNAP may represent a novel class of RNAP exhibiting a minimal 
architecture. In addition to ORF6, ORF7 of pGKL2 is presumed to act as a subunit of the 
ORF6 RNAP. ORF7 encodes a 15 KDa protein with amino acid sequence homology with 
RNAP. In contrast to ORF6 RNAP, ORF7p sequence similarity is restricted to two 
regions at the C-Terminal end of β’ (Schaffrath et al., 1997, Schaffrath et al., 1995b).  
Both ORF6 RNAP and ORF7 have been shown to be essential for maintenance of pGKL1 
and pGKL2. Attempts to delete ORF6 from pGKL2 by homologous recombination 
resulted in a mixed population of wildtype pGKL2 and ΔORF6 hybrid plasmids. 
Selection of the hybrid plasmid did not lead to a loss of the wildtype plasmid, showing 
ORF6 RNAP is essential (Schaffrath et al., 1995). Efforts to delete ORF7 resulted in a 
similar outcome (Schaffrath et al., 1997). Targeted deletion by homologous 
recombination led to integration of an auxotrophic marker into the chromosome, 
rather than the ORF7 locus on pGKL2. It was concluded the inability to replace ORF7 
reflects its essentiality for plasmid maintenance.  
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The promoters of the ORF6 RNAP cytoplasmic transcription system have been 
identified. Short sequences termed upstream conserved sequences (UCS) have been 
located upstream each predicted ORF on pGKL1 and pGKL2. UCSs are sufficient to drive 
transcription of heterologous genes inserted into pGKL1 and pGKL2, thus confirming 
their role of promoters. However, no experimental evidence has been published 
showing a direct link between ORF6 RNAP and transcription from UCS promoters.  
Generally speaking, the cytoplasmic transcription system remains poorly defined. 
Aside from ORF6 RNAP and ORF7p, ORF3p and ORF4p have been identified as the 5’ 
methylguanoside capping enzyme and a putative ATP dependant helicase, 
respectively. Both ORF3p and ORF4p have been suggested to function in transcription. 
ORF1p, ORF8p, ORF9p and ORF11p are completely unlike any known proteins and so 
functions have not been assigned. The involvement of these proteins in transcription 
cannot be ruled out. An in vitro approach would allow investigation into the specific 
functions of the individual transcription proteins of pGKL2. To date, an in vitro 
approach has only been used to prove 5’ triphophatase and guanylyltransferase 
activities of ORF3p. ORF6 RNAP, the enzyme central to the transcription system, 
remains completely uninvestigated; its RNAP activity has not been confirmed by in 
vitro transcription assays. In addition to confirming ORF6 RNAP catalytic activity, in 
vitro experiments could contribute to the characterisation of all aspects of the 
transcription system, including the mechanism by which ORF6 RNAP performs RNA 
synthesis.  
In the previous chapters, we have shown that YonO, despite apparently lacking every 
conserved RNAP domain except the aspartate triad, is a DNA dependant RNA 
polymerase. As ORF6 RNAP represents an intermediate between YonO and the 
multisubunit RNAP, we wanted to determine if ORF6 RNAP also has RNA polymerising 
activity.   
8.2. Aim 
The aim of this work was to begin the characterisation of ORF6 RNAP using an in vitro 
approach.  
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8.3. Previous Attempts to Express ORF6 RNAP 
In order to carry out in vitro characterisation, purified ORF6 RNAP is required. Our 
previous attempts at expressing ORF6 RNAP in S. cerevisiae were unsuccessful (MRes 
thesis, 2011). We concluded the AT rich DNA sequence of ORF6 prevented expression 
by the nuclear transcription machinery. AT rich sequences have detrimental effects on 
transcription, possibly causing premature termination through coincidentally 
resembling termination signals and forming weak A:U hybrids.  
As there was no expression in yeast, next we attempted expression in E. coli (MRes 
thesis, 2011). Initially, ORF6 was cloned into the pET-21 expression vector to allow 
IPTG inducible overexpression of ORF6 RNAP bearing a C-terminal His tag. Expression 
from pET-21 is T7 RNAP based and whilst this RNAP was able to transcribe the AT rich 
DNA sequence of ORF6, apparently all expressed protein formed inclusion bodies. To 
address this problem, ORF6 RNAP was purified from isolated inclusion bodies by Ni2+-
NTA chromatography under denaturing conditions (8M urea). However, subsequent 
attempts to refold ORF6 RNAP were unsuccessful. It was hypothesised a small 
percentage of ORF6 RNAP was soluble but not purified due to the C-terminal His tag 
being embedded within the protein. Denaturing Ni2+-NTA chromatography on the 
soluble fraction of the lysate of induced cells confirmed this to be the case. Therefore, 
ORF6 was cloned into the pET-28 expression vector to give ORF6 RNAP an N-terminal 
His tag. This allowed the purification of a small quantity of soluble ORF6 RNAP. The 
ORF6 RNAP purified from E. coli was shown to have limited activity in vitro. Using 
promoter independent elongation complexes, ORF6 RNAP only extended RNA13 by 2 – 
3 nucleotides after 120 minutes of incubation. It was hypothesised that the low activity 
may be due to improper expression of a eukaryotic protein in E. coli.  
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Figure 8-1: The RNA polymerisation activity of ORF6 RNAP purified from E. coli. Taken 
from MRes Thesis, 2011. Soluble ORF6 RNAP purified from E. coli was tested for 
activity by assembling elongation complexes using the GA36 scaffold. Upon addition of 
500 µM NTPs, complexes were incubated for 10 and 120 minutes. Reaction products 
were resolved by 23% denaturing PAGE and visualised using phosphorimaging.  
8.4: Expression of Codon Optimised ORF6 in Saccharomyces cerevisiae 
It was decided to re-attempt expression of ORF6 RNAP in S. cerevisiae, as it was 
suggested improper expression in E. coli led to a loss of ORF6 RNAP activity. However, 
to overcome the difficulty of AT rich DNA it was decided that the DNA sequence of 
ORF6 should be optimised for expression in S. cerevisiae. To optimise the DNA 
sequence for expression in yeast, the wildtype DNA sequence was supplied to the 
commercial company Eurogentec. The codon bias was altered to match that of S. 
cerevisiae, which in turn, reduced the AT content of ORF6 from 74% to 65%. The 
optimised ORF6 gene (from here on referred to as ORF6c+) was synthesised and 
supplied cloned into pUC57, a commonly used cloning vector.  
Previously, ORF6 RNAP was purified via Ni2+-NTA chromatography with an N-Terminal 
His tag. For expression of ORF6 RNAP from ORF6c+ in S. cerevisiae, ORF6c+ was cloned 
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into the pYES2/NT expression vector. pYES2/NT is a commercial 2µ circular plasmid 
which introduces an N-terminal His tag and allows for PGAL1 controlled overexpression. 
PGAL1 is a strong promoter induced in response to activation of galactose metabolism. 
The pYES2/NT:ORF6C+  construct was transformed into the commercially provided S. 
cerevisiae strain INVSc1. 
To express ORF6 RNAP, INVSc1 carrying the pYES2/NT:ORF6C+ construct was grown in 
synthetic complete media minus uracil (SC – URA). Growing cells in media lacking uracil 
allowed for selection of transformants as maintenance of the pYES2/NT:ORF6C+ 
construct, which contained the URA3 selective marker, complemented INVSc1 uracil 
auxotrophy. The media was supplemented with glucose. Whilst glucose represses the 
PGAL1 promoter, it allows for rapid growth and accumulation of biomass prior to 
induction of expression. Cells were harvested and washed before growth overnight in 
SC – URA medium supplemented with raffinose and galactose. Unlike glucose, the 
presence of raffinose does not inhibit galactose metabolism and induction of the PGAL1 
promoter and therefore provided an additional carbon source.  For preliminary 
expression and purification of ORF6 RNAP, 6 litres of culture were harvested.  
For purification of ORF6 RNAP, harvested cells were disrupted by French press and 
lysates were loaded onto a Ni2+ - NTA column. Protein was eluted from the column 
with increasing concentrations of imidazole. Each elution fraction was analysed by SDS 
– PAGE to ascertain if ORF6 RNAP was present. ORF6 RNAP has a calculated molecular 
weight of 115 KDa. A protein of this molecular weight was present in the 200 mM 
imidazole elution fraction. Peptide mass fingerprinting confirmed this protein to be 
ORF6 RNAP. The reduction of AT content and codon optimisation was successful in 
allowing expression of ORF6 in S. cerevisiae. However, the yield of ORF6 RNAP was 
low. Poor heterologous protein expression is a major limitation of using S. cerevisiae. 
To address this, the purification was repeated and scaled up to 20 litres of yeast 
culture (Figure 8-2). Whilst this did increase the total amount of purified protein, 
compared to typical protein expression in E. coli, expression of ORF6 RNAP by S. 
cerevisiae remained low. Despite eluting in 200 mM imidazole, ORF6 RNAP was only 
partially purified. S. cerevisiae proteins are naturally rich in histidine residues, 
accounting for the contaminants also eluting at 200 mM imidazole.  
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Figure 8-2: Ni2+ - NTA Purification of ORF6 RNAP expressed from ORF6C+ in S. 
cerevisiae. S. cerevisiae strain INVSc1 carrying pYES2/NT:ORF6C+ was grown overnight 
in SC – URA medium supplemented with raffinose and galactose. Harvested cells were 
disrupted by French – press and lysates were applied to a Ni2+-NTA column. Unbound 
protein was removed by washing with 5 mM imidazole elution buffer. The column was 
then washed with increasing concentrations of imidazole. All purification fractions 
were subjected to SDS-PAGE. A protein with ~ 115 KDa molecular weight (indicated by 
the box), that of ORF6 RNAP, was eluted by 200 mM imidazole fraction. Peptide mass 
fingerprint confirmed this protein to be ORF6 RNAP.  
8.5. In vitro characterisation of ORF6 activity 
8.5.1. Initial determination of ORF6 RNAP activity   
As demonstrated by YonO, artificially assembled elongation complexes can be used to 
assay the polymerisation activity of a putative RNAP. Therefore, ORF6 RNAP was 
assembled into elongation complexes and tested for activity.  
The ORF6 RNAP elongation complexes were assembled with the standard GA36 
scaffold used throughout this work. ORF6 RNAP ECs were incubated with a high 
concentration (500 µM) of NTPs to see any potential RNAP activity. ORF6 RNAP 
exhibited poor polymerisation activity as after 30 minutes of incubation, RNA13 was 
only extended by 1 – 2 nucleotides. Furthermore, only a fraction of RNA13 was 
extended, indicating the ORF6 RNAP complexes were either paused or very slow. 
Previously, it was hypothesised the poor activity of ORF6 RNAP was due to improper 
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expression in E. coli (MRes Thesis, 2011). This result showed this not to be the case; 
the poor activity of ORF6 RNAP is not dependent on the organism used for expression. 
The extent of ORF6 RNAPs inability to polymerise is demonstrated through comparison 
to the activity of E. coli core RNAP on the same scaffold (compare lanes 2 and 4).  
 
 
Figure 8-3: Activity of ORF6 RNAP purified from S. cerevisiae. Promoter independent 
artificial elongation complexes were assembled on the GA36 scaffold to determine the 
in vitro activity of ORF6 RNAP purified from S. cerevisiae. The red asterisk indicates 5’ 
32P labelling of RNA13. Non-template DNA was omitted during assembly and the 
complexes were not immobilised. Complexes were incubated for 30 minutes at 30 ⁰C 
in the presence of 10 mM Mg2+ and 500 µM NTPs. Reaction products were resolved on 
23% denaturing PAGE gel and visualised through phosphorimaging.  
 
8.5.2. Alternative nucleic acid scaffolds for in vitro transcription 
The GA36 scaffold was developed and optimised for the in vitro characterisation of E. 
coli RNAP (Sidorenkov et al., 1998). Whilst ORF6 RNAP shares considerable homology 
to the multisubunit RNAP, it is possible the properties of the GA36 scaffold, including 
the length of the hybrid and DNA sequence, are not suitable for ORF6 RNAP 
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transcription. The pGKL1 and pGKL2 DNA thought to be transcribed by ORF6 RNAP is 
very AT rich, suggesting ORF6 RNAP is optimised for the transcription of AT rich DNA 
sequences. To investigate this possibility, we formed ORF6 RNAP elongation complexes 
with two alternative scaffolds: T-5S and GA36-8U (shown in Figure 8-4a). The length of 
the hybrid was varied by forming elongation complexes with Scaffold T-5S, which gives 
a 7 bp RNA:DNA hybrid. Template GA36-8U was hybridised to RNA13 to form the 
GA36-8U scaffold. The downstream sequence of the GA36-8U template is a poly-A 
tract, allowing us to see if ORF6 RNAP has a preference for AT rich DNA sequences. For 
comparison, E. coli core RNAP was assembled into elongation complexes with the 
same scaffolds. All elongation complexes were visualised by 5’ 32P labelling of the RNA 
oligonucleotide. As before, transcription reactions were performed in a high 
concentration of nucleotides (500 µM) with a long incubation time (30 minutes). 
Regardless of the scaffold, ORF6 RNAP only extended RNA13 by 1 – 2 nucleotides 
(Figure 8-4b). This suggests the hybrid length and downstream sequence of the 
template DNA are not contributing to the poor ORF6 RNAP activity. As expected, all 
RNA13 was extended by GA36 E. coli elongation complexes. The poly-A tract 
immediately downstream in the GA36-8U scaffold resembles a transcription 
termination signal and is known to cause RNAP to pause and backtrack thus explaining 
the low processivity of E. coli RNAP on this scaffold (Gusarov and Nudler, 1999, Nielsen 
et al., 2013).  
All of our previous investigations into ORF6 RNAP activity have been with nucleic acid 
scaffolds featuring a DNA template, given its significant homology to the multisubunit 
RNAP. Despite accomplishing canonical gene expression in a DNA dependent manner, 
bacterial RNAP and RNAP II have been shown to possess RNA dependant activity 
(Lehmann et al., 2007). To investigate the possibility that ORF6 RNAP is strictly 
dependent on an RNA template, thus explaining the inactivity on the GA36 scaffold; 
we assembled elongation complexes with the RNA21 scaffold (Figure 8-4c). The 
complexes were incubated for 60 minutes in the presence of NTPs. In contrast to YonO 
and E. coli RNAP, ORF6 RNAP only extended the RNA10 primer by 1 -2 nucleotides 
during a 60 minute incubation. When incubated for that length of time with the GA36 
scaffold, ORF6 RNAP extended the RNA beyond 1 -2 nucleotides suggesting a 
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preference for a DNA template. Therefore, it can be concluded the poor activity of 
ORF6 RNAP is not due to a dependence on an RNA template. 
On four different scaffold conformations, one including an RNA template, ORF6 RNAP 
exhibited poor activity. This has led us to tentatively conclude ORF6 RNAP’s inability to 
polymerise is not due to the scaffold. It is appreciated that only four different scaffolds 
were assembled into complexes with ORF6 RNAP. However, ORF6 RNAP was unable to 
polymerise on the simplest artificial scaffold conceivable; RNA hybridised to a template 
DNA strand. This suggests an alternative explanation exists for the poor ORF6 RNAP 
activity.  
 
Figure 8-4: Alternative scaffolds for the assembly of ORF6 RNAP elongation 
complexes. a) Scaffold sequences. The sequences of the alternative scaffolds are 
shown. The red asterisk indicates 5’ 32P labelling of the RNA primer. b) Hybrid length 
and downstream DNA sequence do not influence ORF6 RNAP activity. Scaffolds T-5S, 
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GA36 and GA36-8U were used to form ORF6 RNAP elongation complexes. E. coli core 
RNAP elongation complexes using the same scaffolds were assembled for comparison. 
Non-template DNA was not included and the complexes were not immobilised. 
Transcription was initiated by the addition of 500 µM NTPs and 10 mM Mg2+ and 
allowed to proceed for 30 minutes at 30 ⁰C. Reactions were stopped by the addition of 
formamide containing stop buffer and were resolved on 23 % PAGE gel in denaturing 
conditions. Gels were visualised by phosphorimaging. c) ORF6 RNAP does not utilise 
an RNA template. ORF6 RNAP was incubated with the RNA21 scaffold to allow 
assembly of elongation complexes. YonO and E. coli RNAP complexes were also 
assembled to compare enzymatic activities. Transcription reactions were started by 
the addition of 500 µM NTPs and incubated at 30 ⁰C for 60 minutes.    
8.5.3. Immobilisation of ORF6 RNAP Elongation complexes 
The ability of RNAP to tightly bind the hybrid increases the processivity of elongation 
complexes. Therefore, a possible explanation for the poor catalytic activity of ORF6 
RNAP is an inability to stably bind the hybrid. The previous experiments were 
performed in solution, which does not directly show the stability of assembled 
complexes. To address this, ORF6 RNAP elongation complexes were assembled with 
the GA36 scaffold and immobilised to streptavidin sepharose beads through the 5’ 
biotin tag of the template DNA (Figure 8-5a). Immobilisation can be used to assess if 
RNAP is binding the hybrid as unbound RNA13 and unstable complexes are removed 
by washing with transcription buffer (Sidorenkov et al., 1998). The stringency of this 
washing step can be improved by increasing the ionic strength of the transcription 
buffer. Initially, immobilised ORF6 RNAP elongation complexes were washed with low 
salt transcription buffer (40 mM KCl). Comparison of unwashed and washed elongation 
complexes (lane 1 and 2 of Figure 8-5a) shows that immobilised ORF6 RNAP elongation 
complexes withstood washing, suggesting ORF6 RNAP is capable of binding to the 
hybrid. This rules out weak hybrid binding as an explanation for the low processivity of 
ORF6 RNAP. To assess the stability of ORF6 RNAP elongation complexes, the 
immobilised complexes were also washed with transcription buffer containing 1 M KCl. 
RNA13 was present after washing, indicating the immobilised ORF6 RNAP complexes 
were stable. This was surprising given the non-template DNA strand was not included 
in the assembled complexes. Whilst not essential for transcription by artificial 
elongation complexes, the non-template DNA strand has been shown to be required 
for the assembly of salt stable E. coli elongation complexes (Sidorenkov et al., 1998). 
The non-template strand was included in assembled ORF6 RNAP elongation complexes 
to investigate its contribution to the stability and activity of ORF6 RNAP elongation 
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complexes.  Immobilised complexes were washed with either high (1M KCl) or low 
ionic strength (40 mM KCl) transcription buffer. Surprisingly, the non-template strand 
had a destabilising effect on the ORF6 RNAP complexes, as all complexes disassembled 
in the presence of 1M KCl. Formation of E. coli complexes with and without the non-
template DNA strand demonstrated the typical stabilising effect of the non-template 
strand. In the absence of this strand, the complexes were unable to withstand high 
ionic strength (compare lane 12 of Figure 8-5a to lane 12 of Figure 8-5b). Together, 
these results point towards the stability of ORF6 RNAP being determined by unusual 
interactions with the nucleic acid scaffold.  
To confirm that the immobilised ORF6 RNAP complexes were catalytically active, 
washed complexes were incubated with Mg2+ and NTPs for 30 minutes (Figure 8-5b). 
As before, RNA13 was extended by 1 -2 nucleotides showing the immobilised ORF6 
RNAP were active. However, not all RNA13 was extended in 30 minutes. As only 
specific, assembled elongation complexes remain after washing, this showed that the 
majority of assembled ORF6 RNAP complexes are either incredibly slow or have 
entered an inactive state.   
In addition to polymerisation, RNAP is able to hydrolyse RNA phosphodiester bonds as 
a function of proof reading (Orlova et al., 1995, Zenkin et al., 2006b). To see if ORF6 
RNAP can catalyse this reaction, washed complexes were incubated with Mg2+ alone. 
In an Mg2+ dependant manner, RNA13 was shorted by dinucleotides to produce 
RNA11, RNA9 and RNA7 (lane 3, Figure 8-5a and b). This hydrolysis pattern is 
characteristic of the multisubunit RNAP, which catalyses hydrolysis of the penultimate 
phosphodiester bond to release a dinucleotide (Zenkin et al., 2006b). This suggests 
that despite not being able to polymerise efficiently, ORF6 RNAP is proficient at RNA 
hydrolysis. On this scaffold, ORF6 RNAP appeared to be more efficient at hydrolysis 
than E. coli RNAP. However, this scaffold does not favour hydrolysis by E. coli RNAP. 
The non-complementarity between the 5’ end of RNA13 and the template DNA 
prevents the backtracking required for hydrolysis (refer to Figure 8-5a for the 
sequences of the scaffold).  RNAP utilises the same active centre to synthesise and 
hydrolyse RNA (Steitz, 1998, Sosunov et al., 2003, Sosunov et al., 2005). This raises an 
interesting question regarding how ORF6 RNAP is able to accomplish hydrolysis but not 
polymerisation.  
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A possible explanation for the catalytic activities observed in ORF6 RNAP reactions is 
the presence of contaminating enzymes not removed by Ni2+-NTA chromatography. 
However, since extension and cleavage was observed after washing with 1M KCl, such 
contaminating enzymes would be required to tightly bind the hybrid and withstand 
high ionic strength. This makes it unlikely a contaminant is responsible for the 
observed activities. Furthermore, the same poor extension of RNA13 was 
accomplished by ORF6 RNAP purified from E. coli. This supports the suggestion that 
ORF6 RNAP is the enzyme responsible for extension of RNA13 by 1-2 nucleotides.  
 
Figure 8-5: Stability of ORF6 RNAP elongation complexes. a) Stability of elongation 
complexes assembled without non-template DNA. Top: Sequences of the GA36 
scaffold used for elongation complexes. Middle: Schematic representation of 
immobilised assembled elongation complexes. Bottom: Transcription by immobilised 
ORF6 RNAP elongation complexes. Elongation complexes were assembled and 
immobilised to streptavidin sepharose beads through the 5’ biotin tag of template 
DNA. Non-template DNA was not included in the assembly of elongation complexes. 
Immobilised complexes were washed with low salt (40 mM KCl) or high salt (1 M KCl) 
transcription buffer. Complexes washed in high salt buffer were returned to low salt 
conditions prior to transcription. Reactions were started by the addition of 10 mM 
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Mg2+ alone or 10 mM Mg2+ and 500 µM NTPs. Reactions were incubated at 30 ⁰C for 30 
minutes before the addition of stop buffer. RNA were resolved by 23 % denaturing 
PAGE and visualised by phosphorimaging. b) Stability of elongation complexes formed 
with non-template DNA strand. Same for a) except the non-template DNA strand was 
included during assembly of elongation complexes.   
8.5.4. ORF7p and the Trigger Loop 
The poor extension of ORF6 RNAP elongation complexes resembles that of an RNAP 
with a deleted trigger loop (Yuzenkova et al., 2010). Supporting this notion, no amino 
acid sequence corresponding to the trigger loop has been identified in ORF6 RNAP. 
Together, these observations led us to hypothesise at least one other subunit, 
providing a domain functionally analogous to the trigger loop, is required for efficient 
transcription by ORF6 RNAP. ORF7p has been linked to the transcription system of the 
K. lactis killer system (Schaffrath et al., 1997, Schaffrath et al., 1995a). However, its 
small size (15 KDa) and limited homology to β’ led us to previously assume it was not 
critical for ORF6 RNAP transcription. The published analysis of ORF7p homology to β’ 
did not delineate the functional motifs conserved. Our updated analysis of the ORF7p 
amino acid sequence revealed previously unidentified homology to the trigger loop of 
RNAP II RPB1 (homologue of β’) (Figure 8-6a).  
To determine if ORF7p is able to contribute to catalysis by ORF6 RNAP, we set out to 
express and purify ORF7p. The predicted trigger loop is located towards the N-
terminus of ORF7p. Given its small size, we sought to avoid altering the structure of a 
potential trigger loop through introduction of a His tag at the N-terminal end. 
Therefore, ORF7 was amplified from pGKL2 and cloned into pET-21 to allow for IPTG 
inducible overexpression of a C-terminal His-tagged ORF7p in E. coli. Similarly to ORF6 
RNAP, ORF7p formed inclusion bodies when expression was induced by IPTG. A 
common technique to tackle inclusion bodies is purification under denaturing 
conditions followed by dialysis to induce refolding (Borukhov and Goldfarb, 1993). To 
this end, inclusion bodies were isolated, solubilised in 8 M urea and ORF7p was 
purified through Ni2+ - NTA chromatography under denaturing conditions (Figure 8-6b). 
ORF7p weakly bound the column as 25 mM imidazole was sufficient for elution. ORF7p 
was diluted and dialysed against a standard storage buffer which was sufficient to 
remove the urea and promote refolding of ORF7p.  
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To see the effect of ORF7p on ORF6 RNAP transcription, an excess of ORF7p was 
incubated with ORF6 RNAP elongation complexes. Subsequent to complex assembly, 
transcription reactions were initiated with Mg2+ and NTPs and incubated for up to 30 
minutes. Despite the presence of ORF7p, ORF6 RNAP still exhibited poor 
polymerisation activity (Figure 8-6c) which suggests ORF7p is not sufficient to increase 
the catalytic activity of ORF6 RNAP.  
The addition of ORF7p to ORF6p in vitro assumes the two proteins would specifically 
bind and form a functional enzyme. The ω subunit promotes assembly of RNAP by 
stabilising the β’ subunit (Minakhin et al., 2001). If ORF6 RNAP and ORF7p require an 
analogous chaperone for proper assembly in vivo, addition of ORF7p in vitro would not 
be sufficient for the reconstitution of a fully functional ORF6/ORF7 enzyme. 
Furthermore, ORF7p was purified under denaturing conditions and so its improper 
refolding cannot be ruled out.       
 
Figure 8-6: ORF7p does not increase the catalytic activity of ORF6 RNAP. a) Homology 
of ORF7p to the trigger loop. Manual inspection of the ORF7p and RPB1 (RNAP II β’ 
homologue) amino acid sequence alignment revealed potential conservation of the 
trigger loop in ORF7p. b) Purification of ORF7p. ORF7p expression in E. coli cells was 
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induced by 1 mM IPTG. Resultant inclusion bodies were isolated, solubilised in 8M urea 
and subjected to Ni2+-NTA chromatography. ORF7p was eluted from the column by 25 
mM imidazole. Denatured ORF7p was diluted in 8M urea and dialysed against ORF7 
storage buffer. c) Effect of ORF7p on the activities of ORF6 RNAP elongation 
complexes. A 10 times molar excess of ORF7p was added to ORF6 RNAP during 
assembly of elongation complexes. Transcription reactions were started by the 
addition of 10 mM Mg2+ and 500 µM NTPs and were allowed to proceed at 30 ⁰C for 
the indicated time. Reaction products were resolved on a 23 % denaturing PAGE and 
visualised by phosphorimaging.  
8.6. Co-expression of ORF6 RNAP and ORF7p in S. cerevisiae 
The in vitro addition of ORF7 to elongation complexes assumes ORF7 is readily able to 
bind ORF6 RNAP to form an active enzyme. It was reasoned formation of a functional 
ORF6/ORF7 RNAP enzyme may require chaperones for correct co-folding and 
assembly. To address this we aimed to co-express and subsequently co-purify ORF6 
RNAP and ORF7 from S. cerevisiae. The commercial plasmid pESC-URA was obtained to 
achieve this. pESC – URA is a circular plasmid that contains two divergent galactose 
induced promoters pGAL1 and pGAL10. Cloning of ORF6
C+ under the control of pGAL10 
introduced an N-terminal FLAG tag. Cloning of ORF7 under the control of pGAL1 
introduced a C – Terminal C-myc tag.  The cloned construct was transformed into the 
commercial S. cerevisiae YPH499 strain. Induction of expression was performed by 
growing cells in SC – URA medium supplemented with raffinose and galactose as for 
the expression of ORF6 RNAP from the pYES2/NT vector.   
The hypothesis ORF7p assembles with ORF6 RNAP is based solely on small regions of 
homology between ORF7p and β’. Therefore, there is a possibility ORF7p may not 
actually bind to ORF6 RNAP. However, if our hypothesis is correct and the two proteins 
co-fold during expression in S. cerevisiae, it was reasoned ORF7p would co-purify with 
ORF6 RNAP.  To purify FLAG tagged ORF6 RNAP, cells were disrupted by French press 
and the lysate was incubated in batch with anti-FLAG antibody resin. Subsequent to 
washing, the resin was packed into a gravity flow column and the bound protein was 
eluted with glycine pH 3. As before, the eluted proteins were resolved by SDS PAGE. 
However, the amount of eluted protein was too low to be detected by standard 
Coomassie blue staining. Therefore, protein eluted from the anti-FLAG resin was 
visualised by silver staining. A protein with the correct molecular weight of ORF6 RNAP 
was eluted from the anti-FLAG resin (lane 1 and 2, Figure 8-7). Compared to Ni2+-NTA 
chromatography, FLAG affinity chromatography resulted in a greater level of purity. 
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However, the yield of ORF6 RNAP purified by FLAG affinity chromatography was very 
low which reflects the poor expression of heterologous proteins in S. cerevisiae and 
the low protein binding capacity of antibody based resins (Lichty et al., 2005).  
The sensitivity of the silver stain allowed us to confirm ORF7p did not elute from the 
anti-FLAG resin. From this purification, it cannot be discerned if failure to co-purify 
ORF7p was due to a lack of expression or lack of assembly with ORF6 RNAP. The AT 
rich sequence of ORF7 was not codon optimised for expression in S. cerevisiae. As AT 
rich DNA sequences negatively affect transcription, this suggests RNAP II’s inability to 
transcribe ORF7 is responsible for the absence of co-purification.   
 
 
 
 
 
 
 
 
 
Figure 8-7: FLAG – tag affinity purification of ORF6 RNAP expressed by S. cerevisiae. 
Co-expression of ORF6 RNAP and ORF7p was attempted in S. cerevisiae. ORF6C+ and 
ORF7 were cloned under the control of galactose inducible pGAL10 and pGAL1 
promoters in the pESC – URA vector. An N-terminal FLAG tag and C – terminal C-Myc 
tag were introduced on to ORF6 RNAP and ORF7p, respectively. To purify ORF6 RNAP, 
lysates from induced cells were incubated with anti-flag antibody resin. The resin was 
collected and bound proteins were eluted by washing with glycine pH 3. The proteins 
present in elution fractions were resolved by SDS PAGE and visualised using silver 
staining. ORF6 RNAP inclusion bodies solubilised in laemmli buffer and purified ORF7 
were loaded as size controls. ORF6 RNAP and ORF7 in these samples are identified by 
black and white arrows, respectively.        
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8.7. Co-expression of ORF6 RNAP and ORF7p in E. coli 
It was previously proposed that the AT rich DNA sequence of ORF7 prevented its 
transcription during our attempts to co-express ORF6 RNAP with ORF7p in S. 
cerevisiae. As both ORF6 RNAP and ORF7p were individually expressed by the T7 RNAP 
transcription system, co-expression was attempted in E. coli. To this end, ORF6C+ and 
ORF7 were cloned into the pACYC Duet vector, which features two independent T7 
promoters to allow for the simultaneous expression of two proteins upon IPTG 
induction. To ensure any co-purification is a result of ORF7p directly interacting with 
ORF6 RNAP, an N-terminal His-tag was only introduced onto ORF6 RNAP.    
Previously, IPTG induced overexpression of ORF6 RNAP and ORF7p in E. coli resulted in 
the formation of inclusion bodies. To address this, co-expression was attempted 
overnight at 18 ⁰C with and without 1 mM IPTG induction. The T7 promoter is not 
tightly regulated, resulting in background expression in the absence of IPTG induction. 
This leaky expression can be exploited to express difficult proteins such as those which 
would form inclusion bodies upon overexpression. Additionally, a shift to a lower 
temperature (18 ⁰C) can also reduce inclusion body formation, as demonstrated by the 
expression of YonO.   
Induction of ORF6 RNAP and ORF7 expression with 1 mM IPTG resulted in inclusion 
body formation, which was determined through visual inspection of pelleted cell 
debris after disruption of harvested cells. In contrast, inclusion bodies were not 
observed in the cell debris of uninduced cells. Therefore, the clarified lysates of 
uninduced cells were subjected to Ni2+ - NTA chromatography. Washing the Ni2+- NTA 
column with 100 mM imidazole eluted a 115 KDa protein, which peptide mass 
fingerprinting confirmed to be ORF6 RNAP (Figure 8-8a).  
PMF also revealed that a 15 KDa protein eluted by 100 mM imidazole was ORF7p. 
ORF7p was not expressed with a His tag, suggesting its co-purification with ORF6 RNAP 
is a result of the two proteins interacting. To purify the ORF6 RNAP/ORF7p complex 
further, the 100 mM imidazole elution fraction was applied to a Heparin HiTrap 
column. Both ORF6 RNAP and ORF7p were eluted from the column by 600 mM NaCl, 
providing further evidence of a direct interaction between the two proteins (Figure 8-
8b).   
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It was hypothesised that the inability of ORF7p to increase the processivity and rate of 
ORF6 RNAP transcription was due to a lack of binding between the two proteins in 
vitro. To determine if the ORF6 RNAP/ORF7p complex had increased polymerisation 
activity, elongation complexes were assembled on the GA36 scaffold. 30 minutes of 
incubation in the presence of a high concentration of NTPs (500 µM) revealed that the 
ORF6 RNAP/ORF7p elongation complex was no more active than ORF6 RNAP by itself 
(data not shown).  
Analysis of the ORF7p amino acid sequence raised the possibility that this subunit 
provides ORF6 RNAP with a trigger loop, the mobile domain crucial for multisubunit 
RNAP catalysis (Temiakov et al., 2005, Yuzenkova et al., 2010, Yuzenkova and Zenkin, 
2010). Whilst the co-purification of ORF6 RNAP and ORF7p after two 
chromatographies does not provide direct evidence of an interaction between the two 
proteins, it strongly suggests that this is the case. Therefore, the poor activity of the 
ORF6 RNAP/ORF7p complex indicates additional proteins maybe required for efficient 
ORF6 RNAP polymerisation.  
 
Figure 8-8: Co-purification of ORF6 RNAP and ORF7p expressed in E. coli. a) Ni2+-NTA 
chromatography. T7 express cells carrying the pACYC:ORF6C+:ORF7 construct were 
grown overnight at 18 ⁰C. The lysate of these cells was subjected to Ni2+-NTA 
chromatography. Once the lysate had been applied, the Ni2+-NTA column was washed 
by increasing concentrations of imidazole. The protein content of the elution fractions 
was visualised by SDS PAGE. Peptide mass finger printing was used to confirm that the 
band indicated by the black arrow corresponded to ORF6 RNAP. PMF also confirmed 
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ORF7p was present in the portion of the gel enclosed in the black square. b) Heparin 
affinity chromatography. The 100 mM imidazole fraction was diluted 4 times (to 
reduce the salt concentration) and loaded onto the Heparin HiTrap column. Proteins 
were eluted from the column by washings of increasing concentrations of NaCl. SDS 
PAGE showed that ORF6 RNAP and ORF7p were eluted from the Heparin HiTrap 
column by 600 mM NaCl. As for Figure 8-8a, the arrow and box indicate the bands 
confirmed by PMF to correspond to ORF6 RNAP and ORF7p.  
8.8. Discussion 
ORF6 RNAP is a putative, non-canonical RNAP of the K. lactis killer system. ORF6 RNAP 
is of interest due to it being a single protein that bears homology to both β’ and β 
subunits of RNAP, whilst appearing to utilise only half of the conserved RNAP 
functional motifs. In vitro characterisation of this protein may result in the uncovering 
of novel mechanisms of transcription accomplished by a minimal RNAP.  
Previously, the high AT content of the ORF6 DNA sequence prevented the expression 
of ORF6 RNAP in S. cerevisiae (MRes Thesis, 2011). The detrimental effect of high AT 
content on gene expression has not been limited to the expression of ORF6 RNAP. 
Other investigators of the K. lactis killer system have tackled the complications arising 
from high AT content by resorting to protein expression in less conventional 
organisms. Expression of ORF3p was achieved by Bacillus megaterium, an organism 
with a naturally increased AT content (Tiggemann et al., 2001) whilst the baculoviral 
insect expression system was used for the expression of ORF5p (Schaffrath and 
Meacock, 1995). To overcome high AT content of ORF6, we optimised the ORF6 DNA 
sequence to match the codon bias of S. cerevisiae. This approach was successful, 
allowing expression of ORF6 RNAP in S. cerevisiae.  
When assayed with assembled elongation complexes, the in vitro activity of ORF6 
RNAP purified from S. cerevisiae was poor, with the enzyme displaying the same slow, 
unprocessive activity as ORF6 RNAP purified from E. coli (MRes Thesis, 2011). 
Therefore, the poor activity of ORF6 RNAP purified from E. coli was not due to 
improper expression of a eukaryotic protein as we previously hypothesised. Rather, it 
is likely ORF6 RNAP’s inefficiency stems from a failure to complete the nucleotide 
addition cycle (described in more detail in chapter 1.5). From the in vitro experiments 
presented, it cannot be determined if ORF6 RNAP’s failure to polymerise is due to an 
inability to accomplish substrate binding, catalysis or translocation. 
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Despite its activity being slow, unprocessive and not comparable to other RNAPs, we 
still conclude ORF6 RNAP is a DNA dependant RNAP. This is based on its substantial 
amino acid homology to β’ and β and our evidence showing ORF6 RNAP is able to bind 
an RNA:DNA hybrid to form a stable elongation complex. Immobilisation of complexes 
to streptavidin beads revealed that ORF6 RNAP contrasts to multisubunit RNAPs in that 
the non-template DNA strand reduces the stability of elongation complexes. 
Additionally, a scaffold consisting of only the template DNA strand hybridised to RNA 
was sufficient for salt stable ORF6 RNAP complexes. At present these observations 
cannot be fully explained. However, they may point towards ORF6 RNAP elongation 
complexes having unusual properties, including an alternative binding and 
organisation of nucleic acid strands. If ORF6 RNAP elongation complexes do have 
unusual characteristics, the present nucleic acid scaffolds may not be suitable for 
processive polymerisation. Whilst a scaffold with a reduced hybrid length and differing 
downstream DNA sequence did not increase ORF6 RNAP processivity, scaffolds with 
alternative conformations of the non-template DNA strand were not tested. The 
influence of the non-template DNA strand on the stability of T7 RNAP elongation 
complexes was investigated by using nucleic acid scaffolds with alternative 
conformations. This included varying the length of the non-template strand along with 
its complementarity and position on the template DNA strand (Temiakov et al., 2002). 
A similar approach may allow the elucidation of the factors influencing ORF6 RNAP 
elongation complex stability and processivity.    
Alternatively, an additional subunit may be required for efficient transcription by ORF6 
RNAP. Inspection of its amino acid sequence homology with β’ suggests ORF7p may 
provide ORF6 RNAP with a trigger loop. The fusion of the β’ and β subunit similar to 
that seen in ORF6 RNAP has been reported previously (Ruprich-Robert and Thuriaux, 
2010). However, to our knowledge, ORF7p providing a detachable trigger loop would 
be the first example of an RNAP organised in this way. ORF7p did not increase the 
activity of ORF6 RNAP, possibly due to an inability to correctly assemble into a 
functional enzyme in vitro. It was thought co-expression of the two proteins in S. 
cerevisiae would address this, as any chaperones required for co-folding or assembly 
would be present. However, our attempts to co-express ORF6 RNAP and ORF7p were 
unfruitful, as ORF7p did not co-purify during FLAG affinity chromatography of ORF6 
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RNAP. The AT rich DNA sequence of ORF7 may have prevented its expression during 
galactose induction, although this was considered unlikely due to the short length of 
ORF7.  Alternatively, a K. lactis specific chaperone or factor may be required for 
efficient assembly. However, the K. lactis killer system can be transferred and stably 
maintained in S. cerevisiae strains with deleted mitochondrial DNA (Gunge et al., 1982, 
Gunge and Sakaguchi, 1981). The maintenance of pGKL1 and pGKL2 in S. cerevisiae 
implies a protein specific to K. lactis is not required for correct ORF6 RNAP and ORF7p 
expression. Therefore this points towards a pGKL2 encoded protein being required for 
correct ORF6 RNAP/ORF7p assembly.  
Co-expression in E. coli did result in the co-purification of ORF7p with ORF6 RNAP, 
suggesting the two proteins interacted to form a complex. Above, it was proposed the 
absence of co-purification of ORF6 RNAP and ORF7p from S. cerevisiae was due to the 
requirement of a pGKL2 encoded protein. The apparent interaction of ORF6 RNAP and 
ORF7p during co-expression in bacteria undermines this hypothesis. Rather, it supports 
the alternative suggestion that the AT rich DNA sequence coding for ORF7p prevented 
its expression and subsequent co-purification in S. cerevisiae. Co-purification of ORF7p 
did not result in an increase in the catalytic activity of ORF6 RNAP. Whilst additional 
work would be required to directly show ORF6 RNAP and ORF7p are specifically 
interacting, the co-purification of ORF7p after two steps of chromatography suggests 
this to be the case.  Therefore, the poor activity of ORF6 RNAP indicates the trigger 
loop is not sufficient for transcription. Based on the assumption that the nucleic acid 
scaffolds are suitable for the investigation of ORF6 RNAP, the weak activity of ORF6 
RNAP bound to ORF7p could indicate additional proteins are required for efficient 
transcription. Besides ORF6 RNAP and ORF7p, there are at least 2 additional proteins 
encoded by pGKL2 that are predicted to function in transcription. Both ORF3p and 
ORF4p are related to the Vaccinia virus transcription machinery. Whilst ORF3p has 
been shown to possess mRNA capping activity, ORF4p is homologous to two Vaccinia 
proteins: the D6R subunit of ETF (early transcription factor) and NPH I (Larsen et al., 
1998, Tiggemann et al., 2001, Stark et al., 1990). NPH I is a single stranded DNA 
dependant ATPase with predicted helicase activity (The Vaccinia virus transcription 
machinery is reviewed in Broyles, 2003). Despite being required for transcription 
termination, NPH I has also been shown to reduce pausing of the Vaccinia virus 
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elongation complex. It has been proposed that both the capping enzyme and NPH I 
belong to the elongation complex. Additionally, both proteins belong to the Vaccinia 
virus RNAP holoenzyme that is present in Vaccinia virus virions. Applying this 
information to the ORF6 RNAP transcription system leads to the suggesyion that 
ORF3p and ORF4p belong to the ORF6 RNAP elongation complex and as such these 
proteins may be essential for efficient transcription.  
Throughout this work, our investigation into the ORF6 RNAP transcription system has 
been hindered due to technical difficulties. The propensity for the pGKL2 encoded 
proteins to form inclusion bodies, combined with AT rich DNA sequences and poor 
expression of heterologous proteins by S. cerevisiae, has prevented us from easily 
obtaining pure and soluble ORF6 RNAP required for in vitro characterisation. Future 
work will include an in vivo approach to identify additional proteins required by ORF6 
RNAP. However, this too has the potential to be technically challenging. Co-
immunoprecipitation could be used to identify additional proteins interacting with 
ORF6 RNAP. However, this technique would require the production of antibodies 
raised against ORF6 RNAP, which typically depends on large quantities of protein 
purified to homogeneity. Antibodies can be generated from protein denatured in 8M 
urea and resolved by SDS PAGE. This would allow ORF6 RNAP inclusion bodies to be 
used for the production of antibodies. The need for antibodies against ORF6 RNAP 
could be circumvented by expressing ORF6 RNAP tagged with an epitope for which 
antibodies are commercially available. This can be achieved using the plasmid shuffle 
system that was developed as a tool for the genetic manipulation of pGKL2 (Schaffrath 
and Meacock, 1996). This system has already been used to transfer the ORF6 DNA 
sequence onto pGKL1, which complemented the deletion of the native ORF6 on pGKL2 
(Schaffrath et al., 2000). It was supposed the shuffling of modified DNA could be 
exploited to introduce an epitope tag on ORF6 RNAP.  
In addition to co-immunoprecipitation, antibodies against ORF6 RNAP would make a 
range of techniques available for the investigation of ORF6 RNAP. Specifically, the 
antibodies could be used for immunofluorescence microscopy. This would allow us to 
observe the localisation of ORF6 RNAP, which may shed light on the relationship 
between the K. lactis killer plasmids and the mitochondria. Alternatively, visualisation 
183 
  
of ORF6 RNAP in vivo could be achieved through the introduction of a GFP (green 
fluorescent protein) tag using the same plasmid shuffle system described above.  
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Chapter 9: Concluding Discussion 
 
This body of work was dedicated to the characterisation of two putative novel RNAPs, 
YonO and ORF6 RNAP. Whilst we have been largely unsuccessful in our attempts to 
characterise ORF6 RNAP, we have confirmed that YonO, a hypothetical protein of the 
SPβ bacteriophage, is expressed and essential for SPβ development. RNAseq analysis 
explained this essentiality by indicating that YonO is required for the expression of the 
late genes during the development of SPβ. YonO, in stark contrast to ORF6 RNAP, was 
proficient in transcription despite not possessing any detectable catalytic domains of 
the multisubunit RNAP aside from the aspartate triad. We showed that YonO functions 
as a DNA dependant RNAP, rather than a rdRNAP as predicted bioinformatically. We 
also showed that YonO is capable of initiating transcription on double stranded DNA 
independent of accessory factors. This is in sharp contrast to multisubunit RNAPs, that 
without exception require accessory factors to recognise and melt DNA and assist in 
the initial catalysis. RNAP recognition of DNA independent of σ70 has been reported for 
the synthesis of the M13 bacteriophage DNA replication primer (Zenkin and Severinov, 
2004). However, even in this instance, σ70 was required for RNAP to pass through 
abortive initiation and into elongation. Furthermore, σ70 facilitates the binding of the 
first substrate NTP, initial catalysis and the progression into elongation (Kulbachinskiy 
and Mustaev, 2006). This and the ability to efficiently transcribe without essential 
domains of the multisubunit RNAP serve to highlight that YonO transcription is very 
unusual.  
Despite ORF6 RNAP possessing significant homology to RNAP including half of the 
conserved active centre, it was unable to perform rapid and processive polymerisation. 
Provision of ORF7p, an additional protein encoded by pGKL2 bearing similarities to the 
trigger loop, did not increase ORF6 RNAP activity. From our results alone, we cannot 
conclude if ORF6 RNAP is a functional RNAP of the K. lactis killer system, as it did not 
polymerise RNA in manner characteristic of an RNAP. However, its essentiality, 
homology and the residual DNA dependant RNAP activity we observed strongly 
suggest it is indeed an RNAP (Schaffrath and Meacock, 1996, Schaffrath et al., 2000, 
Ruprich-Robert and Thuriaux, 2010). ORF6 RNAP and ORF7p are not the sole proteins 
of the K. lactis cytoplasmic transcription machinery. ORF3p and ORF4p have been 
185 
  
shown to be transcription proteins through experimental evidence and homology, 
respectively (Larsen et al., 1998, Tiggemann et al., 2001). Four pGKL2 ORFs are unlike 
any other proteins and so remain without assigned functions. Any number of these or 
nuclear encoded proteins may stimulate the activities of ORF6 RNAP through provision 
of catalytic residues like the bacterial Gre factors, acting as a protein chaperone akin to 
the ω subunit or through an unknown mechanism. Considering a potential 
requirement for additional subunits, it may be that ORF6 RNAP is a ‘non-canonical’ 
multisubunit RNAP. Such RNAPs have been uncovered bioinformatically. ‘Non-
canonical’ multisubunit RNAPs are typically viral and have differing subunit 
organisations and various degrees of homology to the β’ and β subunits. This is 
demonstrated by the multisubunit RNAP of the insect infecting baculovirus (Ruprich-
Robert and Thuriaux, 2010). Baculovirus RNAP is comprised of four subunits, two of 
which are distantly related to Rpb1 (RNAP II homologue of β’) and Rpb2 (RNAP II 
homologue of β) through conservation of the DPBB folds whilst the remaining subunits 
are unlike any other transcription proteins. In contrast to other non-canonical 
multisubunit RNAPs, ORF6 RNAP has significant homology to both β’ and β subunits 
putting ORF6 RNAP into a stand-alone subfamily of ‘non-canonical’ RNAPs.  
YonO and ORF6 RNAP have homologues in other bacterial and yeast species, 
respectively. The closest homologues of YonO reside in other fermicutes, including 
multiple Bacillus and Clostridia species. A YonO homologue is carried on the genome of 
the Clostridium botulinum strain D-1873 bacteriophage. This bacteriophage is 
maintained as a circular plasmid during pseudolysogeny and is responsible for 
encoding powerful neurotoxins (Hwang et al., 2007). Our work infers that the YonO 
homologue encoded by this phage is also capable of accomplishing transcription and 
contributes to the development of the bacteriophage. If this is the case, then 
investigations into YonO may have medical importance given the induction of D-1873 
bacteriophage can spread toxigenicity amongst C. botulinum species (Oguma et al., 
1976). More distant homologues of YonO have been identified in cyanobacteria. 
Reflecting their relationship to YonO, these proteins have also been labelled putative 
rdRNAPs (Iyer and Aravind, 2012). However, as demonstrated by our work, this does 
not rule out DNA dependant RNA polymerisation. A number of the cyanobacterial 
YonO homologues have acquired RNase H-like domains. Given RNase H degrades RNA 
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hybridised to DNA, the presence of an RNase H-like domain conjoined to a putative 
RNAP is intriguing. Given the use of cyanobacteria for biofuel production, novel RNAPs 
may be of biotechnological value. Linear cytoplasmic plasmids have been identified 
across a wide range of yeast genera including Pichia etchellsii, Pichia acacia, Pichia 
inositovora and Saccharomyces kluyveri (Hishinuma and Hirai, 1991, Jeske and 
Meinhardt, 2006, Klassen et al., 2001). Common to all of these species is the 
maintenance of a large cytoplasmic plasmid that is closely related to pGKL2. Amino 
acid sequence alignments revealed each plasmid encodes 10 – 11 proteins which, with 
the exception of ORF1, correspond to the proteins encoded by pGKL2. As ORF6 RNAP is 
conserved, it suggests that the utilisation of a cytoplasmic transcription system is 
common amongst yeast species harbouring linear cytoplasmic plasmids.  
Given the presence of homologues across a wide range of organisms, YonO and ORF6 
RNAP can be viewed as representatives for two new groups of RNAPs. In particular, our 
work confirming the RNAP activity of YonO can be used as a starting point for a new 
field of investigations into one of this new group of RNAPs. In this regard YonO is 
similar to T7 RNAP. T7 RNAP represents a whole family of nucleic acid polymerases 
including bacterial RNAPs, mitochondrial RNAP and DNAP I. The discoveries made from 
its investigation have shed light on the biology of a whole family of enzymes. An 
additional parallel which can be drawn between YonO and T7 RNAP is at the time of its 
discovery, T7 RNAP was also a novel RNAP encoded by a bacteriophage. The discovery 
and subsequent characterisation of T7 RNAP has greatly increased our understanding 
of transcription, with T7 RNAP still being investigated after 40 years of research. 
Furthermore, the understanding of the T7 RNAP transcription system led to the 
development of T7 RNAP based overexpression of recombinant proteins in E. coli. By 
providing a method of obtaining large quantities of RNA or protein, T7 RNAP 
overexpression has revolutionised molecular biology. According to the parallels 
running between YonO and T7 RNAP, the characterisation of YonO also has the 
potential to, whilst advancing our understanding of fundamental mechanisms of 
transcription, open up a new area of research. Depending on the outcomes of future 
investigations, such as a direct comparison between the expression levels of YonO and 
T7 RNAP, YonO could also be exploited for use as an alternative system for the 
overexpression of recombinant proteins.   
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